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The regulatory (R) subunit of Protein Kinase A (PKA) serves to modulate the 
activity of PKA in a cAMP-dependent manner and exists in two distinct and structurally 
dissimilar, endpoint cAMP-bound 'B' and C-subunit-bound 'H'-conformations. Here we 
report mechanistic details of cAMP action as yet unknown through a unique approach 
combining X-ray crystallography with structural proteomics approaches- amide 
hydrogen/deuterium exchange and ion mobility mass spectrometry, applied to the study 
of a stereospecific cAMP phosphorothioate analog and antagonist((Rp)-cAMPS). X-ray 
crystallography shows cAMP-bound R-subunit in the ‘B’ form but surprisingly the 
antagonist Rp-cAMPS-bound R-subunit crystallized in the ‘H’ conformation which was 
previously assumed to be induced only by C-subunit-binding. Apo R-subunit crystallized 
in the ‘B’ form as well but HDX mass spectrometry showed large differences between 
apo, agonist and antagonist-bound states of the R-subunit. Further ion mobility reveals the 
apo R-subunit as an ensemble of multiple conformations with collisional cross-sectional 
areas (CCS) spanning both the agonist- and antagonist-bound states. Thus contrary to 
earlier studies which explained the basis for cAMP action through 'induced fit' alone, we 
report evidence for conformational selection, where the ligand-free apo form of the R-
subunit exists as an ensemble of both 'B' and 'H' conformations. While cAMP 
preferentially binds the 'B' conformation, Rp-cAMPS interestingly binds the 'H' 
conformation. This reveals the unique importance of the equatorial oxygen of the cyclic 
phosphate in mediating conformational transitions from 'H' to 'B' forms highlighting a 
novel approach for rational structure-based drug design. Ideal inhibitors such as Rp-
cAMPS are those that preferentially 'select' inactive conformations of target proteins by 
 
x 
satisfying all 'binding' constraints alone without inducing conformational changes 
necessary for activation. 
We extended our study to a larger construct of PKA R-subunit containing both 
CNB domains. Our study reports the stepwise process governing cAMP-dependent 
activation of Protein Kinase A (PKA). In the absence of cAMP, PKA exists in an inactive 
complex of catalytic (C) and regulatory (R) subunits. cAMP binding induces large 
conformational changes within the R-subunit leading to dissociation of the active C-
subunit. Although crystal structures of end-point, inactive and active states are available, 
the molecular basis for cooperativity in cAMP-dependent activation of PKA is not clear. 
In this study we report application of amide hydrogen/deuterium exchange mass 
spectrometry on tracking the stepwise cAMP-induced conformational changes using a 
single point mutant (R209K) at the cyclic nucleotide binding domain (CNB)-A site. Our 
HDX results reveal that binding of one molecule of cAMP increases HDX in important 
regions within the second CNB-B domain. Increased exchange was also seen at the 
interface between CNB-B and the C-subunit suggesting weakening of the R:C interface 
without dissociation. Importantly, binding of the first molecule of cAMP greatly increases 
the conformational mobility/dynamics of two key regions coupling the two CNBs, the 
"C/C$:A and "A:B helix. We believe that the enhanced dynamics of these regions forms 
the basis for the positive cooperativity in the cAMP-dependent activation of PKA. In 
summary, our results reveal the close allosteric coupling between CNB-A and CNB-B 
with the C-subunit providing important molecular insights into the function of CNB-B 
domain. 
With our expertise on the cAMP-binding domain, we sought to extend our 
analysis to a prokaryotic CNB domain. In prokaryotic pathogens, cAMP mediates 
 
xi 
virulence in addition to the physiological process. Mycobacterium tuberculosis is among 
those pathogens in which a burst of cAMP accompanies macrophage infection. Recently, 
a unique cAMP regulated lysine acetyltransferase MSMEG_5458 was identified in 
M.smegmatics this CNB domain is fused with GNAT-like protein acetyltransferase In the 
current study, we have monitored the conformational changes that occur upon cAMP 
binding to the CNB domain in these proteins, using a combination of bioluminescence 
resonance energy transfer (BRET) and amide hydrogen/deuterium exchange mass 
spectrometry (HDXMS). Coupled with mutational analyses, our studies reveal the critical 
role of the linker region (positioned between the CNB domain and the acetytransferase 
domain) in allosteric coupling of cAMP binding to activation of acetytransferase catalysis. 
Importantly, major differences in conformational change upon cAMP binding were 
accompanied by stabilization of the CNB and linker domain alone. This is in contrast to 
other cAMP binding proteins, where cyclic nucleotide- binding has been shown to 
involve elaborate allosteric relays. Finally, this powerful convergence of results from 
BRET and HDXMS reaffirms the power of solution biophysical tools in unraveling 
mechanistic bases of regulation of proteins, in the absence of high resolution structural 
information. 
 We extended our study to another cyclic nucleotide binding domain called GAF 
domain that is distinct from CNB domain in both structure and amino acid sequence. 
GAF domains are small molecule binding regulatory domains present in both prokaryotes 
and eukaryotes. Cyclic nucleotide binding N-terminal GAF domains in mammalian 
phosphodiesterases (PDE) and cyanobacterial adenylylcyclases (AC) regulates their 
activity in a cAMP dependent manner. Interestingly, even though differences in the mode 
of dimerization (parallel and antiparallel) and ligand occupancy (single and double) 
 
xii 
between PDE and AC GAF domains are known from their crystal structures, the GAF 
domains from PDE can functionally substitute for the tandem GAF of AC CyaB1 for 
altered specificity. However, the converse experiment in which amino acids in the PDE2 
GAF domain were replaced with those from CyaB1 did not lead to altered specificity. In 
addition, the basis for the nucleotide specificity is not yet known. In our study, we have 
monitored structural dynamics of cyclic nucleotide mediated GAF domains using amide 
hydrogen/deuterium exchange in presence of both cAMP and cGMP. Our results imply 
that binding of a ligand leads to high rearrangements in secondary structural elements of 
the protein, which lead to a conformational change from ‘open’ to ‘close’. Our 
experiments with cAMP and cGMP ligand bound states and comparison of these states 
with apo protein elucidated that the extent of closed or compact conformation attained by 
binding of ligands is huge in cGMP bound state rather than CyaB2 GAF domain 
‘preferred’ cAMP bound state.  In summary, our results reveal that cAMP and cGMP 
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3.1 Monitoring conformational changes in KATms by BRET. A) 
Cartoon representation of the construct of KATms used for BRET. 
Full length KATms (residues 1_333) is sandwiched between GFP 
and luciferase (Luc). AT, acetyltransferase domain. B) Lysates were 
prepared from HEK293T cells expressing the KATms construct and 
BRET measured in the presence of cAMP (1 mM), acetyl CoA (50 
µM) USP (1 µM), Rp_cAMPS (1 mM) or Sp_ cAMPS (1 mM) as 
indicated. Basal represents the ratio observed of lysates taken 
directly for measurements. C) Varying concentrations of cAMP 
were added to lysates from cells expressing the KATms construct 
and the BRET ratio measured. D) Constructs expressing either wild 
type or mutant KATms as indicated were transfected into HEK293T 
cells and lysates prepared. Aliquots were taken for BRET 
measurements. Data shown in all experiments represent the mean ± 
SEM of duplicate determinations with assays repeated thrice. 
96 
   3.2 Sequence coverage map for KATms protein. Amino acid sequence 
of KATms (1 – 333) from N- to C-terminal. Solid line represents 
the pepsin digest fragments analyzed by semi automated HX-
express.  
97 
3.3 HDXMS of KATms in the presence and absence of cAMP. A) 
Butterfly plot showing the average relative fractional exchange 
(deuterons exchanged/maximum exchangeable amides) (y-axis) for 
all the pepsin digest fragments of KATms listed from N- to C-
terminus (x-axis) for Apo (top) and cAMP-bound (bottom).  Each 
trace represents a time point for deuterium exchange 1 min 
(orange), 2 min (brown), 5 min (blue), 10 min (black), and represent 
the results from two independent experiments. B) Difference plot 
highlighting changes in deuterium exchange upon cAMP binding. 
Color scheme for traces are the same as in A. Two blue color boxes 




decreased exchange upon cAMP binding. Domain organization of 
KATms, N-terminal, CNB and C-terminal lysine acetyltransferase 
domain (GNAT) linked by a putative interdomain linker is shown as 
an inset. 
3.4 Mass spectra of representative peptides analyzed in HDXMS.  A) 
ESI-Q-TOF mass spectra for 3 pepsin digest-fragments of KATms, 
showing significant differences in deuterium exchange upon 
cAMP/Sp-cAMPS binding. Comparison in the apo, ligand bound 
states following 10 min deuterium exchange. (i) Isotopic envelope 
for peptide in apo KATms; (ii) Isotopic envelope for peptide in Rp-
cAMPS-bound KATms; (iii) Isotopic envelope for peptide in Sp-
cAMPS-bound; (iv) Isotopic envelope in cAMP-bound KATms; (v) 
Undeuterated sample. Mass spectra for pepsin fragment peptides 
shown are KATms (90-115) m/z = 928.164, z=3; KATms (56-76) 
m/z = 1079.11, z = 2, and KATms (153-173) m/z = 757.74, z = 3. 
B) Kinetic plots of deuterium exchange for the 3 peptides above: 
Apo KATms, open circle (o); cAMP-bound, (%); Sp-cAMPS-
bound, (!); Rp-cAMPS-bound (&). 
102 
3.5 Conformational changes in the CNB domain of PKA and KATms.  
A) Structure of cAMP-bound CNB-A of PKA R-subunit (PDB ID: 
1RGS (Su et al., 1995)) highlighting in blue the regions showing 
decreased deuterium exchange in the presence of cAMP. Residues 
Glu 200 and Arg 209 coordinate binding to the ribose 2'-OH, and 
the equatorial and axial oxygen atoms of cAMP are displayed in 
sticks. Arrow A highlights the Arg 209- equatorial oxygen- Asp 170 
allosteric relay in PKA RIa. Arrow B highlights the hydrophobic 
switch mediated by Leu 203 and Ile 204 with a:B/C helices. B) 
CNB domain of KATms was modeled in the SWISS MODEL 
automated server using structural coordinates of PKA RIa (PDB 
ID:1RGS) as a template. cAMP-bound KATms CNB domain model 




exchange in the presence of cAMP. 
3.6 HDXMS of KATms in the presence of Sp-cAMPS or Rp-cAMPS. 
A) Butterfly plot showing the average relative fractional exchange 
(Deuterons exchanged/Maximum exchangeable amides) (y-axis) for 
all the pepsin digest-fragments of KATms listed from N- to C-
terminus (x-axis) for Rp-cAMPS-bound (top) and Sp-cAMPS-
bound (bottom); each trace represents a time point for deuterium 
exchange 1 min (orange), 2 min (brown), 5 min (blue), 10 min 
(black). These data represent the results from two independent 
experiments. B) Difference plot localizing changes in deuterium 
exchange between cAMP analogs Rp-cAMPS and Sp-cAMPS. 
Color scheme for plots same as in A. Two blue color boxes with 
dashed lines highlight the regions of the protein showing decreased 
exchange in presence of Sp-cAMPS binding. Domain organization 
of KATms, N-terminal, CNB and C-terminal acetyltransferase 
domains connected by a linker region is shown as an inset. 
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3.7 Allostery in KATms mediated via the linker region. A) KATms was 
incubated with varying concentrations of acetyl CoA, either in the 
presence or absence of cAMP.  Western blot analysis of the samples 
was performed using acetyl lysine antibody and densitometric 
analysis of immunoreactive bands was analyzed as detailed in 
experimental procedures.  The data shown represents the mean ± 
SEM of assays performed thrice.  B) Varying concentrations of 
USP were used in an acetylation reaction using KATms either in the 
presence or absence of cAMP.  Samples were subjected to western 
blot analysis using an acetyl lysine antibody. The blot shown is 
representative of assays performed thrice and demonstrates that in 
the presence of cAMP, lower concentration of USP can be 
acetylated more efficiently. C) A construct of the CNB and the 
linker domain fused at the N-terminus to GFP and the C-terminus to 




prepared and BRET measured in the presence of varying 
concentrations of cAMP. Values represent the mean ± SEM of 
assays repeated in duplicate at least thrice. 
3.8 Identification of critical residues in the linker region that mediate 
cAMP-induced activation of KATms. A) KATmsP157,160A was 
purified and incubated with 3H-cAMP in the presence of varying 
concentrations of cAMP as indicated.  Radioactivity associated with 
the protein was monitored following filtration through 
nitrocellulose filters.  Values shown represent the mean ± SEM of 
assays repeated thrice. B) Wild type or mutant KATms was 
incubated with either cAMP, Rp-cAMPS or Sp-cAMPS or buffer 
alone in the presence of acetyl CoA and USP and then subjected to 
western blot analysis with acetyl lysine antibody (Nambi et al., 
2010).  Following blotting, the membrane was stained with 
Coomassie stain to visualize equivalent amounts of USP in the 
lanes. Data shown is representative of a blot repeated thrice. C) 
Continuous acetylation assays were performed with either wild type 
or mutant KATms in the absence or presence of either cAMP, Sp-
cAMPS or Rp-cAMPS (Nambi et al., 2010).  The kinetic traces are 
shown in Supplemental Figure 3 and the fold increase in rate over 
that seen in the absence of cAMP is represented.  The data shown is 
the mean ± SEM of assays repeated thrice. 
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3.9 Acetyltransferase activities of wild type and KATmsP157,160A 
proteins. Activities were measured using the coupled assay . 
Proteins (1 µg each) were assayed in the presence of 30 µM acetyl-
CoA and 50 µM USP. The initial rate of formation of NADH is 
shown, after subtracting the change in absorbance at 340 nm that is 
seen in assays performed in the absence of the enzymes, which was 
usually ~ 1% of the change seen in the presence of enzyme. 
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3.10 Conserved mechanism of allosteric activation of KATmt by cAMP. 




(KATms). Shown in green are residues in the CNB domain.  
Residues highlighted in yellow indicate regions that showed 
maximum differences in HDXMS in the presence of cAMP which 
are found in the linker region.  Residues highlighted in pink 
represent the acetyltransferase domain.  Arrow head point to the 
conserved proline residues that were mutated in KATms and 
KATmt in this study. B) Pro residues at 160 and 163 were mutated 
to Ala in KATmt and the purified protein was interacted with 3H-
cAMP in the presence and absence of varying concentrations of 
unlabelled cAMP.  Radioactivity bound to the protein was 
monitored following filtration through nitrocellulose filters, and 
data obtained was analyzed by GraphPad Prism. Data shown 
represents the mean ± SEM of triplicate experiments. C) Either wild 
type or mutant KATmt was incubated with USP and acetyl CoA, in 
the presence or absence of cAMP.  Samples were then subjected to 
western blotting with the acetyl lysine antibody.  Following 
blotting, the gel was stained with Coomassie to detect USP. 
3.11 Prediction of secondary structure in KATms using NetSurfP. 
Residues mutated in this study (P157 and P160) fall between two 
regions that are predicted to be a-helices 
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4.1 Sequence coverage map of GAF-B domain.  127 
4.2 A) ESI-QTOF mass spectra for two different pepsin digest 
fragments of GAF-B domain, which showed significant difference 
upon cAMP/cGMP binding. B) Time course (0.5-10min) of 
deuterium exchange for peptides [(318-331) and (344-366)].  
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4.3 Structure of cAMP bound GAF-B domain highlighting the regions 
showing reduction in deuterium exchange (blue) in the presence of 
cAMP. 
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4.4 Structure of cAMP bound GAF-B domain highlighting the regions 





List of abbreviations 
Å: angstrom (10-10 m) 
ATP: Adenosine triphosphate 
BME: !- Mercaptoethanol 
CHES: N-Cyclohexyl-2-aminoethanesulfonic acid 
cAMP: Cyclic adenosine 3’, 5’- monophosphate 
 cGMP: Cyclic guanosine 3’, 5’- monophosphate  
DTT: Dithiothreitol 
E.coli :Escherichia Coli 
EDTA: ethylenediaminetetraacetic acid  
EGTA: ethylene glycol tetraacetic acid  
ESI QTOF: Electrospray ionization Quadrupole Time-of-flight  
IPTG : Isopropyl thio-galactoside 
LB: Luria-Bertani 
MALDI-TOF: Matrix Aisted Laser Desorption-Time of Flight 
MES: 2-(N-morpholino) ethanesulfonic acid  
MOPS: 3-(N-morpholino) propanesulfonic acid 
MS: Mass spectrometry 
MW: Molecular weight 
NMR : Nuclear magnetic resonance 
PKA: cAMP-dependent protein kinase, Protein Kinase A 
PEG: Polyethylene glycol 
R: regulatory subunit of cAMP-dependent protein kinase 
 
xxiv 
rmsd: Root mean square deviation 
rpm : Rotation per minute 
TFA: Trifluoroacetic acid 
WT: Wild-type 
KATms: MSMEG_5458 
BRET: Bioluminescence resonance energy transfer 
AMINO ACIDS 
 
Ala (A)  alanine 
Arg (R)   arginine 
Asn (N)   asparagine 
Asp (D)   aspartic acid 
Cys (C)   cysteine 
Gln (Q)   glutamine 
Glu (E)   glutamic acid 
Gly (G)   glycine 
His (H)   histidine 
Ile (I)              isoleucine 
Leu (L)             leucine 
Lys (K)             lysine 
Met (M)            methionine 
Phe (F)              phenylalanine 
Pro (P)              proline 
Ser (S)              serine 
Thr (T)             threonine 
Trp (W)            tryptophan 
Tyr (Y)             tyrosine 
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Cyclic nucleotides in biology: 
Cyclic nucleotides play a crucial role in both prokaryotes and eukaryotes. 3`5`-cyclic 
nucleotide mono phosphate (cNMP) mediated signal transduction is one of the most 
critical second messenger dependent pathways that generate intracellular responses to 
extra cellular signals (Rehmann et al., 2007). Two main classes of cNMPs that play key 
role in most of the second messenger mediated signaling include, 3` 5` - cyclic adenosine 
monophosphate (cAMP) and 3` 5` - cyclic guanosine monophosphate (cGMP) (Scott, 
1991). Two distinct classes of enzymes involved in metabolism of these cyclic 
nucleotides, adenylyl/guanylyl cyclases (ACs/GCs) which produce cNMPs and 
phosphodiesterases (PDEs) which catalyzes the break down of cNMPs. Fluctuations in 
the levels of cNMPs are associated with many diseases. cAMP mediates its effect by 
binding to an effector module as an allosteric regulator and are important for multiple 
cellular processes like gene expression, cell proliferation, differentiation, chemotaxis, 
apoptosis, and metabolism (Johnson et al., 2001a) (Doskeland et al., 1993). The cyclic 
nucleotide binding (CNB) domain is an ancient motif that appears to have co-evolved as 
the primary receptor for cAMP and cGMP (Canaves and Taylor, 2002). CNBs function 
as regulatory modules in different classes of proteins, such as catabolite activator protein 
(CAP), cyclic nucleotide gated channels (HCN) (Kaupp and Seifert, 2002), and Guanine-
nucleotide-exchange factors, where effector protein activity is controlled by cAMP 






CNB domains are mostly associated with diverse functional domains/subunits, whose 
functions are regulated through diverse cellular signals in cAMP dependent manner 
(Figure i). The key structural element in CNBs where cAMP is stabilized by conserved 
network of interactions with the protein is called phosphate binding cassette (PBC) 
(Diller et al., 2001). The structural biology of CNBs reveals a highly conserved 
architecture with two subdomains: a !-subdomain with an eight stranded !-sheet, 
containing a solvent shielded pocket for cAMP binding and a non-contiguous "-
subdomain. Unlike !-subdomain, the "-subdomain is variable both in sequence and in 
architecture and is a site for interacting proteins.  
In eukaryotes, CNBs function as regulatory modules in different classes of 
proteins, i) cAMP dependent protein kinase (PKA) which mediates various cellular 
processes through serine/threonine phosphorylation of target substrate (Gill and Garren, 
1971) (Taylor et al., 1990), ii) cyclic nucleotide gated (CNG) channels involved in 
transport function (Kaupp and Seifert, 2002), iii) guanine-nucleotide-exchange factors in 
wich effector protein/domain activity is controlled by binding of cAMP to CNB domains 
and v) Protein kinase G (PKG) (Scott, 1991). In prokaryotes, the first characterized CNB 
domain is the CAP (catabolite gene activator protein) family of transcriptional regulators 
(Weber et al., 1982) in which DNA binding helix-turn-helix (HTH) domain is covalently 
fused with CNB domain (Benoff et al., 2002). In prokaryotes, CNBs as regulatory 
domain are not just associated with transcription factor, but are also with proteins in ATP 
production, protein phosphorylation and NADH production (Kannan et al., 2007). Novel 
association of CNB domain was recently found to be with Histidine Kinases in bacterial 
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two component system and an AAA class of ATPase (Kannan et al., 2007; Neuwald et al., 
1999)(Figure i).  Divergence of CNB domains is a result of two evolutionary events those 
are association of CNB domain with wide variety of effector domains and its sequence 











Figure i: Classification and domain organization of CNB domain associated 
proteins. A) Phylogenetic tree of the 30 identified CNB domain containing families. 
Dark teal and gold represents eukaryotic and prokaryotic branches respectively. Red 
and blue dots indicate novel families in bacteria and families with non-canonical PBC 
respectively. B) Domain organization of known and novel CNB domain containing 




3`-5` cyclic nucleotide signaling pathway in eukaryotes: 
cAMP signaling is a highly conserved pathway that transduces the action of a wide 
variety of hormonal stimuli and plays a role in almost every biological process. In 
eukaryotes, ligand (hormone, neurotransmitter etc) binds and activates membrane bound 
G-Protein Coupled Receptors (GPCRs) (Figure ii). Activation of GPCR is followed by a 
conformational change within the GPCR bound heterotrimeric inactive G-protein 
complex (G-alpha, G-beta and G-gamma) that leads to the release of the G"s subunit upon 
exchanging GDP for GTP.  Modulation of downstream effectors is under control of this 
ternary complex. Particularly, G alpha protein exists into 4 subfamilies (G!s, G!i, G!q and 
G!12/13) (Hamm, 1998). Coupling of 1 or more of these subfamilies to the GPCRS will 
result in various cellular responses (Cabrera-Vera et al., 2003). Activation or inhibition of 
ACs is coupled to the binding of G"s or G"i to GPCR respectively and results in 
maintenance of cAMP synthesis in the cell (Cabrera-Vera et al., 2003). G"s bound 
activated AC catalyses the conversion of adenosine triphosphate (ATP) to cAMP. The 
primary component in this signal cascade is the PKA, which mediates most cAMP 
actions by phosphorylating down stream elements. Termination of the cAMP response is 
conferred by large super family of enzymes called phosphodieterases (Fimia and 
Sassone-Corsi, 2001) (Lugnier, 2006). cAMP specific phosphodiesterases catalyzes the 
hydrolysis of cAMP to 5`AMP. Thus, the intracellular levels of cAMP are maintained by 
both ACs and PDEs. GTPase activity within G-alpha subunit leads to the hydrolysis of 
bound GTP to GDP and causes the reassociation of G-alpha to G-beta: G-gamma 



























Figure ii: Overview of cAMP pathway. The elements of the cAMP signaling 
pathway include GPCRs, G protein complex, adenylyl cyclases (ACs) and 
phosphodiesterases (PDEs). GPCRS receives hormonal signal and undergoes a 
conformational changes which leads to a release of G"s protein from G protein 
complex and activates AC by binding to it. AC catalyze the generation of cAMP 
from ATP, PDE mediates the hydrolysis of cAMP to 5` AMP for termination of 
cAMP response.  Protein Kinase A (PKA) is the central downstream target for 
cAMP. The kinase core of PKA is the catalytic (C) subunit, which exists in an 
inactive, tetrameric complex with a homodimeric regulatory (R) subunit (R2C2, 
holoenzyme). cAMP binding to the R-subunit facilitates dissociation of the active 





cAMP dependent protein kinase (PKA): 
The major receptor for cAMP in the mammalian cell is PKA. Inactive PKA is a tetramer 
consisting of two catalytic (C) subunits bound to one homodimeric regulatory subunit (R). 
The dynamic equilibrium between active and inactive PKA is tightly controlled by levels 
of cAMP within the cell and it’s binding to the R-subunit of PKA(Johnson et al., 2001b). 
PKA belong to one of the largest gene families (kinase), accounting for 2% of the 
mammalian genome (Plowman et al., 1999). Phosphorylation by these kinases mediates 
most of cellular function, whereas abnormal phosphorylation is a cause or consequence 
of various diseases. This makes PKA as one of the most important targets for drug design 
and therapy.  
 PKA, also known as cAMP dependent protein kinase is a key regulator of many 
cellular processes such as gene expression, metabolism, cell growth, cell division, memory 
and lipolysis. In mammalian cell, based on regulatory domains, there are two subfamilies 
of PKAs namely type1 and type 2. PKA R-subunit exists as 4 R-subunit isoforms RI", 
RI!, RII" and RII!  and C-subunit exists as 3 isoforms C", C!, C( (Doskeland et al., 
1993). Imbalance between levels of expression of these isoforms leads to malignancy of 
cells (Cho-Chung and Nesterova, 2005).  
The expression and association pattern of these tissue specific isoforms are 
thought to be responsible for various cAMP mediated responses in the cell (Taylor et al., 
1990). There are two classes of physiological inhibitors of C-subunit: One is the R subunit 
which acts as receptor for cAMP to activate PKA as mentioned earlier and the other is 
heat stable protein kinase inhibitors (PKI) which exports C-subunit from nucleus by 




leading to inactivation of PKA-C subunit (Ashby and Walsh, 1972) (Ashby and Walsh, 
1973). 
Unique role of PKA type-1: 
R-subunits are modular with distinct domains mediating dimerization/docking and two 
domains containing binding sites for cAMP (two molecules cAMP bind /monomer R-
subunit). While the different isoforms of the R-subunit are similar in their domain 
organization, they differ in their subcellular localization and physiological function.  RI" 
is the most critical isoform in mammals. Of all R-subunit isoforms, RI" knockout mice 
alone are embryonically lethal with severe defects in heart development. This suggests 
that RI" is uniquely required for maintaining cAMP mediated activity of PKA and also 
its regulation (Amieux and McKnight, 2002). Further evidence for the crucial role of RI" 
in mammals has come from identification of mutations in the RI" gene in patients with 
cardiac myxomas and Carney complex. Tissues from Carney complex patients had 
unregulated PKA activity, which is in consistent with the fact that RI" is required for 
maintaining appropriate control of PKA activity, compared to other three regulatory 
subunits (Takano et al., 2009). Mutations in RI" have also been implicated in several 
other diseases such as Systemic lupus erythematosus and certain multiple endocrine 
tumor syndromes signifying the critical role that RI" plays in mammalian cAMP 
signaling (Kammer et al., 2004).  
Regulation of PKA activity: 
The C-subunit is a globular protein and consists of an N- and C-terminal lobe, which 
encloses an ATP and substrate-binding cleft. In inactive state PKA exists as a 
holoenzyme form (H-form) in which two C-subunits binds to two R-subunit dimers.  
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PKA R-subunit has structurally three important domain; N-terminal dimerization 
domain followed by pseudo substrate region to which PKA C-subunit binds and at the C-
terminal two tandem CNB domains called CNB-A and CNB-B. Each of these CNBs 
represents a conserved structural motif for cAMP binding from bacteria to human (Leon 
et al., 2000). First molecule of CNB-B domain which cooperatively facilitates binding of 
a second molecule of cAMP to CNB-A and leading to the release of the catalytic subunit. 
The CNB-B thus acts as “gatekeeper” for modulating cAMP access to domain A (Kim et 
al., 2007). The CNB-A has also been found to be part of the direct interaction site with 
PKA C-subunit. The CBD-A has been known to have a faster off-rate compared to CNB-
B for cAMP (Kim et al., 2005).  
Deletion mutagenesis combined with yeast-two hybrid screens confirmed RI-(94-
244) as the minimum fragment required to inhibit PKA-C with high potency (Huang and 
Taylor, 1998) and is the basis for our study. 
In the process of activation R-subunit undergoes large conformational changes in 
its transition from H-form to cAMP bound, B-form. One of the striking differences is the 
loss of a kink at the ("B: "C) junction. ":A, ":Xn are helices that assume a new position 








3`-5` cAMP signal transduction in prokaryotes: 
cAMP in prokaryotic pathogens not only play a role in physiological processes like 
catabolite repression, sporulation, regulation of competence, chromosomal replication, 
and secondary metabolism (Botsford and Harman, 1992) (Susstrunk et al., 1998), but also 
regulates several virulence pathways thus effecting host organism (Kaper et al., 2004) 
Figure iii: Surface and cartoon representation of RI"(91-244):C:Mg2+AMP- PNP. 
A) Electrostatic surface potential of the holoenzyme complex (left) and complex 
interface opened up to view the surface potential of individual subunits (right). Linker 
region, PBC and pseudosubstrate region/inhibitor sequence of R-subunit form 
interface with C-subunit. B) Conformational changes of RI" in the cAMP-bound and 
C-bound conformations. The pseudo substrate /inhibitory/linker region (residues 91 to 
112, in red) is disordered in the cAMP-bound conformation and ordered in the C-
bound conformation by binding to it. Residues 199 to 210, in yellow at PBC are 
stretched away from the ! barrel upon C-subunit binding. The B and C helices become 
one extended helix (gray) in the holoenzyme complex. Tyr 205 residue (yellow) at the 
tip of the PBC undergoes different orientation in C-subunit bound state. Figure 





(Ahuja et al., 2004) (Smith et al., 2004). One such organism is Mycobacterium 
tuberculosis, which is the most successful human pathogen causing tuberculosis. 
M.tuberculosis is an exceptional pathogen in the microbial world which encodes an 
unusually large number of 15 biochemically distinct adenylyl cyclases and catalyzes the 
production of cAMP from ATP (McCue et al., 2000). High Levels of cAMP 
concentration in M.tuberculosis compared with other bacteria (Padh and 
Venkitasubramanian, 1976); (Botsford, 1981) is consistent with large number of adenylyl 
cyclases. In addition to the high levels of cAMP production mycobacteria a unique 
downstream effector of cAMP like MSMEG_5458 and Rv0998. In MSMEG_5458 from 
M.smegmatis CNB domain is uniquely fused to a GNAT-like protein acetyltransferase 
domain. Previous studies have shown that acetyltransferase domain catalyzes the transfer 
of acetyl group from Acetyl-CoA to epsilon group of lysine residue of Universal stress 
protein (USP) (Nambi et al., 2010). The biological function and cAMP mediated 
mechanism of action of MSMEG_5458 and Rv0998 is not yet known. Thus, it is very 
crucial to study the mechanism underlying the cAMP production, utilization, and 
degradation in mycobacteria for identification of novel targets for developing new drugs 
(Shenoy and Visweswariah, 2006).  
 In addition to CNB domains, cyclic nucleotides also bind to one more group of 
proteins containing GAF (cGMP regulated mammalian phosphodiesterases (PDEs), 
cycnobacterial adenylyl cyclases (ACs), and a formate-hydrogen lyase transcriptional 
activator) domains. CNB domain and GAF domains are distinct from each other in both 
structure and amino acid sequence. Thus, GAF and CNB domains evolved independently 
to bind cyclic nucleotides. These GAF domains are small molecule binding proteins and 
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can bind to a variety of ligands including tetrapyrroles, formate, haeme, bilin and cyclic 
nucleotides (Anantharaman et al., 2001; Zoraghi et al., 2004). Cyclic nucleotide binding 
GAF domains associate with effector molecules such as phosphodiesterases and 
Anabaena adenylate cyclases regulating the effector domain activity in a cAMP 
dependent manner. These two classes of proteins are separated from each other by atleast 
two billion years in evolution. Chimeras generated from GAF domain of PDEs and ACs 
of CyaB1 is able to regulate the activity of CyaB1 ACs for different ligand specificity. 
Among all PDEs sequence conservation at catalytic subunit is very high compared to 
regulatory domains. For instance, the sequence similarity and architecture of the PBC 
pocket are lower among GAF domains, indicating that GAF domain specific drugs may 
have selectivity and fewer side effects than catalytic subunit derived inhibitors. Cyclic 
nucleotide binding to the GAF domain induces structural changes, which are then 
transmitted to the associated effector domain.  
Objectives 
One of the major puzzles in the field of cAMP signaling is that out of numerous cAMP 
analogs screened, only the R-enantiomers of thio-substituted cAMP analogs or 
phosphorothioates ((Rp-cAMPS and abbreviated to Rp), where the equatorial oxygen of 
cAMP is substituted with sulfur) have been observed to be antagonists of PKA (Schwede 
et al., 2000) (Dostmann and Taylor, 1991). In addition to establishing the molecular basis 
for antagonism of Rp, our results address the basis for the 1000-fold difference in affinity 
between the cAMP-bound and apo R-subunit for the C-subunit (Anand et al., 2007). In 
this study, we have used a combination of X-ray crystallography and solution mass 
spectrometry (solution phase amide H/D exchange and ion mobility mass spectrometry)  
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to describe the structure and conformational dynamics of the R-subunit by comparing the 
apo, cAMP-bound, the agonist Sp- and inverse agonist Rp-bound states. We extended 
this study to PKA R-subunit with two CNB domains in order to study the molecular basis 
for cooperativity and allosteric coupling of the two cAMP binding events with the help of 
an intermediate state in which w CNB-B domain is occupied by a single molecule of 
cAMP. In addition to the structural information obtained based on the studies of isolated 
CNB and tandem CNBs, we performed experiments to determine the activation 
mechanism of a recently discovered prokaryotic CNB domain containing MSMEG_5458 
protein. In addition we performed experiments to derive nucleotide specificity and mode 
of ligand binding of GAF domains in cyanobacteria.  
 
1) Conformational dynamics mediated by the soluble phosphate (cAMP) and C-subunit 
in ternary complex with R-subunit: structural insights into the mechanism of 
activation of PKA. 
2) To monitor the conformations of reaction intermediates and the role of CNB-B in the 
regulation of PKA using amide hydrogen/deuterium exchange mass spectrometry 
(HDX-MS). 
3) Conformational Dynamics of MSMEG_5458 by Amide H/D exchange Mass 
Spectrometry reveals the cAMP Mediated Activation. 
4) Distinct modes of binding and conformational changes induced by cAMP and cGMP  






H/D exchange mass spectrometry: 
Hydrogen/deuterium exchange mass spectrometry is one of the most widely used 
techniques for exploring protein-protein, protein-ligand, and protein-nucleic acid 
interactions. In addition to applications in interaction studies, H/D exchange (HDX) is 
also widely performed for monitoring conformational dynamics and protein folding. 
HDX method has numerous advantages over other techniques such as NMR and X-ray 
crystallography; HDX experiments require low concentration of the proteins and there 
are no size limitations on the proteins that can be studied. 
There are two types of exchangeable hydrogens present on protein, which are in 
continuous exchange with solvent environment. Out of these two types, rates of side 
chain hydrogen exchange is too fast to detect, whereas protein back bone amides 
exchange relatively slow and are amenable to study (Figure iv). Protein exposed to 
deuterium oxide lead to the incorporation of deuterium by exchange with H at the amide 
backbone.  
 
Figure iv: Representation of peptide back bone of a protein representing solvent 




 In secondary structure elements backbone amide hydrogens are involved in 
hydrogen bonding. Therefore, the exchange rates of these amide hydrogens are a 
reflection of structure dynamics and stability. The exchange of amide hydrogen is 
dependent on two factors; degree of solvent accessibility and hydrogen bonding 
(Hoofnagle et al., 2003a). Different methods of deuterium incorporation allow us to study 
different aspects of protein dynamics. There are two types of labeling experiments 
(deuterium incorporation): pulse labeling and continuous labeling (Figure v) (Deng et al., 
1999). 
Figure v: Schematic representation of hydrogen exchange mass spectrometry 
experiments. A) Pulse labeling experiment: In this method, protein is treated with 
perturbant (chemical denaturant, pH, temperature etc), unfolded region of the protein 
gets labeled with pulse of D2O (red). Deuterium exchange is quenched by reducing the 
pH and temperature. B) Continuous labeling. In this method protein is diluted in D2O 
(final Deuterium concentration is >95%). Deuteration is carried out at different time 
points and exchange is quenched by decreasing the pH and temperature. Quenched 
reaction mixture is treated with pepsin followed by injected to ESI-QTOF or MALDI. 
Figure adapted from (Wales and Engen, 2006). 
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In pulse labeling experiments, protein is treated with perturbing agent (a ligand, substrate, 
pH, or a chemical denaturant) or it is undergoing structural changes through protein 
folding before it is exposed to deuterium. In this method protein is exposed to deuterium 
for a very brief time (the pulse for mille sec). Pulse labeling experiment is widely used 
for detection and structural characterization of short-lived folding intermediates in 
kinetics. 
In continuous labeling experiments, protein is exposed to deuterium environment 
such that the final deuterium concentration is >95% and the protein is diluted. Reaction is 
carried out at room temperature, pH 7 to 8 for series of time points. Lowering the pH and 
temperature to 2.5 and 0oC respectively, quenches the deuterium exchange. Decreased pH 
and temperature causes 105 reduction in exchange rate. Global exchange or global 
conformation of the protein will be obtained by direct analysis of quenched samples with 
HPLC-ESI-MS or MALDI-MS. To achieve local changes on the protein, digesting the 
protein with pepsin followed by analysis with HPLC-ESI-MS or MALDI-MS. Pepsin is a 
non-specific acid protease and catalyzes proteolysis at desired pH 2.5.  
The level of deuterium incorporated into each peptide can be determined by 




m100% - m0% 
D =  





D is the deuterium content of a peptide with N peptide amide hydrogen’s. The centroid 
mass of a peptide at time t min is mt. Centroid mass of a peptide for H/D exchange at 
time 0 min is m0%. Centroid mass of a peptide for H/D exchange has undergone full 
exchange is m100%. 
Under physiological conditions proteins are continuously folding and unfolding. 
Amide hydrogens may exchange directly from unfolded protein or folded protein or from 
both (Hvidt and Nielsen, 1966) (Englander et al., 1979) (Woodward et al., 1982) 
(Englander and Mayne, 1992) (Clarke and Itzhaki, 1998) (Raschke and Marqusee, 1998) 
(Bahar et al., 1998).   
   
       
       
 
 
K1 and K-1 are rate constants for both folding and unfolding (Eq.1). Kint is the exchange 
rate for peptide in the random coil. Sum of exchange from the folded state (Kf) and the 
globally unfolded state (Ku) is observed exchange rate Kex.  
                                             Kex = Kf + Ku 
In the case of K_1>>Kint, EX2 kinetics is referred, in this case folding and unfolding is 













mechanism is best described as exchange at the native state, in this state single mass peak 
gradually shifts to higher mass with time(Bai et al., 1994). In contrast, in EX1 mechanism, 
two distinct mass peaks, one that is protonated and one that is largely deuterated, develop 










Ion mobility mass spectrometry: 
Ion mobility mass spectrometry is a combination of ion mobility spectrometry (IM) and 
MS. IM separates ions based on their mobility in a medium, which in turn depends on 
charge and shape of the ion. MS gives information about mass to charge ratio (m/z). Thus, 
the combination of both the techniques will assist in identifying ions based on their mass, 
as derived from MS, and the overall structure simultaneously. The basic principle behind 
Figure vi: EX1 and EX2 kinetics: A) In EX1 mechanism, two distinct mass peaks 
develop after a short period of time, one peak is protonated and the other is highly 
deuterated. B) EX2 kinetics, in this mechanism folding and unfolding is faster than 
deuterium exchnage which results in  single mass peak shifts gradually from lower mass 





IMS is, ions gets separated on the basis of its characteristic behavior in the gas phase, 
under the influence of electric field and either low vacuum or atmospheric pressure 
(Uetrecht et al., 2010). These environmental conditions will result in a specific drift 
velocity. Mobility of the ions in given condition depends on size, shape and charge. Thus, 
this gas phase electrophoretic technique can be used to analyze structural information of 
the ion. Ions with a larger apparent diameter will experience a larger collisions compared 
to ions with smaller apparent diameter, consequently the velocity of these ion through the 
drift cell is retarded. Simplicity, high sensitivity, speed of the instrument and faster 
generation of results made this instrument as a stand alone method for many decades to 




































Figure vii: Schematic representation of ion seperation through IMS. A) In 
TWIMS (travelling wave IM combined with MS) alternating phases of RF voltage are 
applied on stacked ring ion guide (top) on this travelling wave is superimposed. 
Packets of ions released and are pushed along in front of a potential wave in TWIMS. 
Ions with low mobility experience the most friction in presence of reverse gas flow 
and results in roll over the crest of the wave and exit the cell last (Uetrecht et al., 
2010). B) Chromatogram displaying ion with smaller diameter elute first (low drift 











Cyclic AMP analog blocks kinase activation by stabilizing inactive 
conformation: Conformational selection highlights a new concept in 













cAMP is an important second messenger that allows both prokaryotes and eukaryotes to 
sense cues from the environment and then translate extracellular signals into a biological 
response (Rehmann et al., 2007). In eukaryotes, one of the principal targets of cAMP is 
the cAMP-dependent protein kinase, Protein Kinase A (PKA), whose regulatory subunit 
(R-subunit) contains two tandem CNBs. In the absence of cAMP, PKA exists as an 
inactive tetrameric holoenzyme with the homodimeric R-subunits bound to two catalytic 
(C) subunits. cAMP binding to the CNBs of the R-subunits induces conformational 
changes, leading to dissociation of the C-subunit and activation of PKA  (Corbin et al., 
1988). PKA is the only known example where cAMP-dependent conformational changes 
lead to dissociation of the effector protein (C-subunit), whereas in all other CNB-
containing proteins, the consequences of cAMP removal and binding result in induced 
conformational changes without dissociation of the target domains/proteins (Berman et 
al., 2005). Of the many isoforms of the C- and R-subunits, C" and RI" are most widely 
distributed across all mammalian tissue and are the best studied isoforms of PKA 
(Amieux and McKnight, 2002). Of the two CNBs (CNB-A and CNB-B) in RI", the N-
terminal CNB-A, together with a pseudo substrate region (IS) (Poteet-Smith et al., 1997) 
and corresponding to the deletion fragment, RI"(91-244), is sufficient for mediating high-
affinity interactions with both cAMP and the C-subunit (Huang and Taylor, 1998) 
(Figure 1.1A). The most critical interaction sites for the C-subunit are localized entirely 
within this fragment (Kim et al., 2005). Although regions N-terminal to the 
pseudosubstrate site have been predicted to associate weakly with the C-subunit on the 
basis of limited proteolysis footprinting experiments (Cheng et al., 2001), there were no 
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significant differences in HDX that could be attributable to regions N-terminal to the 
pseudosubstrate site between the full-length apo RI" and RI":C (Hamuro et al., 2004) 
complexes. Furthermore comparisons of the HDX between apo and cAMP-bound RI" 
showed no differences in the N-terminal region of the protein (Hamuro et al., 2004). 
RI"(91-244) thus serves as a generic prototype for the CNB domain as well as a minimal 
model for mapping interactions with both cAMP  as well as the C-subunit, and  has been 
analyzed comprehensively in solution using amide Hydrogen/Deuterium (H/D) exchange 
mass spectrometry (Anand et al., 2002) and nuclear magnetic resonance spectroscopy 
(NMR) (Das et al., 2007). 
The structure of the PKA holoenzyme complex (Kim et al., 2005) (Kim et al., 
2007) revealed a dramatic conformational change in the R-subunit compared to the 
cAMP-bound form and was termed the ‘H-conformation’ (Figure 1.1B).  Structures of 
the CNB domain have been solved with the ligand cAMP (Diller et al., 2000) (Su et al., 
1995) and this cAMP-bound conformation has been denoted the ‘B-conformation’ 
(Figure 1.1C). A comparison of the structures of the B and H forms demonstrated for the 
first time that the CNB domain has a remarkable dynamic range in terms of the 
conformations it can assume.  This established the R-subunit as a conformational toggle 
switch between B (Diller et al., 2000) (Su et al., 1995) and H (Kim et al., 2005) 
conformational states (Figure 1.1D). The phosphate binding cassette (PBC) within the !-
subdomain reveals a conserved hydrogen bonding network, connecting residues that are 
critical for specific binding to cAMP (Berman et al., 2005). This presumably provides a 
solvent-shielded and phosphodiesterase resistant environment for cAMP. One of these 
residues is Arg 209 (in PKA, CNB-A), which is positioned with precise geometry to 
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anchor the equatorial oxygen of the critical phosphodiester bond of cAMP (Figures 1.1E, 
F). A second residue is Glu 200, which is within H-bonding distance of the 2'OH of the 
ribose moiety. Substitutions at both these residues abolish cAMP binding to the PKA R-



































































Since RI"(91-244) containing CNB-A is a versatile minimal model for examining 
cAMP as well as C-subunit interactions and conformational changes, we have used this 
double deletion construct in this study, henceforth referred to as RA. Our results reveal 
that the apo and cAMP-bound R-subunit crystallized in the B-conformation and the two 
structures are nearly superimposable. Surprisingly, the Rp-bound RA crystallized in the 
H-form, in the same conformation as the inactive RA:C holoenzyme complex (Kim et al., 
2005). Our results show that while X-ray crystallography reveals a snapshot of the apo 
RA-subunit in the ‘B’ conformation, an analysis of temperature factors, amide deuterium 
exchange measurements and collisional cross sectional areas of molecules from ion 
mobility mass spectrometry indicate that the R-subunit is highly dynamic and exists as an 
ensemble of at least two end-point B (Su et al., 1995) and H (Kim et al., 2005) 
conformations.  It is clearly evident that cAMP and a cAMP-agonist (Sp) preferentially 
recognize and bind the ‘B’ conformation, whereas the C-subunit and the cAMP-
Figure 1.1: Conformational dynamics of the PKA R-subunit and cAMP-dependent 
regulation of PKA. A) Domain organization of PKA RI". An N-terminal 
dimerization/docking domain (D/D (grey)) is followed by an inhibitory region/pseudo 
substrate region (IS, (red)) and two tandem cAMP binding domains, CNB-A and CNB-
B at the C-terminal end. A deletion mutant, RI" (74-379) (RAB) with IS, CNB-A and 
CNB-B. A smaller deletion mutant containing IS and CNB-A alone, RI" (91-244) (RA), 
is sufficient for high affinity binding to the C-subunit (7). B) Structure of the R-subunit 
in the C-subunit-bound conformation (H-conformation) (from the RA: C complex 
structure, PDB: 3FHI). The "-subdomain is in pale green and the !-subdomain is in tan. 
C) Structure of the R-subunit (bound to cAMP, PDB: 1RGS) in the B-conformation. D) 
Apo R-subunit toggles between cAMP-bound and C-subunit-bound states E) The width 
of the Phosphate Binding Cassette (PBC) pocket in the H form is 10.1Å (between the 
C" atoms of Leu 201 and Pro 208). F) The corresponding width of the PBC pocket in B 
form is 8.7 Å. cAMP binds with high affinity to the pocket with two critical and 
conserved amino acids, Glu 200 and Arg 209, which coordinate binding to the ribose 2'-
OH and the equatorial oxygen of cAMP, respectively. Asp 170, present in the !1-!2 
loop, is seen forming a salt bridge with Arg 209 which is critical for allosteric 
communication between the PBC and the C-subunit-interface. All the above figures 




antagonist (Rp) preferentially recognize and bind the ‘H’ conformation. We propose this 
represents ‘conformational selection’ in apo RI".  In contrast, interconversion of cAMP-
bound B-form and C-subunit-bound H-form likely occurs via ‘induced fit’. Our study 
provides valuable insights into the allosteric regulation of PKA by cAMP and has 
important implications for designing small molecule disruptors of protein-protein 
interactions.  
1.2 Materials and Methods 
1.2.1. Reagents 
BL21 (DE3) E. coli strains were purchased from Novagen (Madison, WI). TALON metal 
affinity resin was from Clontech laboratories (Mountain View, CA). 8-aminoethyl 
adenosine-cAMP, 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Rp-isomer, 
cAMP, cGMP and 8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp-isomer 
were from Biolog Life Science Institute (Bremen, Germany). 5'-adenylylimidodiphosphate 
 (AMP-PNP) was from Sigma-Aldrich (Singapore). Poroszyme-immobilized pepsin 
cartridge was from Applied Biosystems (Foster city, CA). Deuterium oxide (D2O) and 
protein sequence analysis grade trifluoroacetic acid (TFA) were from Fluka BioChemika 
(Buchs, Switzerland). Crystal plates, crystallization screens were from Hampton 
Research (Aliso Viejo, CA) and Jena Bioscience GmbH (Jena, Germany).  All other 
reagents were reagent grade. 
1.2.2. Expression and purification of PKA C-subunit 
The PKA C-subunit with an N-terminal hexahistidine tag was expressed in E. coli [BL21 
(DE3)] and purified using the Talon resin. Large scale expression was achieved by 
culturing bacteria at 37 ºC until mid exponential phase, followed by induction with 500 
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*M IPTG overnight at 20 ºC. Cells were harvested at 6000)g (Beckman Coulter JA-10 
rotor) for 20 min and the cell pellet was resuspended in lysis buffer [50 mM potassium 
monobasic phosphate, 20 mM Tris–HCl (pH 8.0), 100 mM NaCl, 5 mM !-
mercaptoethanol (BME), and 5 mM imidazole]. Cells were lysed by a sonicator 
(Misonix) and centrifuged at 17000)g (Sigma, Sartorius, 19776-H rotor,) at 4 ºC for 40 
min and the supernatant was incubated with talon resin at 4 ºC for 1 h. The resin was then 
transferred into columns (Bio Rad). Washes were performed with both lysis buffer and 
wash buffer (Lysis buffer, pH 7.5) followed by elution buffer containing lysis buffer with 
200 mM imidazole, pH 7.0. Further purification was achieved by size-exclusion 
chromatography [S200 column, AKTA system (GE Healthcare)].  
1.2.3. Expression and purification of PKA RA 
 PKA RA was expressed in E. coli [BL21 (DE3)] and purified using cAMP sepharose 
affinity chromatography as described earlier (Diller et al., 2000). Cells, grown upto mid-
exponential phase, were induced with 500 *M IPTG overnight at 20 ºC. Cells were 
harvested at 6000)g (Beckman Coulter JA-10 rotor) for 20 min and the cell pellet was 
resuspended in lysis buffer (20mM MES pH 6.5, 100 mM NaCl, and 2 mM EDTA) and 
lysed by sonication. Centrifugation of cell lysates was carried out at 17000)g for 40 min 
and the supernatant was precipitated with 45% ammonium sulfate. The ammonium 
sulfate precipitate was separated from supernatant by centrifugation at 6500)g for 15 min 
and resuspended in lysis buffer followed by incubation with cAMP sepharose resin 
overnight at 4 ºC. The resin was then transferred into columns and purified RA was eluted 




The protein was further purified by size-exclusion chromatography [S75 column, AKTA 
(GE Healthcare)]. 
1.2.4. Purification of PKA holoenzyme 
 RA and C-subunit in a 3:1 molar ratio were dialyzed for 16 h, against buffer containing 
10 mM MOPS (pH 7.0), 100 mM NaCl, 1 mM EGTA, 2 mM MgCl2, 1 mM DTT and 
10% glycerol using Spectra/pore 3.5 kDa molecular weight cut off membrane. The 
holoenzyme was further purified by size-exclusion chromatography (S75 column, AKTA 
FPLC system).  
1.2.5. Crystallization, data collection, structure solution and refinement, of apo RA and 
cAMP-bound RA  
PKA RA was set up for crystallization at 25 oC in hanging drops using the vapor diffusion 
method in 0.1 M sodium cacodylate trihydrate pH 6.5, and 30% w/v polyethylene glycol 
8000.   
 The crystals were transferred to a cryoprotectant solution (mother liquor containing 
20% glycerol) and flash-frozen in liquid nitrogen. X-ray diffraction data were collected at 
the Beamline 9.1 (The Stanford Synchrotron Radiation Lightsource, CA). Diffraction 
data were processed and scaled using HKL2000. The final data were integrated and 
scaled in the space group P6522 (a = b = 56.4, c = 168 Å) with satisfactory statistics 
shown in Table 1.1. Initial phases of apo RA were generated by molecular replacement 
using the A-domain (residues 113-244) (PDB code 1RGS) (Su et al., 1995) as a search 
model using AMoRe of the CCP4 program suite (1994).  There was one molecule in the 
asymmetric unit, corresponding to a solvent content of 45% (VM = 2.2 Å3/Dalton). The 
phases were improved by solvent flattening using DM. The resulting Fo map calculated 
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from the improved phases showed a well-defined electron density for RA. The model was 
rebuilt manually using Turbo-Frodo and this was followed by iterative cycles of structure 
refinement using CNS 1.2 (Brunger et al., 1998). The final refinement for each chain 
converged to R and Rfree values of 23.5% and 28.5%, respectively with good geometry 
(Table 1.1).  The final model contained residues 108 to 244 and evaluated using 
PROCHECK (Table 1.1) (Laskowski et al., 1996). Data collection and refinement for 
cAMP-bound RA were carried out as for apo RA and details are shown in Table 1.1. 
1.2.6. Crystallization, data collection, structure solution, and refinement of Rp-bound 
PKA RA 
The purified RA:C holoenzyme was concentrated to 9 mg/mL using Vivaspin 
concentrators (Sartorius Stedim Biotech GmbH, Goettingen, Germany). 2 mM AMP-PNP 
was added and incubated for 3 days to allow for intrinsic ATP hydrolysis (Herberg et al., 
1993) and complete displacement of hydrolyzed ADP, to ensure saturation with the non 
hydrolysable ATP analog (AMP-PNP). This was followed by overnight incubation with 1 
mM Rp. Integrity of the holoenzyme was confirmed by analyzing the sample by size-
exclusion chromatography (data not shown). 
 Crystal screenings were performed at room temperature with Hampton and JB 
screens by the hanging drop vapor diffusion method. Reproducible crystals were obtained 
after 3 days in the JB 6 (D6) condition (100 mM MES (pH 6.5), 2 M ammonium sulfate).   
Crystallization of PKA RA:C holoenzyme in the presence of 0.2 mM AMP-PNP and Rp  
generated crystals of RA-bound to Rp alone. In both cases there was no trace of the C-
subunit in the crystal. We again suspect the high salt in the crystallization conditions 
resulted in dissociation of the C-subunit. Prior to data collection, crystals were briefly 
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soaked in a cryoprotectant consisting of paratone and mineral oil (1:1 ratio) and flash 
frozen in liquid nitrogen. A complete dataset was collected on a Bruker Platinum 135 
CCD detector mounted on a Bruker MicrostarH X-ray generator. The dataset was 
processed and scaled using the HKL2000 program (Otwinowski and Minor, 1997) 
Matthew’s coefficient confirmed that the crystal was that of Rp-bound RA and not that of 
Rp-bound to the RA:C holoenzyme. The presence of Rp (and not cAMP or cGMP) was 
unequivocally confirmed, based on bromine density at the C8 position of Rp (Figure 1.5). 
The structure was solved by molecular replacement, using the Molrep program (1994) 
and the RA coordinates of the holoenzyme complex from the PDB file 3FHI (Kim et al., 
2005) as the search model. Interestingly, the coordinates of the holoenzyme complex 
gave better solutions than when the coordinates of cAMP-bound RAB (PDB: 1RGS) (Su 
et al., 1995) were used. Automatic model building was achieved with Arp/wARP 
(Perrakis et al., 1999) and manual adjustment was made with Tomfrodo (Jones et al., 
1991). Alternating cycles of model building and refinement, using the CNS program 
(Brunger et al., 1998), were performed until the final R-factor and R-free dropped to 
25 % and 32 % respectively. A PROCHECK analysis did not show any residue in the 
disallowed regions of the Ramachandran plot. Separately, we also set up crystallization of 
Rp-bound RA as follows.  RA was purified and concentrated to 6 mg/mL. This protein 
was incubated with 1 mM Rp and screened for crystals. JB 5 condition (20%PEG 8K, 
100 mM CHES pH 9.5) yielded crystals that we used for data collection, structure 





Table 1.1: Crystallographic data collection and refinement statistics 
Date Set        RA-Rp      apo RA                   RA-cAMP 
Space group        P3121     P6522         P3212 
Cell constants (Å)       a=66.9, c=58.8   a=56.4, c=168        a=62.64, c=158.2  
Wavelength (Å)      1.5418    1.00           1.00 
Average redundancy      20.2 (15.1)     4.4 (3.1)          6.6 (6.7) 
Completeness (%)      99.9 (99.9)     94.4 (95.0)          99.4 (100)  
<I>/<#I>       30.55 (4.31)              23.6 (10.3)         16.8 (3.1)  
Rsym$ (%)       7.5 (31.9)      7.4 (26)          5.7 (48.8) 
Refinement 
Resolution range (Å)       50-2.3     50-2.7          22.3-1.5 
Number of reflection       6646 (390)     4160 (455)          54558 (2772) 
(Working/free) 
R.m.s. 
Bond lengths (Å)        0.006     0.007           0.006 
Angles (°)        1.2      1.4            1.317  
Rwork|| (%)/Rfree¶ (%)        24/32     23.5/28.5           15/18   
 
 
$Rsym = %h%i|I(h) - I(h)i|I%h%i I(h)i, where I(h) is the mean intensity after rejections.  
§Numbers in parentheses correspond to the highest resolution shell of data, which was 
2.75 to 2.7 Å for RA-Apo, 2.4 to 2.3 Å for RA-Rp and 1.53 to 1.5 Å for RA-cAMP.  
 || Rwork = %h||Fobs(h)| -|Fcalc(h)||I%h|Fobs(h)|; no I/# cutoff was used during refinement.  
¶ 10.0% of the truncated data set (reflections) was excluded from refinement to calculate 







1.2.7 Amide hydrogen/deuterium (H/D) exchange mass spectrometry  
Apo RA was concentrated to 50 *M using Vivaspin concentrators (Sartorius Stedim 
Biotech GmbH, Goettingen, Germany). Samples were prepared by adding 1 mM cAMP, 
Rp and Sp each to 50 *M apo RA protein. 2 *L each of apo, cAMP-, Rp- and Sp-RA in 
buffer (50 mM MES, 200 mM NaCl, 2 mM EDTA, 1 mM DTT) were diluted with 18 *L 
D2O (99.9%) to yield a final concentration of 90% D2O. Exchange was carried out at 20 
ºC for various time points (0.5, 1, 2, 5 and 10 min). The exchange reaction was quenched 
by adding 40 µL of pre-chilled 0.1% TFA to get a final pH read of 2.5. 50 µL of the 
quenched sample (~ 130 pmol protein sample) was then injected on to a chilled 
nanoUPLC sample manager (beta test version, Waters, Milford, MA) as previously 
described (Wales et al., 2008). The sample was washed through a 2.1 x 30 mm 
immobilized pepsin column (Porozyme, ABI, Foster City, CA) using 100 µL/min 0.05% 
formic acid in water.  Digested peptides were trapped on a 2.1 x 5 mm C18 trap 
(ACQUITY BEH C18 VanGuard pre-column, 1.7 µm resin, Waters, Milford, MA). The 
peptides were eluted using an 8-40% gradient of acetonitrile in 0.1% formic acid at 40 
µL/min, which was supplied by a nanoACQUITY Binary Solvent Manager onto a reverse 
phase column (Acquity UPLC BEH C18 column, 1.0 x 100 mm, 1.7 µm, Waters, Milford, 
MA). Peptides were detected and mass was measured on a Synapt HDMS mass 
spectrometer (Waters, Manchester, UK) acquiring in the MSE mode, a non-biased, non-
selective CID method (Bateman et al., 2002; Li et al., 2009; Shen et al., 2009; Silva et al., 
2005). 
 Sequence identifications were made from MSE data from undeuterated samples 
using ProteinLynx Global Server 2.4 (beta test version) (Waters, Milford, MA) (Li et al., 
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2009) (Geromanos et al., 2009) and searched against sequence of RA with no enzyme 
specified and no modifications of amino acids. Identifications were only considered if 
they appeared at least twice out of three replicate runs.  The precursor ion mass tolerance 
was set at < 10 ppm and fragment ion tolerance was set at < 20 ppm. Only those peptides 
that satisfied the above criteria through Database search pass 1 were selected and are 
listed in Table 1.4 (Li et al., 2009). The default criteria for false positive identification 
(Value= 4) was applied. A decoy database containing the reverse sequence of RA was 
created. No peptide identifications were found to be assigned to the decoy sequence and 
that of the C-subunit of PKA when the above default parameter for false positive 
identifications was applied. Increasing this parameter increased the number of 
identifications seen for the decoy sequence underscoring the stringency of sequence 
identifications with the default parameter setting. It should be noted that MSE does not 
produce quadrupole isolated MS/MS spectra, and hence they are not optimal for 
submission to traditional search engines. Therefore to further confirm the identity of the 
pepsin fragments, we also carried out independent Data Dependent Analysis (DDA) of an 
undeuterated sample of RA. The MS/MS files generated were converted to .pkl files and 
searched against the RA sequence along with the decoy sequence used above with the 
Mascot search program (v2.1.0). A total of 14 peptide identifications corresponding to 
MOWSE scores + 20 are listed in Table 1.2. This threshold MOWSE score was chosen 
because ions with scores of 12 and below also appeared in the decoy sequence. These 
results showed that MSE data searched with PLGS 2.4 maximized identification of 















These identifications were mapped to subsequent deuteration experiments using 
prototype custom software (HDX browser, Waters, Milford).  Data on each individual 
peptide at all time points were extracted using this software, and exported to HX-Express 
(Weis et al., 2006) for analysis. A total number of 37 peptide fragments yielded primary 
sequence coverage of 93%. 
 Continuous instrument calibration was carried out with Glu-Fibrinogen peptide 
(GFP) at 100 fmol/µL. We also visually analyzed the data to ensure only well-resolved 
peptide isotopic envelopes were subjected to quantitative analysis. The lowest signal to 
noise ratio among all analyzed peptides was four. A control experiment was carried out to 
Residue Number Peptide m/z  Ion Score 
101-107 AEVYTEE 840.36 54 
102-107 EVYTEE 769.32 20 
112-127 YVRKVIPKDYKTMAAL 632.7 67 
136-148 FSHLDDNERSDIF 797.86 60 
149-156 DAMFPVSF 913.42 35 
150-156 AMFPVSF 798.39 29 
156-171 FIAGETVIQQGDEGDN 846.89 39 
157-171 IAGETVIQQGDEGDN 773.35 85 
157-172 IAGETVIQQGDEGDNF 846.89 52 
161-172 TVIQQGDEGDNF 661.8 59 
181-187 DVYVNNE 852.37 30 
189-198 ATSVGEGGSF 911.4 43 
201-212 ALIYGTPRAAT 567.32 28 
204-221 IYGTPRAATVKAKTNVKL 644.39 59 
Table 1.2: Subset of off line pepsin digest fragments of RI" (91-244) analyzed by DDA 
method followed by database search using MASCOT. Peptides having Ion score more 




calculate the deuterium back exchange loss during the experiment by incubating ligand-
free RA with deuterated buffer A for 24 h at room temperature. All reported deuterium 
exchange values were corrected for a 32.7% back exchange by multiplying the raw 
centroid values by a multiplication factor of 1.49 (Anand et al., 2010). 
1.2.8. Gas phase protein structure measurement by ion mobility mass spectrometry    
Gas phase measurements of Collisional Cross Sections (CCS) were conducted on a 
SYNAPT HDMS Mass Spectrometer (Waters, Manchester, UK). Ion mobility 
measurements were carried out on native conformations using a travelling wave ion 
mobility method as described (Ruotolo et al., 2005). Briefly, samples were infused from a 
solution (0.3 mg/mL in 200 mM ammonium acetate, pH 7.2) of apo, cAMP- and Rp-
bound RI"(91-379) (henceforth referred to as RAB) (cAMP, Rp at 1 mM final 
concentrations) into the source region using borosilicate glass nano-electrospray tips 
(Waters, Manchester, UK). Operating and separation voltages were optimized for the 
experiment, ensuring that no measureable loss of conformation was produced from the 
instrument (data not shown). CCS measurements and calibration were carried out using 
Driftscope 2.1 (Waters, Manchester, UK) working with a modified version of an existing 
protocol (Ruotolo et al., 2008) by infusing 0.2 mg/mL myoglobin in a 50% methanol 
solution containing 0.1% formic acid, in reference to previously published CCS values 
(http://www.indiana.edu/~clemmer/Research/research.htm). 
 For comparison, coordinates from Protein Data Bank (PDB) files for apo and  
protein conformations, based on X-ray crystallography data were used to generate 
theoretical CCS measurements using the open source code MOBCAL (Mesleh et al., 




So far, structures of several end-point conformations of RI" have been solved by X-ray 
crystallography. These include structures of cAMP-bound RAB (Su et al., 1995), C-
subunit-bound RA(Kim et al., 2005), and C-subunit-bound RAB(Kim et al., 2007). These 
structures have provided molecular insights into the cAMP binding pocket and R:C 
interface, as well as provided details of the distinct B- and H-conformational states.  
1.3.1 Structures of apo and cAMP-bound RA   
In our 2.7 Å structure, a single apo RA molecule occupies the asymmetric unit and only 
residues 108 to 243 could be traced, indicating high disorder in the N-terminal 17 
residues spanning the pseudosubstrate site, as observed in the X-ray structure of cAMP-
bound RAB (Su et al., 1995) (PDB:1RGS). Furthermore, the overall topology of the 
molecule is identical to the cAMP-bound conformation (B-form) (Figure1.2A), indicating 
that the apo protein is completely superimposable with the cAMP-bound state.  However 
the structure of apo RA is highly dynamic as it is characterized by high B-factor values 
for the main chain atoms throughout the molecule (Figure 1.2B). The structure of cAMP-
bound RA was solved using molecular replacement with cAMP-bound RAB (PDB: 1RGS) 
as the input model and this structure is highly similar to cAMP-bound RAB (Su et al., 
1995) (Figure 1.3A). The asymmetric unit of this 1.5 Å resolution structure contains two 
molecules. Interestingly, absence of the aromatic capping residue Trp 260, which is 
missing in this deletion mutant, is compensated by stacking interactions mediated by Tyr 
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Figure 1.2: Crystal structure and temperature factors of apo RA. A) Crystal structure 
of apo RA represented in ribbon diagram. N and C terminals are labeled; "-subdomain and 
!-subdomain of RA are shown in brown and tan colors respectively. B) B-factors of apo 
RA. X- and Y-axis of the above graph represents amino acid numbering from N- to C- 
terminal and B-factors respectively. B-factors of apo RA are potentially indicative of 
higher backbone flexibility throughout the molecule. The PBC (198-211) outlined by a red 










































Figure 1.3: Crystal structure and temperature factors of cAMP bound RA. A) Crystal 
structure of cAMP bound RA represented in ribbon diagram. The "-subdomain and !-
subdomain of RA are shown in brown and tan colors respectively. B) B-factors of cAMP 
bound RA.  X and Y axis represents amino acid numbering form N- to C-terminal and B-
factors for cAMP bound RA respectively. The PBC (198-211) outlined by a red box shows 
lower overall B-factors which suggests greater ordering of the molecule in the cAMP-bound 




1.3.2 Structure of RA bound to Rp  
Although the two structures of apo and cAMP-bound RA show differences in temperature 
factors (Figure 1.2B and 1.3B), there is no clear explanation to address the 1000-fold 
difference in affinity between the cAMP-bound and apo R-subunit for the C-subunit 
(Anand et al., 2007). Based on our recent report that Rp binding to RA leads to a higher 
affinity for the C-subunit (Anand et al., 2010) wherein it functions more as an inverse 
agonist, we next set out to solve the structure of the PKA holoenzyme bound to Rp, 
which would represent an intermediate in cAMP-mediated activation. Despite using a 
non-hydrolyzable ATP analog (Kim et al., 2005), the obtained crystals were those of Rp-










Dissociation of the C-subunit presumably could have resulted from the high ionic 
strength in the crystallization buffer (Corbin et al., 1975). Rp-bound RA crystallized in the 
trigonal space group P3121.  The structure was solved by molecular replacement using the 
conformation of the RA in the holoenzyme complex (Kim et al., 2005) (PDB: 3FHI). The 




identity of the Rp ligand was confirmed by electron density for bromine at the C8 








The structure of Rp-bound RA is identical to the C-subunit bound conformation 
(H-form) but not to the B-form (Figure 1.6A and 1.7A). This was entirely unexpected and 
indicated that the basis for Rp functioning as an inverse agonist for PKA was due to its 
inability to induce a conformational change from the H to the B form. To test whether Rp 
functions as an inverse agonist only upon binding to the holoenzyme (preformed H-
conformation); we crystallized apo RA bound to Rp in the absence of C-subunit. The 
structure of Rp-bound RA solved using these crystals was identical to that obtained with 
crystals of Rp-bound RA generated from cocrystallization of RA:C and Rp. These 
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Figure 1.5: Electron density map showing interactions between Rp and RA in 
stereo. The electron density, contoured at the 1.5 level, is shown for the residues at PBC 
that interact with Rp. The equatorial sulfur, axial oxygen and 2'OH group atoms of Rp 
interact with the guanidinium nitrogen of Arg 209, amide nitrogen of Ala 202 and 
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B) 
Figure 1.6: Crystal structure and temperature factors of Rp bound RA. A) Crystal 
structure of Rp bound RA represented in ribbon diagram. The "-subdomain and !-
subdomain of RA are differentiated with brown and tan colors respectively. B) B-factors 
of Rp bound RA. X and Y axis represents amino acid numbering form N- to C-terminal 
and B-factors for cAMP bound RA respectively. The PBC (198-211) outlined by a red 




1.3.3 Structural differences between Rp-bound RA and apo, cAMP- and C-subunit-
bound states 
 Superposition of the structures of Rp-bound RA with that of RA:C (Kim et al., 2005) 
shows a lower RMSD (0.910 Å) (Figure 1.7A) compared to the superposition with 
cAMP-bound RA ( ( 2.858 Å) (Figure 1.7B). This reflects that the Rp-bound RA assumes 






1.3.3.1. "-subdomain:  Rp is anchored within the PBC at the center of the !-barrel, by a 
similar network of contacts found in cAMP-bound RA (Table 1.3 and Figure 1.5). 
Distances between the sulfur of Rp and critical residues (Ala 202 and Arg 209) of the 
PBC pocket are different from those seen for the equatorial oxygen of cAMP. A 
particularly large increase in distance (~ 0.7 Å) is seen between the sulfur of Rp and the 
backbone amide nitrogen of Ala 202, a critical residue along with Arg 209 responsible 
for anchoring the cyclic phosphate of cAMP (Su et al., 1995) (Canaves et al., 2000). In 
A) B) 
Figure 1.7: Superposition of structures of RA-Rp with cAMP-bound RA and C-bound 
RA. A) RA: C (pale green) and RA:Rp (smudge green) are completely superimposable. B) 




contrast, the distances between the guanidinium moiety of Arg 209 and backbone 
carbonyl oxygen of Gly 199 are shorter, reflecting a stronger bond between these atoms 
in the Rp-bound structure.  
Table 1.3: Hydrogen bonding distances (Å) between the ligands Rp and cAMP 
bound RA. 
 
Atom1  Atom2   RA:Rp      RA:cAMP 
S1P (O1P) Arg209 NH2/NH1 3.0          3.2 
S1P (O1P) Ala202 N  3.3          2.6 
O2P Ala210 N  2.7          2.9 
O2' Gly199 N  2.6          2.7 
O2' Glu200 OE1/OE2 3.1          2.8 
ArgNH1 Gly199 O  2.8          3.5 
 
 Although, overall topologies of the PBC in the Rp-free and bound states are the 
same, a comparison of the communication networks in these structures reveal important 
differences. These are primarily seen in the PBC and !-sheets 2 and 3. Residues 161-163, 
which are part of !7 in the structure of the RA:C holoenzyme, are disordered in the 
structure of Rp-bound RA. This reflects C-subunit-induced conformational changes in the 
R-subunit. In addition to the above residues, the carbonyl group of the highly conserved 
Gly 169, which is critical for the cAMP mediated activation of PKA (Abu-Abed et al., 
2007) makes a H-bond with Arg 226 in both the Rp-bound RA and RA:C structures.  
1.3.3.2. !-subdomain: The conformationally mobile region of the "-subdomain, the 
":B/C helix region that forms part of the C-subunit-binding surface, adopts the H-




1.3.4 Amide hydrogen/deuterium (H/D) exchange mass spectrometry analysis 
 To further probe conformational dynamics of the R-subunit, we carried out HDX mass 
spectrometry experiments of apo, cAMP-, Rp -, Sp- and C-subunit bound RA. Earlier 
studies on the H/D exchange of the apo, cAMP-bound and holoenzyme states had shown 
clear evidence of allostery between the two subdomains of the protein (Anand et al., 
2002).We were interested in extending this analysis to cover the two thio-substituted 
analogs. We set out to use ESI-QTOF MS to measure the HDX, which yielded primary 











Our HDX results indicate that apo RA is a highly dynamic molecule that shows 
high rates of amide deuterium exchange across the entire molecule which directly 
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Figure 1.8: Sequence coverage map for the RA. Amino acid sequence of RI" (91-
244) showing the secondary structure elements with boundaries. Solid line denotes the 




Table 1.4). cAMP binding causes a large decrease in HDX, suggesting higher ordering of 
several residues both within the PBC as well as in peripheral regions of the molecule. A 
nearly identical effect was also observed for Sp-bound RA (Table 1.4 and Figure 1.10). 
Although Rp binding did cause greater ordering of the molecule relative to the apo 
protein, there were significant differences in exchange at multiple regions, compared to 
the cAMP/Sp-bound proteins (Table 1.4 and Figure 1.10). 
Table 1.4: Summary of amide H/D exchange for apo and ligand/C-subunit-bound 










RA RA-C Apo RA Sp-RA Rp-RA 
92-102 GCRRRGAISAE 523.79(2) 5.8 ± 0.17 2.8 ± 0.12 5.7 ± 0.07 6.0 ± 0.1 5.8 ± 0.07 
101-107 AEVYTEE 840.36(1) 4.6 ± 0.06  4.7 ± 0.02 4.5 ± 0.05 4.5 ± 0.07 
102-107 EVYTEE 769.32(1) 3.6 ± 0.03  3.6 ± 0.02 3.6 ± 0.03 3.6 ± 0.03 
112-120 YVRKVIPKD 559.34(2) 5.0 ± 0.10  5.5 ± 0.06 5.1 ± 0.10 5.4 ± 0.11 
112-126 YVRKVIPKDYKTMAA 595.00(3) 9.2 ± 0.28 9.1 ± 0.18 11.3 ± 0.23 9.6 ± 0.26 10.1 ± 0.23 
112-127 YVRKVIPKDYKTMAAL 632.70(3) 9.5 ± 0.27  11.2 ± 0.24 9.5 ± 0.52 10.3 ± 0.36 
121-126 YKTMAA 684.34(1) 3.5 ± 0.11  4.2 ± 0.06 3.7 ± 0.12 3.8 ± 0.11 
127-136 LAKAIEKNVL 549.85(2) 4.0 ± 0.10 4.0 ± 0.12 5.3 ± 0.20 4.1 ± 0.14 4.2 ± 0.12 
136-143 FSHLDDNE 488.71(2) 1.5 ± 0.09 1.4 ± 0.11 1.8 ± 0.02 1.6 ± 0.09 1.3 ± 0.13 
136-148 FSHLDDNERSDIF 797.86(2) 1.9 ± 0.10 2.1 ± 0.12 3.0 ± 0.06 1.9 ± 0.10 1.7 ± 0.09 
140-149 DDNERSDIFD 613.25(2) 1.1 ± 0.14  2.3 ± 0.12 1.1 ± 0.14 1.0 ± 0.06 
142-148 NERSDIF 440.71(1) 1.2  ± 0.44  1.7 ± 0.07 1.0 ± 0.08 1.0 ± 0.08 
143-148 ERSDIF 766.37(1) 0.5 ± 0.05 0.7 ± 0.02 0.8 ± 0.03 0.6 ± 0.03 0.5 ± 0.02 
143-150 ERSDIFDA 952.44(1) 0.7 ± 0.13 0.8 ± 0.03 1.1 ± 0.04 0.5 ± 0.05 0.6 ± 0.06 
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149-156 DAMFPVSF 913.42(1) 1.0 ± 0.03 1.0 ± 0.03 1.1 ± 0.01 0.9 ± 0.04 1.0 ± 0.02 
150-156 AMFPVSF 798.39(1) 1.0 ± 0.04 1.2 ± 0.04 1.2 ± 0.05 1.0 ± 0.04 1.0 ± 0.04 
156-171 FIAGETVIQQGDEGDN 846.89(2) 3.3 ± 0.18  6.4 ± 0.1 3.3 ± 0.2 3.7 ± 0.12 
157-171 IAGETVIQQGDEGDN 773.35(2) 3.8 ± 0.11  6.7 ± 0.09 3.7 ± 0.11 4.0 ± 0.13 
157-172 IAGETVIQQGDEGDNF 846.89(2) 3.4 ± 0.16 5.7 ± 0.19 6.1 ± 0.14 3.3 ± 0.2 3.7 ± 0.14 
160-172 ETVIQQGDEGDNF 726.32(2) 2.9 ± 0.12  5.8 ± 0.07 3.0 ± 0.11 3.2 ± 0.14 
161-172 TVIQQGDEGDNF 661.80(2) 2.8 ± 0.18 4.2 ± 0.11 5.4 ± 0.07 2.8 ± 0.24 3.2 ± 0.19 
162-172 VIQQGDEGDNF 611.28(2) 2.8 ± 0.15  5.4 ± 0.07 2.8 ± 0.11 3.1 ± 0.15 
164-172 QQGDEGDNF 1009.39(1) 2.4 ± 0.09 2.7 ± 0.11 4.6 ± 0.07 2.4 ± 0.10 2.6 ± 0.11 
169-176 GDNFYVID 942.41(1) 2.0 ± 0.09 1.9 ± 0.00 4.0 ± 0.06 2.1 ± 0.07 2.2 ± 0.06 
181-187 DVYVNNE 852.37(1) 1.4 ± 0.03 1.7 ± 0.13 2.1 ± 0.09 1.5 ± 0.03 1.5 ± 0.02 
189-198 ATSVGEGGSF 911.40(1) 3.5 ± 0.07 5.3 ± 0.14 5.7 ± 0.08 3.5 ± 0.07 3.6 ± 0.10 
198-203 FGELAL 649.36(1) 0.1 ± 0.0 1.8 ± 0.01 3.6 ± 0.0 0.1 ± 0.0 1.3 ± 0.29 
202-212 ALIYGTPRAAT 567.32(2) 1.2 ± 0.1 5.1 ± 0.21 6.6 ± 0.18 1.0 ± 0.09 2.7 ± 0.12 
202-217 ALIYGTPRAATVKAKT 554.33(2) 1.5 ± 0.16 5.4 ± 0.2 7.4 ± 0.20 1.1 ± 0.05 3.3 ± 0.10 
204-215 IYGTPRAATVKA 624.36(2) 1.0 ± 0.17  6.1 ± 0.19 0.8 ± 0.09 2.7 ± 0.11 
204-221 IYGTPRAATVKAKTNVKL 644.39(3) 2.8 ± 0.08 4.3 ± 0.2 5.6 ± 0.34 1.2 ± 0.08 2.8 ± 0.08 
205-212 YGTPRAAT 836.42(1) 1.5 ± 0.10  5.0 ± 0.09 1.0 ± 0.10 2.8 ± 0.11 
206-212 GTPRAAT 673.36(1) 0.8 ± 0.11 3.4 ± 0.14 4.7 ± 0.10 0.7 ± 0.07 2.4 ± 0.12 
222-228 WGIDRDS 424.70(2) 0.7 ± 0.07 0.9 ± 0.03 1.6 ± 0.08 1.0  ± 0.05 1.0 ± 0.04 
222-229 WGIDRDSY 506.23(2) 0.5 ± 0.04 0.9 ± 0.03 1.2 ± 0.05 0.5 ± 0.02 0.6 ± 0.02 
223-229 GIDRDSY 825.37(1) 0.5 ± 0.03  1.3 ± 0.04 0.5 ± 0.03 0.7 ± 0.02 
230-238 RRILMGSTL 523.81(2) 2.5 ± 0.09 2.3 ± 0.07 3.1 ± 0.03 2.5 ± 0.06 2.5 ± 0.07 
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Most importantly, at the PBC, decreased exchange in the cAMP- and Sp-bound 
states and intermediate exchange between the apo and cAMP-bound states was observed 
upon Rp binding (Figure 1.9B and 1.9D). Within the PBC, the apo RA and RA:C showed 
highest amide deuterium exchange, consistent with the absence of ligand whereas cAMP 
and Sp-bound proteins showed lowest exchange. Interestingly, peptides within this region 
in Rp-bound RA showed increased exchange, compared with other ligand bound proteins 
(Figure 1.9A, 1.9B and 1.9D), reflecting potentially weaker interactions of Rp with Arg 
209 and Ala 202. Subtractive analysis of the overlapping peptides showed that there were 
no significant differences at residues 203-206 as well as 213-217 between the Rp-bound 
and other ligand-bound states indicating that the most significant differences could be 
localized to peptides spanning residues Glu 200 and Ala 202 on one hand and Arg 209 
and Ala 210 on the other.  
Our results also show that amide deuterium exchange at the N-terminal 
pseudosubstrate region (92-102) of RA:C is lower than in the ligand-bound states 
(Figure1.9C), consistent with this region binding to the substrate binding cleft of the C-
subunit. It is interesting to note that the highly disordered conformation of the 
A total of 37 pepsin digest fragments were analyzed. These peptides spanned 
approximately 93% of the primary sequence of RA.  
* Non-overlapping 95% confidence intervals relative to control values determined by 
PrizmTM computer program.  
aAverage number of deuterons exchanged determined from fitting plots of the time 
course of deuteration during a 10-min exposure to deuterium oxide to a single -
exponential equation. Values reported are the mean and standard error of the 
amplitude term of fits and results from at least two independent experiments.  
bSequence identifications of pepsin-digest fragments of RA were obtained with MSE 
data searched with ProteinLynx Global Server (PLGS, v. 2.4). Peptide mass tolerance: 
10 ppm, fragment ion mass tolerance: 20 ppm with no cleavage enzyme specified and 
with no modifications. All peptides were identified in database search pass 1(Li et al., 




pseudosubstrate region and N-terminus appear to be independent of the B or H-
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 Crucial differences between the Rp-bound and cAMP/Sp-bound states are evident 
in the PBC. This is completely consistent with the differences in H-bonding distances 
seen in these residues from the crystal structures described in Table 1.3. Subtractive 
analysis of peptides further localizes the differences to two regions within PBC that show 
differences. A first region is Glu 200 and Ala 202 (1.2 additional deuterons exchanged in 
residues 199-203 in Rp:RA  compared to Sp/cAMP-bound RA) and a second region from 
207-212 which includes important residues such as Arg 209 and Ala 210 that shows 
D) 
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206 - 212                    GTPRAAT 
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Figure 1.9:  Amide H/D exchange mass spectrometry shows that apo RA is highly 
dynamic and highlights clear differences in deuterium exchange in RA between Rp 
and other ligand-bound states. A) ESI-QTOF mass spectra for a peptide spanning 
residues RA(202-212) (m/z= 567.32(2)) comparing amide exchange in the apo, ligand-
bound and C-subunit-bound states. (i) Undeuterated apo RA. (ii) The isotopic envelope for 
the same peptide from Sp-bound RA following 10 min deuteration (iii) The isotopic 
envelope for the same peptide from cAMP-bound RA following 10 min deuteration; (iv) 
The isotopic envelope for the same peptide from Rp-bound RA following 10 min 
deuteration; (v) The isotopic envelope for the same peptide from RA:C following 10 min 
deuteration; (vi) The isotopic envelope for the same peptide from apo RA following 10 
min deuteration. B) Time course of deuterium exchange at residues (202-212). Open 
circle (,), apo RA; Closed circle (%), cAMP-bound RA; Open diamond (-), RAC complex; 
closed triangle (.), Sp-bound RA; Closed Square (&), Rp-bound RA. C) Time course of 
deuterium exchange at residues 92-102. Symbols are as in 5B. D) Summary of deuterium 
exchange data for peptides spanning PBC in ligand-free and ligand-bound states. 
Overlapping nested peptides obtained greatly improve data resolution for the PBC region. 
The PBC region in RA: Rp is more dynamic when compared to all other ligand bound 




increased exchange of ~ 1.6 deuterons in Rp:RA  compared to the other ligand-bound 
states. Overall, Rp-bound RA shows significantly increased exchange across the entire 
PBC pocket reflecting a more dynamic occupancy of the PBC by Rp compared to Sp or 
cAMP.   
1.3.5 Ion mobility mass spectrometry 
Although apo RA crystallized in the B-conformation, it still did not provide mechanistic 
insight into the basis for the 1000-fold difference in binding affinity for the C-subunit 
seen between the cAMP-bound and apo states of the protein. HDX did however reveal 
that the apo state was highly dynamic and distinct from the ligand-bound states. To 
further highlight the differences in conformation between apo and ligand-bound states, 
we carried out ion mobility mass spectrometry studies to specifically probe differences in 
molecular shape between all the above states. Theoretical collisional crossectional area 
(CCS) measurements of the cAMP-bound (B-conformation) and C-subunit-bound RA (H-
conformation) from the structural coordinates of these two conformations predicted only 
small (<5% changes in CCS) changes that were below the resolution of our Synapt 
HDMS mass spectrometer. However, the changes predicted for the larger deletion 
construct encompassing both CNB-A and CNB-B, RAB, between the two conformations  
were much greater (~18%) and hence, we set out to determine experimental values for 







































Figure 1.10: Conformational selection in apo RAB revealed by ion mobility mass 
spectrometry. A) Drift time profiles (m/z versus ion drift times in milliseconds) for 
three charge state ions (z=+10, +11 and +12) for Rp-bound RAB. B) Chromatograms 
for Rp (red) and Sp-bound RAB (green). Rp and Sp-bound RAB have differences in drift 
times for the z=+11 charge state ions reflecting differences in the Collisional cross 
sectional areas (CCS) for H- and B-conformations respectively. C) Chromatogram for 
apo RAB (purple) overlaid on those of Rp-bound and Sp-bound RAB. apo RAB show an 
intermediate peak drift time with a profile indicating significant overlap with both Rp 





Three to four charge states (z= +9, +10, +11 and +12) were observed (Figure 
1.10A). A comparison of the drift times observed showed distinct differences between the 
Rp- and Sp-bound states with the Sp-bound state showing a shorter drift time indicative 
of a more compact molecule compared to the Rp-bound state. This is entirely consistent 
with theoretical CCS measurements of the B and H-conformations with the H-
conformation being larger (Figure 1.10B). Interestingly, apo RAB shows a drift time 
distribution that spans both Sp- and Rp-bound states indicating that this represents an 
ensemble of multiple conformations encompassing both the B- and H-conformational 
states (Figure 1.10C). 
1.4 Discussion 
1.4.1 Conformational selection in the R-subunit: Rp stabilizes inactive H-conformation 
Conformational dynamics forms the molecular basis for the functioning of all signaling 
proteins. The ability of regulatory proteins to toggle between multiple conformations in 
response to ligand binding, other proteins or post-translational modifications forms the 
basis for signal transduction. Recent experimental evidence has allowed postulation of a 
‘conformational selection’ hypothesis, which suggests that the ability of proteins to exist 
in ensembles of multiple conformational states is an inherent property of the protein 
(Boehr et al., 2009). This introduces an additional dimension to earlier models that 
suggested binding events with extraneous proteins or ligands or post-translational 
modifications might be solely responsible for inducing conformational changes in 
proteins.  
From our solution studies we demonstrate that the ability of the apo form of the 
R-subunit to mediate mutually exclusive high affinity interactions with cAMP or C-
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subunit depends on its ability to exist in an ensemble of multiple conformations. This has 
been demonstrated clearly in the CNB from Epac by elegant NMR experiments where it 
has been estimated that the protein existed in an 80:20 distribution of B and H-forms 
(Harper et al., 2008). While hints of such an ensemble were obtained from our 
crystallographic studies, HDX results show that the apo protein displayed the greatest 
amide deuterium exchange among all the states of the R-subunit tested. This suggested 
that the apo form of the R-subunit was conformationally highly dynamic and metastable. 
Our ion mobility mass spectrometry results show the apo R-subunit with a distinct profile 
for the collisional cross-sectional area that straddles the profiles of the cAMP-bound and 
Rp-bound states (Figure 1.10C). This provides clear evidence that the apo R-subunit is 
indeed an ensemble of multiple conformational states and encompasses the two end-point 
B and H-conformations and is completely consistent with elegant NMR experiments 
comparing dynamics of Rp and Sp-bound RA (Das and Melacini, 2007). Binding of 
cAMP or C-subunit would then occur through 'conformational selection' where cAMP, 
which is a natural ligand, specifically binds to and selects the B-conformation whereas 
the C-subunit binds preferentially to the H-conformation (1.11C). This clearly explains 
the 1000-fold difference in affinity between apo and cAMP-bound R-subunit for the C-
subunit. Thus the higher affinity of apo R-subunit for the C-subunit is entirely due to 
'conformational selection' while C-subunit binding to cAMP-bound R-subunit (B-
conformation) requires binding-induced dissociation of cAMP for stable holoenzyme 
complex formation; 'induced fit'. This is supported by the observation that Rp functions 
more as an inverse agonist rather than a cAMP antagonist in the activation of PKA 
(Anand et al., 2010). It is interesting that a single thio substitution in Rp enables it to bind 
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selectively to the H-form (Figure 1.11C) in contrast to the cAMP-favored B-form (Figure 
1.11A). This indicates that the sulfur substitution at the equatorial oxygen is uniquely 
important for determining the preferred conformation that a ligand can bind. In summary, 
apo R-subunit is uniquely poised to interact with all ligands and the C-subunit via 
conformational selection while interconversion of stable end-point conformations as seen 
in the cAMP-dependent activation of PKA holoenzyme is through induced fit (Boehr et 
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Figure 1.11. Structures of apo and cAMP-bound RA in the B-conformation and Rp-
bound RA in the H-conformation. A) Structure of apo RA in the B-conformation 
showing the helical "-subdomain in brown and &-subdomain in tan.  B) Structure of the 
cAMP-bound RA also in the B-conformation is completely superimposable with apo RA 
except for cAMP bound to the PBC pocket. C) Structure of Rp-bound RA in the H-
conformation showing the helical "-subdomain in smudge green and &-subdomain in 
tan. Structures determined independently from crystals of Rp bound to RA:C 




1.4.2 Mechanism of cAMP action and basis for antagonism of Rp  
While conformational selection describes the ability of Rp and cAMP to preferentially 
select the H-inactive and B-active conformations respectively, comparison of structures 
of the two states highlights the unique binding interactions of Rp relative to cAMP. Our 
structure of cAMP-bound RA clearly shows the important contacts between the specific 
moieties of cAMP and residues within the PBC. These provide high specificity for cAMP 
binding to the conserved PBC pocket (Canaves and Taylor, 2002) (Su et al., 1995). The 
important contacts include the anchoring of the 2'OH by both the side chain of Glu 200 
and the backbone nitrogen of Gly 199. The axial oxygen of cAMP is anchored by a single 
contact with the backbone amide nitrogen of Ala 210. The adenine ring mediates stacking 
interactions with Trp 188 from a neighboring molecule in the asymmetric unit while in 
solution, stacking interactions have been proven to be mediated with Tyr 244 (Ringheim 
et al., 1988). All the above interatomic distances are nearly identical between structures 
of cAMP-bound and Rp-bound RA (Figures 1.1F, 1.5 and 1.12). The importance of all 
these contacts for binding interactions have been confirmed by mutagenesis (Huang and 
Taylor, 1998) and by the observation that 2'deoxy-cAMP is incapable of binding PKA R-
subunit (Schwede et al., 2000). These are listed in Table 1.3 and shown as black dashed 
lines in Figure 1.12 and represent contacts important for binding and occupancy of PBC 
by cAMP and Rp. However, the distance between the equatorial sulfur and residues Ala 
202 and Arg 209 are significantly different in Rp and is summarized in Table 1.3 and the 
H-bonds are represented by red dashed lines in Figure 1.12. These confirm the 
importance of the equatorial oxygen not only for anchoring of cAMP to the pocket 
through critical interactions with the backbone nitrogen of Ala 202 and the guanidinium 
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side chain of Arg 209, but also for allosteric communication through the above residues 












It is clear that the mechanism of cAMP action is through induced fit and involves 
binding to PBC followed by allosteric conformational changes. A combination of our X-
ray crystallography and solution mass spectrometry results clearly indicates that while all 








Figure 1.12: Substitution of equatorial oxygen with sulfur in Rp weakens H-bonding 
network critical for cAMP-mediated allostery. Equatorial oxygen is anchored to both 
the guanidinium nitrogen of Arg 209 and the backbone amide nitrogen of Ala 202. 
Differences in H-bond distances with the sulfur in Rp are in red. All other bond 
distances including those of the axial oxygen with Ala 210 and 2` OH with carboxy 
side chain of Glu 200 and backbone amide nitrogen of Gly199, which are similar in 
both the cAMP and Rp-bound RA, are in black. Equatorial oxygen in cAMP is 
essential for allosteric communication through two networks of residues: 1) Equatorial 





is uniquely important for mediating allosteric relays necessary for propagation of the 
effects of cAMP binding. This is entirely consistent with this being the critical atom for 
determining whether preferred binding exists for the B or H-conformations. Details of the 
allosteric networks of residues leading from the equatorial oxygen are described below. 
Comparison of our cAMP-bound and Rp-bound structures of RA confirm the role 
of specific allosteric communication relays, proposed to propagate the effects of cAMP 
binding throughout the molecule to facilitate dissociation of the C-subunit. HDX results 
further show very clearly that substitution of the equatorial oxygen by sulfur in Rp 
increases deuterium exchange within two specific regions of the PBC. These are the 
regions spanning Glu 200, Ala 202 and 207-212, spanning Arg 209. A network of 
conserved residues from the PBC that have been demonstrated to be important for 
cAMP-mediated allostery of PKA are those A) between the hydrophobic core region of 
the PBC and the hinge region formed by the highly important ":B-C helices (Rehmann et 
al., 2003) and B) between  Arg 209 of PBC with Asp 170 from strands !1-!2 (Anand et 
al., 2010); (Abu-Abed et al., 2007) (Figure 1.12). The hydrophobic core of the PBC 
includes conserved residues, Leu 201, Ala 202, Leu 203 and Ile 204 responsible for 
communication with the ":B-C region via the Tyr 229 residue. This has been 
demonstrated in Epac2 by mutagenesis experiments to be an important conformational 
switch between the inactive H and active B-conformations (Rehmann et al., 2003) as well 
as NMR (Das et al., 2008). The extensive conformational change in this region in our 
structure of Rp-bound RA and differences in HDX between cAMP-bound and Rp-bound 
states clearly validates the previous results.  
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 Clear differences in the position of Asp 170, critical for a second relay via Arg 
209, are seen between our structures of the cAMP-bound and Rp-bound RA (Figures 1.1F 
and 1.12). Previous mutagenesis (Gibson et al., 1997) as well as structural comparison of 
the B (Su et al., 1995) and H-conformational states (Kim et al., 2005) are consistent with 
our results.  
Our findings confirm that the equatorial oxygen is critical for cAMP action and 
this is borne out by the important contacts that this atom mediates with residues of the 
PBC. This oxygen is positioned precisely to coordinate and bridge the interactions of the 
2'OH of the ribose moiety together with the axial oxygen which are essential for binding, 
with the allosteric relays listed above. The basis for cAMP action is therefore a 
combination of stabilization of the PBC followed by allosteric relays propagated from the 
equatorial oxygen of the cyclic phosphate. 
The S-P bond in phosphorothioates is more electronegative than the O-P bond of 
cAMP, making Rp a stronger acid relative to cAMP (Frey and Sammons, 1985) (Liang 
and Allen, 1987) (Basch et al., 1991). This reduces the strength of H-bonding of the 
sulfur with both Ala 202 as well as Arg 209 (Table 1.3, Figure 1.12) leading to disruption 
of both allosteric relays. Substitution of the axial oxygen in Sp on the other hand has no 
effects on allostery. This is completely consistent from both HDX and X-ray 
crystallography, whereby increased deuterium exchange together with the increased 
interatomic distances seen in the crystal structure confirm that Rp binding to PBC is more 
dynamic than Sp/cAMP. Rp thus preferentially binds the ‘inactive-H’ conformation 
through conformational selection while satisfying all the binding constraints associated 
with the 'active-B' conformation. 
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1.4.3 Identification of highly selective allosteric inhibitors that specifically bind and 
stabilize 'inactive' conformations 
Our results provide the following major insights into cAMP-dependent regulation of 
PKA. Firstly, we demonstrate that the apo R-subunit is equally capable of binding cAMP 
or C-subunit through 'conformational selection’ although the dominant conformation is 
likely to be the H-form (Harper et al., 2008). This is due to the apo state existing as an 
ensemble of multiple conformations. This also explains its higher affinity for the C-
subunit compared to cAMP-bound R-subunit. Secondly, the molecular basis for cAMP 
action is now better understood as occurring via binding interactions with PBC followed 
by specific allosteric conformational changes mediated solely by the equatorial oxygen of 
the cyclic phosphate. Thirdly, our results demonstrate the basis for antagonism of Rp. 
Substitution of the equatorial oxygen by sulfur alters the preferred conformation for 
binding to the H-form and disrupts all the allosteric conformational relays while retaining 
binding interactions necessary for docking to the PBC.  
The above studies of the R-subunit provide insights into 'rational' drug design. 
Firstly it is important to obtain structural information of more than a single end point 
conformation of the target protein of interest. Complementary solution studies are equally 
essential to define the conformational ensemble behavior of the target in solution in the 
absence of effector proteins/ligands. Since the goal of inhibitor selection is to design 
ligands that maintain the target in an inactive conformation, it is necessary to distinguish 
between contacts on the protein necessary for binding from those important for inducing 
allosteric conformational changes. The ideal inhibitors are therefore those that satisfy all 
'binding' constraints without inducing conformational changes necessary for activation. 
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This principle is evident from the synthesis of specific inhibitors such as Gleevec for Abl-
kinase which specifically recognizes and stabilizes the inactive conformation and is a 
classic example of conformational selection. These classes of conformation-specific 
inhibitors show better target-specificity and are therefore more desirable (Liu et al., 
2006).  In our study, the key to how Rp functions as a mechanistic inhibitor of PKA, is 
that it too preferentially binds the inactive 'H' conformation of the R-subunit as it contains 
all the important binding moieties yet it fails to induce allosteric conformational changes.   
Our analyses also highlight and support increasing evidence emerging for the 
importance of protein flexibility (which allows conformational selection) in rational drug 
design. In addition to crystallographic snapshots, conformational dynamics of proteins in 
solution lead to better identification of small molecule disruptors of protein-protein 




















CHAPTER 2  
 
 
Cooperativity and allostery in cAMP-dependent activation of Protein Kinase 












2.1 Introduction  
cAMP binding to the CNBs of the R-subunits induces conformational changes, leading to 
dissociation of the C-subunit and activation of PKA (Johnson et al., 2001b). Out of 4 
isoforms of the C and R subunits, C" and RI" are most widely distributed throughout all 
mammalian tissue and are the most important isoforms of PKA (Amieux and McKnight, 
2002). PKA R-subunit is an extended molecule containing an N-terminal dimerization 
domain and pseudosubstrate region followed by CNB-A and CNB-B respectively 
(Figure: 2.1A). The R-subunit lacking the N-terminal dimerization domain, RI"(92-379), 
retains high affinity binding to the C-subunit and provides a minimal monomeric model 
for examining R-C interactions as well as cAMP binding to CNB-A and CNB-B 
(Figure:2.1A) (Kim et al., 2005) (Su et al., 1995). A specific conserved set of residues 
critical for binding to cAMP is referred to as the phosphate binding cassette (PBC) 
(PBC:A and PBC:B for CNB-A and CNB-B respectively) (Berman et al., 2005). In 
contrast, PKA C-subunit is a globular protein with a bilobal structure characteristic of all 
kinases, where the small N-terminal lobe and larger C-terminal lobe enclose a cleft which 
binds ATP and provides binding sites for substrates or inhibitors (Zheng et al., 1993). 
Structures of cAMP-bound conformations of the CNB domain, denoted the “B-
conformation”, reveal a highly conserved architecture with two subdomains: a !-
subdomain with an eight-stranded !-sheet, containing the solvent-shielded pocket for 
binding cAMP and a non-contiguous "-subdomain (Figure: 2.1B). The structure of a 
PKA holoenzyme complex (Kim et al., 2005) (Kim et al., 2007) revealed a large 
conformational change in the R-subunit which is denoted as the “H-conformation” 
(Figure: 2.1B). The PBC region within the !: subdomain reveals a conserved hydrogen 
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bonding network, connecting residues that are critical for specific binding to cAMP 
(Berman et al., 2005). The key residues include single conserved arginines in both 
domains, Arg 209 and Arg 333, which are important for anchoring the phosphate moiety 
of cAMP (Figure: 2.1C). cAMP binding to CNB-# and anchoring of the cyclic AMP 
phosphate with Arg 209 is critical for the activation of C- subunit as it has been shown 
that the R209K mutation abolishes the tight binding of cAMP at CNB-A (Herberg et al., 
1996) and blocks activation of PKA.  
It has been known that cAMP binds to the PKA holoenzyme in a positive 
cooperative manner wherein a first molecule of cAMP binds first to the CNB-B domain 
followed by binding to CNB-A, leading to holoenzyme dissociation and activation 
(Herberg et al., 1996; Ogreid and Doskeland, 1983). Although numerous crystal 
structures of free individual R subunits and in complex with the C-subunit have been 
solved providing high-resolution insights into the end-point conformations of PKA, the 
molecular basis for cooperativity and allosteric coupling of the two cAMP binding events 
is not clear as it requires structural characterization of an intermediate state with the 
CNB-B domain alone bound to a single molecule of cAMP (Figure: 2.2A). NMR studies 
on the wild-type and single point mutants of RI" (119-379) have revealed the 
connectivity between CNB-A and CNB-B domains (McNicholl et al.) but they still do not 
describe the conformation of an intermediate in the cAMP-mediated activation pathway, 



















































Figure 2.1: #) Domain organization of RI". N-terminal dimerization/docking domain 
(D/D) (gray hashed box) connected by a linker region to two tandem cAMP-binding 
domains, CNB-A and CNB-B in green. The linker contains a PKA pseudosubstrate 
which is essential for facilitating interactions of RI" with the C-subunit in red. B) 
Mechanism of type I PKA regulation. In PKA holoenzyme, the C- subunit (gray) is 
kept inactivated when bound to the R- subunit (green) (structure of the RI"(92-379):C 
holoenzyme complex (PDB ID: 2QCS)), (Kim et al., 2007). ATP and the 
pseudosubstrate region occupy the active site cleft formed by the two lobes of the C-
subunit. Binding of 2 molecules of cAMP to CNB-A and CNB-B of the holoenzyme 
induces conformational changes leading to dissociation of the C-subunit and its 
activation. The R-subunit thus adopts distinct conformations, bound to C-subunit 
(green, H-conformation) (Kim et al., 2007) and bound to cAMP (brown, B-
conformation) (PDB ID: 1RGS) (Su et al., 1995). C) Close-up views of the Phosphate 
binding cassettes (PBC) (brown) from both CNB-A and CNB-B. In PBC:A, the 
critical conserved residues Arg 209 and Glu 200 and in PBC:B, Arg 333 and Glu 324 














Amide hydrogen/deuterium exchange coupled with QTOF mass spectrometry is a 
powerful tool to study protein-protein interactions and monitor conformational dynamics 
of proteins (Hoofnagle et al., 2003a). We have used this technique to characterize an 
important intermediate in the cAMP activation pathway of PKA by monitoring the effects 
of cAMP binding to the point mutant RI"(92-379) R209K. The X-ray crystal structure of 
holoenzyme (PDB ID: 2QCS) has revealed four sites on the R-subunit that interact with 
the C-subunit in the holoenzyme complex (Kim et al., 2007), one site contributed by the 























Intermediate H - Form
Figure 2.2: Cartoon showing step-wise cAMP-mediated activation of PKA (*- 
represents a molecule of cAMP, X- represents mutation that abolishes high-affinity 
binding of cAMP). Activation of type I PKA is cooperative and sequential with cAMP 
binding first to CNB-B and then to CNB-A. Mutation of Arg 209 to a Lys in CNB-# of 
R- subunit abolishes high-affinity cAMP binding to the CNB-# without significantly 
affecting binding of cAMP to CNB-B. The holoenzyme, RI"(92-379)R209K:C provides 
an ideal model system to probe the effects of a single cAMP binding to CNB-B and 
studying effects of a single cAMP bound intermediate in the cAMP–dependent 





reveal that binding of one molecule of cAMP increases deuterium exchange within the 
CNB-B domain. Increased exchange was also seen at the interface between CNB-B and 
the C-subunit suggesting weakening of the R-C interface without dissociation. 
Importantly, binding of the first molecule of cAMP greatly increases the conformational 
mobility/dynamics of two key regions coupling the two CNBs, the "C/C` of CNB-# 
domain ("C/C`:#) and "A helices of the CNB-B domain ("A:B). We believe that the 
enhanced dynamics of these regions forms the basis for the positive cooperativity in the 
cAMP-dependent activation of PKA. In summary, our results reveal the close allosteric 
coupling between CNB-A and CNB-B and the C-subunit providing important molecular 
insights into the function of CNB-B domain. 
2.2 Materials and Methods  
2.2.1. Reagents  
BL21 (DE3) E.coli strains were from Novagen (Madison, WI). TALON metal affinity 
resin was from Clontech Laboratories (Mountain view, CA). 8-AminoEthylAmino 
(AEA)-cAMP was from Biolog Life Science Institute (Bremen, Germany). ATP and 
cAMP were obtained from Sigma-Aldrich Corp. (Singapore). Poroszyme immobilized 
pepsin cartridge was from Applied Biosystems (Foster city, CA). Deuterium oxide 
(99.9% deuterium) was obtained from Sigma-Aldrich Corp. (Singapore). Trifluoroacetic 
acid (TFA) and acetonitrile were from Fisher Scientific (Singapore). All other chemicals 
were at least reagent grade.  
2.2.2. Purification of RI!(92-379)(R209K) and C- subunit  
cAMP affinity chromatography resin for R-subunit purification was synthesized by 
coupling 8-AEA-cAMP to the NHS-activated sepharose 4 Fast Flow® beads as 
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recommended (GE Life Sciences, Singapore). cAMP free RI"(92-379)R209K was 
expressed and purified as described previously (Anand et al., 2007) (Herberg et al., 1996). 
Hexahistidine tagged C-subunit of PKA was expressed and purified as described 
previously (Herberg et al., 1993). The holoenzyme, RI"(92-379)R209K:C was purified 
by size exclusion-gel filtration chromatography on an AKTA system (GE Life Sciences) 
as described earlier (Herberg et al., 1996) by using the buffer 50 mM MOPS, pH 7.0, 50 
mM NaCl, 2 mM MgCl2, 0.2 mM ATP and 5 mM BME.  
2.2.3. Amide Hydrogen/Deuterium Exchange Mass Spectrometry  
The size exclusion chromatography purified cAMP-free RI"(92-379)R209K:C 
holoenzyme complex was concentrated to 50 µM using vivaspin concentrators (Sartorius 
Stedim Biotech GmbH, Goettingen, Germany). 2 µL of the samples in storage buffer (20 
mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM MgCl2, 5 mM BME) were diluted and 
incubated with 18 µL of D2O (99.90%) resulting in a final deuterium concentration of 
90% in buffer A (20 mM MOPS, pH read 7.0, 50 mM NaCl, 2 mM MgCl2, 0.2 mM ATP, 
5 mM BME). HDX was carried out at 20ºC for various time points (0.5, 1, 2, 5 and 
10min). In order to test the effects of cAMP binding to CNB-B of RI" of the holoenzyme, 
we incubated the 50 µM protein complex with a final concentration of 70 µM cAMP. 
Given a Kd of the CNB-B domain in the holoenzyme complex for cAMP (Kd ~ 0.8 µM 
for CNB-B domain) (Herberg et al., 1996), we predicted that the CNB-B domain site of 
the protein complex would be completely saturated with cAMP allowing for 
characterization of a single cAMP-bound holoenzyme intermediate. Deuterium exchange 
reactions were carried out for both holoenzyme samples in the presence and absence of 
cAMP and cAMP-bound RI"(92-379)R209K as described previously (Anand et al., 
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2010) The exchange reaction was quenched by addition of 40 µL of pre-chilled 0.1% 
TFA to get a final pH read of 2.5. 50 µL of the quenched sample (~ 100 pmol protein 
sample) was then injected on to a chilled nanoUPLC sample manager (beta test version, 
Waters, Milford, MA) as previously described (Wales et al., 2008). The sample was run 
through a 2.1 x 30mm immobilized pepsin column (Porozyme, ABI, Foster City, CA) 
using 100uL/min 0.05% formic acid in water. The digested peptides were trapped on a 
2.1 x 5 mm C18 trap (ACQUITY BEH C18 VanGuard Pre-column, 1.7 µm, Waters, 
Milford, MA) and eluted using an 8-40% gradient of acetonitrile in 0.1% formic acid at 
40uL/min, supplied by a nanoACQUITY Binary Solvent Manager (Waters, Milford, 
MA), on to a reverse phase column (ACQUITY UPLC BEH C18 Column, 1.0 x 100 
mm,1.7 µm, Waters, Milford, MA) for resolution. Peptides were detected and mass 
measured on a SYNAPT HDMS mass spectrometer (Waters, Manchester, UK) acquiring 
in MSE mode (Bateman et al., 2002) (Silva et al., 2005). 
Peptides were identified from MSE data in the non-deuterated samples using 
ProteinLynx Global Server 2.4 (beta test version) (Waters, Milford, MA) (Geromanos et 
al., 2009) (Li et al., 2009). Identifications were only considered if they appeared at least 
twice out of three replicate runs. These identifications were mapped on to subsequent 
deuteration experiments using prototype custom software (HDX browser, Waters, 
Milford, MA). Data on each individual peptide at all time points were extracted using this 
software, and exported to HX-Express (Weis et al., 2006) for analysis.  
Continuous instrument calibration was carried out with Glu-Fibrinogen peptide 
(GFP) at 100fmol/µL. We also visually analyzed the data to ensure only well-resolved 
peptide isotopic envelopes were subjected to quantitative analysis. A control experiment 
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was carried out to calculate the deuterium back exchange loss during the experiment as 
described previously (Anand et al., 2010). Briefly, this was carried out by incubating 
ligand-free RI"(91-244) with deuterated buffer A for 24 h at room temperature (20ºC). 
Even after extended deuteration, RI"(91-244) still showed some ordered regions that 
were not completely deuterated. For an accurate measurement of back exchange loss, we 
therefore focused only on peptides from within highly solvent exchangeable regions of 
the protein, identified as those regions that show greater relative exchange at shorter time 
points (10 min exchange). The region in RI"(91-244) spanning residues 111-130 is a 
highly solvent exchangeable region and all 3 overlapping peptides used for calculations 
of back exchange span this region and showed nearly maximal exchange in ligand-free 
RI"(91-244) following 10 min deuterium exchange and would thus represent fully 
deuterated samples following 24 h exchange. An average deuteration back exchange of 
~33% was calculated from average back exchange values for 3 peptides: RI"(111-123) 
(m/z = 547.65) (back exchange - 34.4%), RI"(111-126) (m/z = 632.701) (back exchange 
= 30.4%) and RI"(111-119) (m/z = 595.34) (back exchange = 33.7%). All deuterium 
exchange values reported were corrected for a 33% back exchange by multiplying the 
raw centroid values by a multiplication factor of 1.49 (Anand et al., 2010). The analyzed 
data were then mapped on to the crystal structures of PKA holoenzyme (PDB ID: 2QCS) 







2.3 Results and Discussion  
To monitor the step-wise cooperative activation of type I PKA by cAMP, we used HDX 
measured by ESI-QTOF mass spectrometry. The RI"(92-379)R209K:C holoenzyme was 
used as a model to monitor the effects of binding of a single cAMP molecule to the CNB-
B domain, thereby enabling probing conformation of a key intermediate in the activation 
pathway. Furthermore, this also enabled us to unravel the role of CNB-B domain in 
mediating the cooperative activation of PKA. We first set out to measure HDX of the 
RI"(92-379) R209K:C holoenzyme both in the presence and the absence of cAMP as 
well as cAMP-bound RI"(92-379)R209K. Mutation of Arg 209 to a lysine within the 
PBC:A of RI" abolishes high-affinity binding of cAMP to CNB-A site, without 
significantly altering cAMP binding to CNB-B (Herberg et al., 1996). 
2.3.1. Pepsin digestion of RI!(92-379)R209K and C- subunit  
# total of 29 pepsin digest fragments for RI"(92-379)R209K and 24 fragments for the C-
subunit were detected and analyzed in the study. These covered 90% and 88% of their 
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The maximum deuterons exchanged after 10 min are summarized in Tables 2.1 
and 2.2. The data are reported as the average number of deuterons incorporated after ten 
minutes of deuterium exchange from two independent determinations. The undeuterated 
and the deuterated (10 min) isotopic envelopes for a subset of 6 peptides ( m/z = 762.44, 
z = 1, RI" (198-204); m/z = 523.81, z = 2, RI" (230-238); m/z = 643.84, z = 2, RI" (239-
247); m/z = 872.48, z =3, RI" (248-270); m/z = 873.91, z =2, RI" (275-290); m/z = 
649.36, z =1, RI" (322-327)) from RI"(92-379)R209K under various conditions are 
shown in Figure: 2.4 These peptides from RI"(92-379)R209K in holoenzyme showed the 
largest changes in HDX between the presence and absence of cAMP following 
deuteration. The time course of deuteration for these 6 peptides and are shown in Figure: 
2.5. The data presentation either by table or plots result in the same conclusions (Anand 



























Figure 2.3: Amino acid sequence of RI"(92-379)R209K (#) and C(1-350) (B) showing 
secondary structure elements with boundaries. Solid lines with arrow at two ends 
indicate the pepsin digest fragments analyzed in the study with total sequence coverage 
































Figure 2.4: ESI-QTOF mass spectra of pepsin digest fragments from different regions 
of RI"(92-379)R209K in RI"(92-379)R209K:C holoenzyme that showed the largest 
changes in amide H/D exchange. (i) The isotopic envelope for the peptides from cAMP 
bound RI"(92-379)R209K subunit after 10 min deuteration (ii) The isotopic envelope 
for the peptides from cAMP bound RI"(92-379)R209K:C holoenzyme after 10 min 
deuteration; (iii) The isotopic envelope for the peptides from cAMP free RI"(92-





Table 2.1: Effect of cAMP binding on the R-subunit peptides from RI"(92-379)R209K:C 
holoenzyme and RI"(92-379)R209K measured by HDX. 




                Maximum Deuterons 
R- subunit pepsin digest fragments Charge 
 
Exchange
able            Exchanged after 10 min 












EVYTEE (101-106) (769.33) 1 5 3.0 ± 0.06 3.3 ± 0.00 4.0 ± 0.05 
YVRKVIPKDYKTMAA (111-125) (446.50) 4 13 10.5 ± 0.21 10.7 ± 0.10 12.1 ± 0.05 
YVRKVIPKDYKTMAALAKAIEKNVL 
(111-135) 573.34) 5 23 14.6 ± 0.28 15.9 ± 0.60 17.0 ± 0.07 
FSHLDDNERSDIF (136-149) (797.86) 2 12 1.7 ± 0.02 1.7 ± 0.01 3.7 ± 0.04 
IAGETVIQQGDEGDNF (157-172) (846.89) 2 15 6.7 ± 0.08 6.4 ± 0.10 6.7 ± 0.19 
YVIDQGEMDV (173-182) (1168.52) 1 9 1.3 ± 0.01 1.3 ± 0.00 1.8 ± 0.03 
DVYVNNE (181-187) (852.37) 1 6 3.1 ± 0.07 3.0 ± 0.10 2.6 ± 0.01 
WATSVGEGGSF (188-198) (1097.49) 1 10 5.0 ± 0.00 5.5 ± 0.10 6.8 ± 0.12 
FGELALI (198-204) (762.44) 1 6 2.5 ± 0.05 1.2 ± 0.10 0.1 ± 0.02 
ALIYGTPKAAT (202-212) (553.32) 2 9 5.7 ± 0.07 6.3 ± 0.00 7.9 ± 0.08 
ALIYGTPKAATVKAKT (202-217) (545.00) 3 14 6.1 ± 0.01 7.6 ± 0.30 9.1 ± 0.47 
VKAKTNVKL (213-221) (500.83) 2 8 1.7 ± 0.04 1.5 ± 0.10 1.8 ± 0.03 
WGIDRDSY (222-229) (506.23) 2 6 0.9 ± 0.00 0.8 ± 0.00 1.3 ± 0.02 
RRILMGSTL (230-238) (523.81) 2 8 1.3 ± 0.00 2.4 ± 0.00 3.4 ± 0.03 
RKRKMYEEF (239-247) (643.84) 2 8 2.2 ± 0.02 4.1 ± 0.00 4.6 ± 0.05 
LSKVSIL (248-254) (759.50) 1 6 2.5 ± 0.02 3.1 ± 0.10 3.1 ± 0.02 
LSKVSILESLDKWERLTVADALE (248-
270) (872.48) 3 22 8.6 ± 0.18 16.1 ± 0.50 10.0 ±0.06 
TVADALEPVQ (264-273) (521.77) 2 8 3.1 ± 0.02 3.6 ± 0.00 3.4 ± 0.01 
PVQFEDGQKIVVQGEPGDE (271-289) 
(1036.00) 2 16 6.3 ± 0.09 5.3 ± 0.10 5.4 ± 0.09 
EDGQKIVVQGEPGDEF (275-290) (873.91) 2 14 4.2 ± 0.03 3.0 ± 0.20 3.0 ± 0.05 
IILEGSAAVL (292-301) (493.30) 2 9 3.7 ± 0.13 3.7 ± 0.10 4.5 ± 0.01 
QRRSENEEF (302-310) (597.78) 2 8 4.0 ± 0.02 4.0 ± 0.00 4.6 ± 0.06 
VEVGRLGPSDYFGE (311-324) (762.87) 2 12 3.7 ± 0.06 3.1 ± 0.00 1.8 ± 0.03 
FGEIAL (322-327) (649.36) 1 5 2.1 ± 0.03 1.1 ± 0.10 0.2 ± 0.11 
LMNRPRAAT (328-336) (515.28) 2 7 3.9 ± 0.02 2.9 ± 0.10 1.6 ± 0.05 
VARGPLKC (338-345) (422.25) 2 5 0.7 ± 0.02 0.6 ± 0.00 0.4 ± 0.13 
VKLDRPRF (346-353) (515.81) 2 6 0.7 ± 0.00 1.0 ± 0.10 1.3 ± 0.03 
ERVLGPCSD (354-362) (975.45) 1 7 2.3 ± 0.03 3.1 ± 0.00 3.2 ± 0.04 
ILKRNIQQYNSF (363-374) (762.42) 2 11 9.0 ± 0.09 8.5 ± 0.00 6.8 ± 0.03 
 
 
Values reported are the mean and standard error calculated from two independent 
experiments. All deuterium exchange values reported were corrected for ~ 33% back 







Values reported are the mean and standard error calculated from two independent 
experiments. All deuterium exchange values reported were corrected for ~ 33% back 
exchange by multiplying the raw centroid values by a multiplication factor of 1.49.
    
Maxim
um  Maximum Deuterons 
C- subunit pepsin digest fragments Charge 
 
Exchan
geable Exchanged after 10 min 
(Sequence) (m/z) (Z) Amides RI"(92-379) 
RI"(92-
379) 
      R209K:C 
R209K:C + 
cAMP 
FLAKAKED (18-25) (461.25) 2 7 4.5 ± 0.48 4.7 ± 0.04 
LKKWETPSQNTAQL (27-40) (822.44) 2 12 8.1 ± 0.07 7.8 ± 0.06 
TPSQNTAQLDQFDRIKTLGTG-     
SFGRVMLVKHKESGNHYAMK (32-72) (919.08) 5 39 12.7 ± 0.14 13.2 ± 0.10 
IEHTLNE (85-91) (428.22) 2 6 0.2 ± 0.04 0.4 ± 0.01 
KRILQAVNFPFL (92-103) (723.44) 2 10 2.2 ± 0.00 2.0 ± 0.00 
VKLEFSFKDNSNL (104-116) (770.91) 2 12 2.5 ± 0.01 2.2 ± 0.05 
VMEYVAGGEMFSH (119-131) (728.84) 2 12 0.3 ± 0.02 0.4 ± 0.09 
EMFSHLRRIGR (127-137) (701.38) 2 10 6.4 ± 0.29 6.3 ± 0.21 
RRIGRFSEPHARF (133-145) (427.97) 4 11 1.4 ± 0.00 1.3 ± 0.02 
IVLTF (150-154) (592.37) 1 4 0.1 ± 0.05 0.1 ± 0.06 
FEYLHSLDLI (154-163) (625.33) 2 9 0.2 ± 0.01 0.3 ± 0.01 
IYRDLKPENLL (163-173) (687.40) 2 9 0.5 ± 0.00 0.6 ± 0.01 
LIDQQG (173-178) (673.35) 1 5 1.5 ± 0.02 1.4 ± 0.02 
YIQVTDFGF (179-187) (942.46) 1 8 0.3 ± 0.00 0.3 ± 0.00 
AKRVKGRTWTLCGTPEYLAPEIIL (188-211) (932.50) 3 21 3.0 ± 0.05 3.5 ± 0.02 
SKGYNKAVDWWALGVL (212-227) (903.98) 2 15 1.9 ± 0.01 1.9 ± 0.04 
IYEMAAGYPPFFADQPIQ (228-245) (1029.49) 2 14 6.1 ± 0.08 6.2 ± 0.09 
YEKIVSGKVRFPSHFSSDLKDLLRNLL (247-273) 
(633.16) 5 25 4.5 ± 0.02 4.5 ± 0.00 
QVDLTKRFGNLKNGVNDIKNHKW (274-296) (681.88) 4 22 7.5 ± 0.07 8.5 ± 0.20 
FATTDW (297-302) (740.33) 1 5 3.4 ± 0.05 2.9 ± 0.02 
IAIYQRKVEAPFIPKFKGPGDTSN (303-326) (669.87) 4 20 10.0 ± 0.16 9.5 ± 0.03 
FDDYEE (327-332) (817.29) 1 4 2.6 ± 0.01 2.5 ± 0.05 
DDYEEE (328-333) (799.27) 1 5 3.4 ± 0.09 3.0 ± 0.02 
IRVSINEKCGKE (335-346) (485.91) 3 11 7.1 ± 0.13 6.9 ± 0.02 
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2.3.2. Evidence that cAMP binding to RI!(92-379)R209K:C holoenzyme does not lead 
to dissociation of the complex  
Binding of cAMP to the RI"(92-379)R209K:C holoenzyme complex under our deuterium 
exchange reaction conditions did not lead to dissociation of the holoenzyme. This was 
confirmed by comparing the deuterium exchange of our results with earlier studies on 
free RI" and holoenzyme complexes (Hamuro et al., 2004). In the holoenzyme, the N-
terminal pseudosubstrate regions were completely shielded from solvent in contrast to the 
free, unbound state. We observed the same effects in the N-terminal pseudosubstrate 
region from our samples of the cAMP-bound RI"(92-379)R209K:C holoenzyme. This is 
consistent with previous studies that showed cAMP binding to CNB-B in the RI"(92-
379)R209K:C holoenzyme failed to dissociate the C and R-subunits (Herberg et al., 1996). 
2.3.3. cAMP binding to RI!(92-379) R209K:C holoenzyme decreases deuterium 
exchange in PBC:B  
The regions from R- subunit includes, (271-289), (275-290), (311-324), (322-327), (328-
336) and (363-374) within CNB-B, showed decreased exchange upon binding of cAMP. 
This is a direct result of binding interactions of these residues with cAMP. From the 
crystal structure of cAMP-bound RI"(113-379) (Su et al., 1995), it can be seen that the 
residues which form part of CNB-B include Arg 333, Glu 289, Tyr 371 and Glu 324. Arg 
333 in PBC:B hydrogen bonds directly with the equatorial exocyclic oxygen of the cAMP 
phosphate and also forms salt bridges with Glu 289. Further, Tyr 371 stacks against 
adenine ring of cAMP in the CNB-B and forms hydrogen bonds with Glu 324 to stabilize 
cAMP binding to PBC:B. The decreased exchange observed in our experiments reflects 
binding of 1 molecule of cAMP to PBC:B (Figure 2.4 and 2.5 - peptides, RI"(322-327) 
and RI"(275-290)). Comparison of the HDX in the cAMP-bound RI"(92-379)R209K:C 
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holoenzyme and cAMP-bound RI"(92-379)R209K showed some differences. While the 
exchange measured was similar in certain regions, the magnitude of HDX protection seen 
upon cAMP binding in the free R-subunit was significantly different from that in the 
cAMP-bound holoenzyme (Figure 2.4 and 2.5 – peptide RI"(322-327)). This presumably 
reflected the C-subunit- induced long-range conformational changes that affected the 






















































































Figure 2.5: Time course of deuterium exchange for peptides from RI"(92-
379)R209K. Open circle (,), RI"(92-379)R209K:C in the absence of cAMP; Close 
circle (%), RI"(92-379)R209K:C in the presence of cAMP. The solid lines denote 
the best fit of the data to a one-phase association non linear exponential curve fit 




2.3.4. Effects of cAMP binding to RI!(92-379)R209K:C holoenzyme: Changes in 
PBC:A of RI!  
Upon binding of cAMP, 1 region in PBC:A spanning residues 198-204 (Figure 2.4 and 
2.5 - peptide RI"(198-204)) showed decreased exchange while another region, RI"(202-
212) and RI"(202-217) showed increased exchange upon cAMP binding to PBC:B. We 
believe there are two possible explanations for this observation. 1) This indicates that 
cAMP binding to the CNB-B induces long-range conformational changes within PBC:A 
and the altered HDX is reflective of that. 2) An alternative intriguing explanation could 
be that a second molecule of cAMP interacts with Glu 200 via the 2`OH moiety leading 
to protection at the RI" (198-204) peptide. A similar effect seen in peptide RI" (322-327) 
can be attributed to cAMP binding to PBC:B. In contrast, increased exchange around 
residues RI" (202-217) is likely due to lack of the anchoring Arg 209 residue. This 
alternative explanation would suggest that a second molecule of cAMP is capable of 
partially binding with CNB-A through the ribose 2`OH group, but is unable to stably 
occupy the site as it lacks the critical Arg 209 anchoring residue. As mentioned earlier, 
cAMP interaction with the Arg 209 residue is highly important for the dissociation and 
activation of PKA.  
Comparison of cAMP-bound RI"(92-379)R209K:C holoenzyme and cAMP-
bound RI"(92-379)R209K subunit (Table 1.1) showed higher exchange in cAMP-bound 
RI"(92-379)R209K subunit within the PBC:A also reflecting the long-range allosteric 
and direct binding effects of C-subunit on the dynamics of CNB-A (Anand et al., 2002) 
(Hamuro et al., 2004). 
2.3.5. cAMP binding to CNB-B increases deuterium exchange at interface between 
CNB-B and C-subunit  
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Even though the C-subunit does not dissociate upon binding of 1 cAMP molecule to 
RI"(92-379) R209K:C holoenzyme complex, the R-C interface shows increased 
deuterium exchange at peptide fragment C(274-296). In the C-subunit, this region 
corresponds to "H-"I region (site 4 of R-C interface contacts) which contacts the "B:B-
"C:B helix (residues 354-362) (Kim et al., 2007). Interestingly, the above region from the 
C-subunit and CNB-B of the R-subunit showed increased exchange (Tables 2.1, 2.2 and 
Figure 2.6) suggesting detachment of CNB-B from the C-subunit. These results reflect 
cAMP-induced conformational changes within the CNB-B domain leading to partial 

















Figure 2.6: cAMP binding to the CNB-B domain shows increased exchange at the 
CNB-B:C-subunit interface, amide H/D exchange data mapped onto the crystal 
structure of holoenzyme, RI"(92-379)R333K:C (the only available type I holoenzyme 
structure with both CNB-# and CNB-B domains , PDB ID: 2QCS) (Kim et al., 2007). 
The R- subunit and the C- subunit are shown in green and gray respectively. Regions 
showing increased exchange upon binding cAMP are in red and suggest disruption of 
the specific intersubunit contacts mediated by the CNB-B domain with the C-subunit 




2.3.6. Global conformational changes in RI!  
In the process of activation of holoenzyme, cAMP binds to CNB-B first followed by 
CNB-A leading to dissociation of the C-subunit (Herberg et al., 1996). Addition of cAMP 
to the RI" (92-379)R209K:C showed extensive changes in HDX throughout the molecule, 
beyond the cAMP binding sites in the two domains. These are summarized below:  
2.3.6.1. Pseudosubstrate region: The N-terminal pseudosubstrate region fragments, (101-
106), (111-125) and "A:# region fragment, (136-149) in RI"(92-379)R209K:C 
holoenzyme showed lower deuterium exchange when compared to the cAMP bound 
RI"(92-379)R209K. And these regions in holoenzyme did not show any difference in 
deuterium exchange upon cAMP binding to the CNB-B. This reflects maintenance of 
integrity of the holoenzyme in the absence of a second molecule of cAMP stably binding 
CNB-A.  
2.3.6.2. !B/C:#, !C’:A and !A:B helix: The "B/C:# and "C`:A helices connect CNB-A 
and B of R-subunit and undergoes a huge conformational change between the C- subunit 
bound H-form and the cAMP bound B-form (Kim et al., 2007). The fragments, (230-238), 
(239-247) and (248-254) which cover "B/C:A and "C`:A helices show greatly increased 
HDX in the holoenzyme complex bound to a single molecule of cAMP at CNB-B (Figure 
2.4 and 2.5 - peptides, RI"(230-238), RI"(239-247)). We believe that this increased 
exchange that is seen only in the single cAMP-bound intermediate is reflective of greater 
conformational mobility (Popovych et al., 2006). The peptide (248-270) showed 
significantly greater exchange (Figure 2.4 and 2.5 - peptides RI"(248-270)) upon addition 

















Interestingly, "A:B helix forms the bridge that communicates binding of cAMP to 
CNB-B to CNB-A. The positioning of this helix is greatly shifted in structures of the 
cAMP-bound and C-subunit-bound states (Figure 2.8A and 2.8B). Several key residues 
including Trp 260, a hydrophobic capping residue for cAMP bound to PBC-A, are part of 












































Figure 2.7: Increased exchange upon binding of a single molecule of cAMP to 
RI"(92-379) R209K:C holoenzyme, within residues 230-270 (spanning ":B/C and ":A 
of CNB-B) region of the R-subunit reflects increased dynamics and is shown in red. 
This region reflects the large conformational changes between the H (green) and B 
(gray) -conformations shown by superposition of PBC:A of cAMP-bound RI" (113-
379) (PDB ID: 1RGS) and PBC:A of C-subunit-bound RI" (92-379) (PDB ID: 
2QCS). The yellow arrow shows alternate positioning of ":B/C helix between the H 
and the B forms. Regions spanning PBC:B show decreased exchange upon binding of 





of 10 exchangeable amides spanning this helix are completely exchanged with solvent 












Interestingly, the cAMP-bound R-subunit showed lower exchange in this region 
comparable to C-subunit-bound holoenzyme complex. This suggests that binding of a 
single cAMP molecule at CNB-B domain shows increased protein mobilities at this 
region. This contributes to a large difference in conformational entropy as seen in cAMP-






































Figure 2.8: Importance of CNB-B ":A in mediating allosteric cooperativity in the cAMP-
activation of PKA. Crystal structure of RI"(92-379) in C-subunit bound, H-conformation 
A) (PDB ID: 2QCS) is compared with the crystal structure of RI"(113-379) in cAMP 
bound conformation, B-form. B) (PDB ID: 1RGS). Regions showing salt bridges between 
Q370-E255, E261-R366, R241-D267 and E143-K240 are critical when the R- subunit is 
in the H-conformation. Binding of a single molecule of cAMP to CNB-B leads to 
disruption of these critical salt bridges and increases the mobilities of ":A and " B/C 
helices facilitating binding of a second molecule of cAMP at CNB-A and leading to 




such a model, the end-point B and H-conformations show reduced conformational 
dynamics compared to the single cAMP-bound intermediate, clearly highlighting the high 
conformational entropic penalty that accompanies binding of the second molecule of 
cAMP to CNB-A of wild-type RI" (Hamuro et al., 2004). The increased dynamics in this 
region reflected by the high HDX seen in this segment of the single cAMP-bound 
intermediate clearly defines the basis for the contribution of the CNB-B domain to 
cooperativity in the cAMP-dependent activation of PKA. Higher exchange at this region 
is also consistent with loss of a salt bridge between Glu 261- Arg 366 of RI" - subunit in 
the H conformation (Kim et al., 2007). 
2.4 Conclusion  
Our study has highlighted a powerful application of HDX mass spectrometry in 
characterizing transient intermediates in the activation cycles of large protein complexes 
not easily amenable by other structural biology tools such as NMR and X-ray 
crystallography. Our results on the cAMP-dependent activation of type I PKA clearly 
demonstrate the important role of the CNB-B domain in mediating the cooperative and 
allosteric cAMP-dependent activation of PKA. By using a point mutant that abolishes 
high affinity binding of cAMP to the CNB-A site, we demonstrate the conformational 
properties of an intermediate containing a single cAMP. Binding of cAMP to CNB-B 
increases HDX at one of the four sites of R-C intersubunit interactions, suggesting that 
conformational changes associated with cAMP binding at the CNB-B domain partially 
disrupt intersubunit interactions without leading to dissociation of the C-subunit. Another 
important result is the increased exchange seen upon cAMP binding at two key regions, 
the "C/C`:A helix and the "A:B helix. Both these regions are critical in relaying the 
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effects of cAMP-binding to CNB-B to CNB-A. The increased exchange in these two 
regions exclusively in the cAMP-bound to the RI"(92-379)R209K:C holoenzyme but not 
cAMP-bound to RI"(92-379)R209K specifically highlights the role of CNB-B domain in 
facilitating the cooperative cAMP-dependent activation of PKA by potentially enhancing 
affinity of binding of a second molecule of cAMP to CNB-A domain. Our results provide 
unique insights into the role of CNB-B domain and its communication with CNB-A 
domain to allow a coordinated and cooperative regulation of PKA where the two domains 
function as closely coupled rather than individual isolated domains.  
Our results highlight the unique capabilities of HDX mass spectrometry in 
structural biology in understanding regulatory cycles of enzyme complexes. It is uniquely 
poised to probe conformational dynamics of transient reaction intermediates and presents 


































The second messenger cyclic adenosine 3`, 5`- monophosphate (cAMP) mediates 
its  actions by binding to proteins containing cyclic nucleotide binding (CNB) or GAF 
(cGMP-speci/c phosphodiesterases, bacterial adenylyl cyclase, and the bacterial FhLA 
transcriptional regulator) domains (Berman et al., 2005; Schultz, 2009). CNB domains 
that bind cAMP are found coupled to diverse effector domains such as cyclic nucleotide-
regulated ion channels, catabolite activator protein (CAP or cAMP-responsive proteins, 
CRP), guanine nucleotide exchange proteins activated by cAMP (Epac), and cyclic 
nucleotide-dependent protein kinase regulatory subunits (Berman et al., 2005; Osborne et 
al., 2011).  CNB domain-containing proteins are found in both prokaryotes and 
eukaryotes, and are easily identifiable by a 12-amino acid motif, referred to as the 
Phosphate Binding Cassette (PBC), containing invariant residues critical for anchoring 
cAMP (Canaves and Taylor, 2002). Indeed the structural biology of diverse CNBs reveals 
a highly conserved architecture with an a-subdomain, and a b-subdomain comprising an 
8-stranded b-sheet containing the PBC. The PBC provides a conserved high-affinity 
binding pocket for both cAMP and cGMP (Berman et al., 2005; Osborne et al., 2011).  
cGMP-binding proteins contain a Ser/Thr residue following a conserved Arg, as opposed 
to an Ala residue found in cAMP-binding proteins (Shabb et al., 1990) 
The allosteric regulation of various proteins that contain cAMP-binding domains 
has been elucidated in extensive detail at the structural level. Crystal structures of the 
cAMP-dependent protein kinase (PKA), CAP, cyclic nucleotide regulated channels and 
Epac 1 reveal interactions of cAMP with the PBC, as well as additional conformational 
changes that are relayed from the CNB domain to the associated effector domains 
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(Rehmann et al., 2007).  These studies have suggested that all CNB domains regulate the 
effector domain upon binding of cAMP through hydrophobic interactions. CNB domains 
have been shown to adopt two stable endpoint conformations, denoted as the ‘B’ (cAMP-
bound, active) and ‘H’ (cAMP-free, inactive) (Badireddy et al., 2011) conformation 
where large changes resulting from repositioning of the C-helix to which the effector 
domain is attached, are observed. Conserved residues in the PBC are critical in anchoring 
the different functional moieties in cAMP, and present a high affinity binding pocket that 
combines precise geometry with specificity. These include a conserved Gly, whose 
backbone amide nitrogen along with the side chain of a Glu residue, anchor the ribose 
2’OH. A conserved Arg anchors the phosphodiester bond, and an aromatic residue, part 
of a ‘lid’ region, stacks against cAMP and stabilizes its binding. A ‘hinge’ region 
consisting of hydrophobic residues is responsible for propagating the effects of cAMP 
binding to distal regions of the protein reviewed in (Rehmann et al., 2007)).  
cAMP-dependent dynamics has also been studied by amide hydrogen/deuterium 
exchange coupled to mass spectrometry (HDXMS), a powerful technique to probe 
dynamics of proteins in solution (Hoofnagle et al., 2003b). These studies on different 
classes of CNB domains (Anand et al., 2002; Anand et al., 2010; Brock et al., 2007; 
Hamuro et al., 2004) have provided important insights into cAMP-mediated allostery. 
While the cAMP binding site and contacts are highly conserved, a number of 
sophisticated allosteric relays couple the binding to distal functional regions of the protein.  
In Epac, this is believed to involve the hydrophobic hinge (Rehmann et al., 2003) and in 
PKA, an electrostatic relay between the Arg of PBC and a conserved Asp (Abu-Abed et 
al., 2007; Anand et al., 2010; Das et al., 2007) is important.  Recently, we have shown 
that the basis for cAMP action in the Regulatory (R)  subunit of PKA was a combination 
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of ‘Induced Fit’ (Anand et al., 2010) and ‘Conformational Selection’ (Badireddy et al., 
2011).  In the ‘Induced Fit’ model, conformational changes following cAMP binding are 
propagated throughout the entire protein, while the ‘Conformational Selection’ model 
assumes CNB domains are metastable and populate all stable endpoint conformations, 
one of which is preferentially ‘selected’ by cAMP. The importance of allosteric relays for 
cAMP action is highly relevant to both models.  Similar mechanisms have been described 
with the CNB domains in Epac,  where evidence of the apo CNB domain existing in an 
ensemble of two or more conformations provided the primary basis for ‘conformational 
selection’(Harper et al., 2008).   
Mycobacteria, including M. tuberculosis which is the causative agent for 
tuberculosis, contain an abundance of proteins involved in cAMP metabolism (Shenoy 
and Visweswariah, 2006). Genome analysis followed by biochemical studies have 
revealed that a number of enzymes are capable of synthesizing and regulating cAMP 
levels in these bacteria, under different environmental conditions (Dass et al., 2008). 
Interestingly, only a single cAMP phosphodiesterase has been characterized so far 
(Podobnik et al., 2009; Shenoy et al., 2005), but the ability of mycobacteria to secrete 
large amounts of cAMP (Dass et al., 2008) suggests that secretion, rather than hydrolysis 
of cAMP, may be a more efficient means of regulating intracellular cAMP. The 
importance of secreted cAMP in modulating macrophage response to M. tuberculosis has 
been described (Agarwal et al., 2009), and elevated levels of cAMP of bacterial origin are 
observed in macrophages following infection by mycobacteria (Kalamidas et al., 2006; 
Shen et al., 2009).   
The high levels of cAMP found in both pathogenic and non-pathogenic 
mycobacteria however suggest that basic cellular processes are regulated by cAMP in 
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these bacteria.  cAMP-binding transcription factors (CRPs), with some similarity to the 
CAP from E.coli, have been characterized and found to regulate a number of genes 
(Stapleton et al., 2010) (Rickman et al., 2005 ) (Gazdik et al., 2009).  We have recently 
described novel proteins that contain a CNB domain fused to an acetytransferase (AT) 
domain (Nambi et al., 2010).  These proteins, the products of the MSMEG_5458 gene 
from M. smegmatis and the rv0998 gene from M. tuberculosis, contain an N-terminal 
CNB domain fused to a C-terminal domain that is similar to the GNAT (GCN5-related N-
acetytransferase) family of enzymes (Nambi et al., 2010). Importantly, these 
mycobacterial proteins are able to acetylate the e-amino group of lysine residues, in a 
cAMP-regulated manner (Nambi et al., 2010; Xu et al., 2011). This domain organization 
is unique to mycobacteria and therefore provides an opportunity to monitor 
conformational changes that occur on cAMP binding to a novel effector domain, namely 
a protein acetytransferase.  
In this study, we monitor the dynamic conformational changes that occur on 
cAMP binding to MSMEG_5458 (henceforth referred to as KATms) using 
bioluminescence resonance energy transfer (BRET; (Biswas and Visweswariah, 2011) as 
well as HDXMS.  cAMP binding to full length KATms induced a conformational change 
that could be detected by an increase in BRET.  Employing HDXMS, we observed that in 
contrast to other CNB domains, no cAMP-dependent changes in deuterium exchange in 
KATms were observable in regions associated with allostery in other CNB domains.  
Instead, we show the importance of a putative helical region between the CBD and the 
AT domain, and identify two residues that are crucial for transmitting the information of 
cAMP-binding to the C-terminal AT domain.  This therefore represents the first example 
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of a primitive CNB domain lacking specific allosteric relays that couple cAMP-binding to 
regulation of an associated catalytic domain. 
3.2 Materials and Methods 
3.2.1. Reagents 
All fine chemicals were from SigmaAldrich, USA. Routine bacterial growth media (Luria 
Bertani) and Terrific Broth were purchased from Colloids Impex, India. Restriction 
enzymes were from MBI Fermentas, Canada, or New England Biolabs, USA. TALON 
metal affinity resin was from Clontech laboratories (Mountain View, CA) and glutathione 
sepharose was procured from GE Healthcare, USA. Tritiated cAMP [3H]-cAMP, (specific 
activity 59 Ci/mmol) was obtained from Perkin Elmer Life Sciences, USA.  Acetyl lysine 
antibody was obtained from Cell Signalling Technologies (CST), USA. Analogs of 
cAMP (8-bromoadenosine- 3`, 5`- cyclic monophosphorothioate Rp- and Sp-isomers, and 
the non-brominated analogs) were from Biolog Life Science Institute (Bremen, 
Germany). Poroszyme-immobilized pepsin cartridge was from Applied Biosystems 
(Foster City, CA). Deuterium oxide (D2O) and protein sequence analysis grade 
trifluoroacetic acid (TFA) were from Fluka BioChemika (Buchs, Switzerland).  
3.2.2. Cloning and Mutagenesis  
Primers used for cloning and mutagenesis (Shenoy and Visweswariah, 2003) are detailed 
in Supplemental Table 1.  Constructs expressing wild type KATms and the R95K and 
E234A mutants have been described earlier (Nambi et al., 2010).  pPRO-KATMSP157,160A 
was generated using mutagenic primers MS5458P157,160A_1 and MS5458P157,160A_2. 
pGEX-Rv0998P160,163A was generated mutagenic primer Rv0998P160,163A_1 and 
Rv0998P160,163A_2.  All mutations were verified by sequencing (Macrogen, S. Korea). 
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To generate the constructs used for BRET2 analysis, a region encompassing 
residues 1-333 of KATms  was amplified using primers MS5458sensFLFWD and 
MS5458sensFLRVS, cloned into pBlue-Script II KS(+), sequenced, and then cloned into 
pGFP2-MCS-RLuc digested with EcoRV and XbaI to generate the plasmid pGFP2-FL-
Rluc. A construct encoding the CNB domain and the linker region (pGFP2-CNBLIN-
Rluc; encoding residues 1-215) was constructed similarly using primers 
MS5458sensFLFWD and MS5458sensCNBLINRVS. 
3.2.3. Expression, purification and characterization of proteins  
For biochemical assays, KATms and Rv0998 (KATmt) were purified essentially as 
described earlier using the cyc- strain of E. coli SP850, in order to obtain protein free of 
cAMP (Nambi et al., 2010). For performing HDXMS, protein was further purified by 
size-exclusion chromatography (S75 column, AKTA system, GE Healthcare) in buffer 
containing 50 mM Tris HCl (pH 8.2), 1 mM DTT, 50 mM NaCl and 10% glycerol.   
Purification of wild type and mutant proteins and cyclic nucleotide binding assays were 
performed as described earlier (Nambi et al., 2010) and binding data was analyzed using 
GraphPad Prism 5.  
3.2.4. In vitro BRET Assays  
HEK 293T cells were transfected with pGFP2-CNBLIN-Rluc or pGFP2-FL-Rluc plasmids, 
and 72 h following transfection, lysed in 50 mM HEPES (pH 7.5), containing 2 mM 
EDTA, 1 mM dithiothreitol, 100 mM NaCl, 10 mM sodium pyrophosphate, 80 µM 
glycerophosphate, 1 mM benzamidine, 1 µg/mL aprotinin, 1 µg/mL leupeptin, 5 µg/ mL 
soyabean trypsin inhibitor, 100 µM sodium orthovanadate and 10% glycerol (Biswas and 
Visweswariah, 2011). Following brief sonication, lysates were centrifuged at 13,000g and 
the cytosol removed. Aliquots of the cytosol (with luciferase activity of ∼10,000 cps) 
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were incubated with the indicated amounts of cNMP, in a buffer consisting of 50 mM 
HEPES, pH 7.5, containing 100 mM NaCl (total volume of 60 µL) at 37 °C for 10 min. 
DeepBlue C (coelenterazine 4a; Molecular Imaging Products) was added to a final 
concentration of 5 µM and readings for 0.5 s were collected in a Victor3 microplate 
reader (Perkin-Elmer). Emission filters used for Rluc and GFP2 emission were 410 nm 
(bandpass 80 nm) and 515 nm (bandpass 30 nm),respectively. BRET2 measurements were 
averaged from 3 readings, and BRET2 ratios, calculated as GFP2 emission divided by 
Rluc emission, were recorded. 
3.2.5. In vitro acetylation assays  
Assay were carried out in a 20 µL total reaction volume containing 25 mM Tris-HCl, pH 
7.5, 100 mM NaCl, 5 mM EDTA, 10 µM acetyl CoA, MSMEG_4207(USP) as substrate 
(Nambi et al., 2010), in the presence or absence of cAMP, using either KATms or 
KATmt as enzymes. Reactions were incubated at 25ºC for 10 min, terminated by boiling 
in sample loading buffer used for SDS gel electrophoresis and subjected to western 
blotting with a polyclonal acetyl lysine antibody as described earlier (Nambi et al., 2010) . 
Acetytransferase assays were also performed as described earlier using an enzyme 
coupled assay (Nambi et al., 2010). The assay reaction mixtures contained 0.2 mM NAD, 
0.2 mM thiamine pyrophosphate (TPP), 5 mM MgCl2, 1 mM DTT, 2.4 mM "-
ketoglutarate, 50 µM acetyl CoA, 50 µM USP, 0.03 units of a-ketoglutarate 
dehydrogenase, 190 nM KATms, 100 mM sodium acetate, 50 mM bisTris, and 50 mM 
Tris, pH 7.5. All assay components except KATms and USP were incubated first at 25 ºC 
for 5 min. The rates were analyzed continuously for 5 min by measuring NADH 
production at 340 nm. For quantitation of immunoreactivity a western blot assay was used. 
Enzymatic assays were performed with varying concentrations of MSMEG_5458, acetyl-
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CoA, and USP as indicated, and incubated for the times indicated at 25 °C. Reactions 
were terminated by addition of SDS sample dye, boiled, and aliquots were loaded onto a 
gel for subsequent western blot analysis using the acetyl lysine antibody and enhanced 
chemiluminescence. Images were   acquired   with   the FluorChem Q MultiImage III 
system (Alpha Innotech), and image intensities were quantified using the AlphaView Q 
version 3.03 software. Values obtained were analyzed by GraphPad Prism 5 using built-in 
equations for enzyme kinetics. 
3.2.6. Amide Hydrogen/Deuterium (H/D) Exchange Mass Spectrometry  
Apo KATms (without cAMP) was concentrated to 80 *M using Vivaspin concentrators 
(Sartorius Stedim Biotech GmbH, Goettingen, Germany). Samples were prepared by 
adding either cAMP, Rp-cAMPS, or Sp-cAMPS (1 mM) to the protein. 2 *L each of 
sample in buffer (50 mM Tris HCl (pH 8.2), 50 mM NaCl, 10% glycerol) was diluted 
individually with 18 *L D2O (99.9%) to yield a final concentration of 90% D2O. 
Exchange was carried out at 20 °C for various times (0.5, 1, 2, 5, and 10 min). The 
exchange reaction was quenched by adding 40 *L of pre-chilled 0.1% trifluoroacetic acid 
to get a final pH read of 2.5. A 50 *L aliquot of the quenched sample (~ 200 pmol protein 
sample) was then injected on to a chilled nanoUPLC sample manager (beta test version, 
Waters, Milford, MA) as previously described (Engen et al., 2008). The sample was 
washed through a 2.1 x 30 mm immobilized pepsin column (Porozyme, ABI, Foster City, 
CA) using 100 *L/min 0.05% formic acid in water. Digested peptides were trapped on a 
2.1 x 5 mm C18 trap (ACQUITY BEH C18 VanGuard precolumn, 1.7 *m resin, Waters, 
Milford, MA) and peptides eluted using an 8%–40% gradient of acetonitrile in 0.1% 
formic acid at 40 *L/min, which was supplied by a nanoACQUITY Binary Solvent 
Manager onto a reverse phase column (Acquity UPLC BEH C18 column, 1.0 x 100 mm, 
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1.7 *m, Waters, Milford, MA). Peptides were detected and mass was measured on a 
Synapt HDMS mass spectrometer (Waters, Manchester, UK) acquiring in the MSE mode, 
a nonbiased, nonselective CID method (Bateman et al., 2002; Li et al., 2009; Shen et al., 
2009; Silva et al., 2005). 
Sequence identifications were made from MSE data from undeuterated samples 
using ProteinLynx Global Server 2.4 (beta test version) (Waters, Milford, MA) (Li et al., 
2009) (Geromanos et al., 2009) and searched against the sequence of KATms with no 
enzyme specified, and no modifications of amino acids. Identifications were only 
considered if they appeared at least twice out of three replicate runs. The precursor ion 
mass tolerance was set at <10 ppm and fragment ion tolerance was set at <20 ppm. Only 
those peptides that satisfied the above criteria through Database search pass 1 were 
selected (Li et al., 2009). The default criteria for false positive identification (Value = 4) 
was applied. It should be noted that MSE does not produce quadrupole isolated tandem 
MS (MS/MS) spectra, and hence is not optimal for submission to traditional search 
engines. These identifications were mapped to subsequent deuteration experiments using 
prototype custom software (HDX browser, Waters, Milford). Data on each individual 
peptide at all time points were extracted and exported to HX-Express (Weis et al., 2006) 
for analysis. A total of 48 peptide fragments yielded primary sequence coverage of 90% 
(Table 3.1).  
Continuous instrument calibration was carried out with Glu-fibrinogen peptide at 
100 fmol/*L. We also visually analyzed the data to ensure only well-resolved peptide 
isotopic envelopes were subjected to quantitative analysis. A control experiment was 
carried out to calculate the deuterium back exchange loss during the experiment by 
incubating ligand-free Protein Kinase A regulatory subunit [RI"(91-244)] with deuterated 
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buffer for 24 h at room temperature. All reported deuterium exchange values were 
corrected for a 32.7% back exchange by multiplying the raw centroid values by a 
multiplication factor of 1.49 (Anand et al., 2010; Badireddy et al., 2011). HDXMS results 
for the cAMP-binding domain of KATms were mapped onto the homology modeled 
cAMP-bound structure generated on the basis of the crystal structures of the CNB 
domains of PKA RI" (PDB ID: 1RGS)  using SWISS-MODELLER (Arnold et al., 2006) . 
3.3 Results 
3.3.1 Conformational changes in KATms monitored by BRET  
We have recently utilized BRET as a means of monitoring conformational changes in 
proteins that interact with cyclic nucleotides (Biswas et al., 2008; Biswas and 
Visweswariah, 2011).  BRET is based on energy transfer between luminescence donor 
and 0uorescent acceptor proteins (e.g. Renilla luciferase  (Rluc)  and  green  0uorescence  
protein  (GFP)) (Pfleger and Eidne, 2006) and is dependent on the distance between the 
donor and the acceptor, their spectral overlap, and their orientation with respect to each 
other. Since the ef/ciency of resonance energy transfer depends on the sixth power of the 
distance between donor and acceptor, even a minimal movement of the two moieties 
toward each other, or away from each other, would result in a change in the BRET ratio, 
which can be monitored in a non-destructive way in solution.   
cAMP-mediated regulation of acetytransferase activity of KATms (Nambi et al., 
2010) suggested that conformational changes occur upon cAMP binding to the CNB 
domain. We therefore attempted to probe these cAMP-dependent conformational changes 
in KATms using BRET.  We used a fusion protein construct of KATms  inserted between 
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GFP2 and luciferase (Fig. 3.1A, (Biswas et al., 2008)). Addition of cAMP to lysates 
expressing the KATms BRET sensor led to a significant increase in BRET ratio (Fig. 
3.1B). The concentration of cAMP required to induce this BRET ratio change was similar 
to the affinity of cAMP binding to purified full length KATms (Fig. 3.1C, (Nambi et al., 
2010)). An analog of cAMP, Sp-cAMPS was able to induce a BRET ratio increase similar 
to that seen with cAMP (Fig. 3.1B).  Addition of Rp-cAMPS increased the BRET ratio to 
a lower extent than that seen for cAMP or Sp-cAMPS.  This is of relevance in 
 experiments that are detailed below.  
Acetyl CoA is used by the AT domain of KATms as a donor of the acetyl group 
that is transferred to the e-amino acid side chain of a specific Lys residue in the Universal 
Stress Protein (USP), MSMEG_4207 (Nambi et al., 2010). We therefore monitored 
BRET in the presence of acetyl CoA and USP at concentrations that would saturate the 
enzyme.  As shown in Fig. 3.1B, no change in BRET was seen in the presence of either 
substrate, and USP did not alter the BRET ratio induced by cAMP in the sensor. 
Therefore, substrate binding to the catalytic site did not alter the structure of KATms to a 
level that could be detected by changes in the BRET ratio. 
To confirm that the increase in BRET ratio seen in the presence of cAMP was a 
consequence of cAMP binding to the CNB domain, we constructed BRET sensors with 
mutations in the CNB and the AT domains. We have shown earlier that mutation of R95 
to Lys (found in the PBC) completely abolished cAMP binding to purified KATms 
(Nambi et al., 2010), and as shown in Fig 3.1D, no increase in the BRET ratio was seen 
upon addition of cAMP to this mutant sensor. In contrast, a mutation in the AT domain 
(E234 to Ala) did not affect cAMP binding to KATms (Nambi et al., 2010) and a robust 
response to cAMP was seen in the E234A mutant BRET sensor construct (Fig. 3.1D). 
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 These results therefore validated the BRET assay as a means of monitoring 










3.3.2 Cyclic AMP binding induces large conformational changes throughout the CNB 
domain  
The change in BRET in the KATms sensor in the presence of cAMP is a result of a 
conformational change that allowed the coming together of GFP and luciferase, or a 
reorientation of the two domains, such that the resonance energy transfer was more 
 
Figure 3.1 Monitoring conformational changes in KATms by BRET. A) Cartoon 
representation of the construct of KATms used for BRET. Full length KATms (residues 
1_333) is sandwiched between GFP and luciferase (Luc). AT, acetyltransferase domain. 
B) Lysates were prepared from HEK293T cells expressing the KATms construct and 
BRET measured in the presence of cAMP (1 mM), acetyl CoA (50 _M) USP (1 _M), 
Rp_cAMPS (1 mM) or Sp_ cAMPS (1 mM) as indicated. Basal represents the ratio 
observed of lysates taken directly for measurements. C) Varying concentrations of cAMP 
were added to lysates from cells expressing the KATms construct and the BRET ratio 
measured. D) Constructs expressing either wild type or mutant KATms as indicated were 
transfected into HEK293T cells and lysates prepared. Aliquots were taken for BRET 
measurements. Data shown in all experiments represent the mean ± SEM of duplicate 
determinations with assays repeated thrice. 
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efficient.  In order to determine the magnitude of conformational change, localize the 
regions of KATms that undergo significant alteration in structure upon cAMP binding, 
and compare dynamics in the cAMP-free and bound states, HDXMS was performed with 
purified KATms.  
 3.3.3 Amide Hydrogen/Deuterium exchange mass spectrometry analysis 
 Deuterium exchange into rapidly exchanging backbone amides in KATms in the  
presence and absence of cAMP was carried out by incubating all protein samples in 
buffer containing D2O (pH 7.0) at 25 °C, followed by quenching and complete pepsin 
proteolysis under amide exchange quench conditions as described in Experimental 
Procedures. A total of 45 pepsin fragmentation peptides yielded sequence coverage of 
~90% (Fig. 3.2). Table 3.1 summarizes the extent of deuteration for all the peptides from 
which quantitative data were obtained. 
 
Figure 3.2: Sequence coverage map for MSMEG_5458 protein. Amino acid sequence 
of MSMEG_5458 (1 – 333) from N- to C-terminal. Solid line represents the pepsin 
digest fragments analyzed by semi automated HX-express.  
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       Deuterons Exchangeda  












1 LTEVRAADL (987.54)(+1) 4-12 8 5.3 ± 0.1 5.7 ± 0.1 5.6 ± 0.1 5.1 ± 0.1 
2 
FTGCRPSALEPLATQLRPLKAEPGQVL 
(723.90)(+4)  18-41 22 12.4 ± 0.1 13.5 ± 0.1 13.2 ±0.0 -  
3 QLRPLKAEPGQVL (724.934)(+2) 32-44 10 4.6 ± 0.0 5.0 ± 0.0 4.9 ± 0.0 4.6 ± 0.1 
4 GQVLIRQGDPALTFMLIESGRV (800.76)(+3) 41-62 20 7.7 ± 0.0 8.5 ± 0.0 8.1 ± 0.1 7.5 ± 0.0 
5 IRQGDPALTFM (624.83)(+2) 45-55 9 4.1 ± 0.0 4.4 ± 0.0 4.2 ± 0.0 4.1 ± 0.0 
6 LIESGRVQVSHAVADGPPIVL (1079.11)(+2) 56-76 18 6.8 ± 0.2 10.1 ± 0.0 10.1 ±0.0 7.8 ± 0.2 
7 VADGPPIVL (880.510)(+1) 68-76 6 3.1 ± 0.1 3.9 ± 0.0 3.8 ± 0.0 3.4 ± 0.0 
 [IESGRVQVSHA] [57-68] 11 3.7 6.1 6.0 4.0 
8 DIEPGLIIGE (1055.559)(+1) 77-86 8 3.4 ± 0.0 4.3 ± 0.0 4.2 ± 0.0 3.6 ± 0.1 
9 LRDAPRTATVVAAEPVIGWVGDRDAF(928.164)(+3) 90-115 23 5.7 ± 0.0 7.4 ± 0.1 7.1 ± 0.1 5.9 ± 0.0 
10 EPVIGWVGDRDAF (1460.73)(+1) 103-115 11 2.7 ± 0.2 2.7 ± 0.0 2.7 ± 0.2 2.4 ± 0.2 
11 PVIGWVGDRDAF (666.341)(+2) 104-115 11 1.9 ± 0.0 2.1 ± 0.0 2.0 ± 0.0 2.0 ± 0.0 
 [RDAPRTATVVAA] [91-102] 11 3.0 4.7 4.4 3.5 
12 DTILHLPGMF (1143.58)(+1) 116-125 8 2.4 ± 0.1 2.5 ± 0.0 2.4 ± 0.1 2.1 ± 0.1 
13 ITPIPVQVRTGEW (748.42)(+2)  140-152 10 5.6 ± 0.0 5.7 ± 0.0 5.9 ± 0.1 6.0 ± 0.0 
14 FYLRPVLPGDVERTLNGPVE (757.74)(+3)  153-172 16 8.0 ± 0.0 9.1 ± 0.0 8.6 ± 0.2 8.0 ± 0.0 
15 FYLRPVLPGDVERTLNGPVEF (806.766)(+3) 153-173 17 8.3 ± 0.0 9.3 ± 0.1 8.9 ± 0.2 8.2 ± 0.0 
16 YLRPVLPGDVERTLNGPVEF (757.746)(+3) 154-173 16 8.5 ± 0.0 9.5 ± 0.0 9.1 ± 0.2 8.3 ± 0.0 
17 ERTLNGPVEF (1161.581)(+1) 164-173 8 5.1 ± 0.1 5.1 ± 0.0 4.7 ± 0.1 4.3 ± 0.1 
 [LRPVLPGDV] 155-164 7 3.4 4.4 4.4 4.0 
18 YLFEVD (785.368)(+1) 195-200 5 3.3 ± 0.0 3.4 ± 0.0 3.4 ± 0.1 3.3 ± 0.0 
 
99 
19 FEVDYADH (995.404)(+1) 197-204 7 3.8 ± 0.1 3.9 ± 0.1 3.9 ± 0.1 3.8 ± 0.1 
20 FEVDYADHFVW (714.32)(+2) 197-207 10 3.7 ± 0.0 3.6 ± 0.0 3.7 ± 0.0 3.6 ± 0.1 
21 VWVMTEGALGPVIADARF (966.506)(+2) 206-223 16 4.6 ± 0.1 4.4 ± 0.1 4.4 ± 0.1 4.5 ± 0.1 
22 VMTEGALGPVIAD (1272.65)(+1) 208-220 11 4.7 ± 0.1 4.5 ± 0.0 4.3 ± 0.0 4.4±0.2 
23 TEGALGPVIAD (1042.54)(+1) 210-220 9 2.9 ± 0.0 2.9 ± 0.0 2.9 ± 0.1 2.7 ± 0.0 
24 TEGALGPVIADARF (708.88)(+2) 210-223 12 3.8 ± 0.0 3.8 ± 0.0 3.8 ± 0.0 3.8 ± 0.0 
25 RFVREGHNATMAE (759.37)(+2)  222-234 12 4.6 ± 0.4 4.6 ± 0.2 4.4 ± 0.1 4.4 ± 0.0 
26 VREGHNATMAE (1214.55)(+1) 224-234 10 3.6 ± 0.1 3.7 ± 0.0 3.4 ± 0.4 3.5 ± 0.3 
27 VAFTVGDD (823.381)(+1) 235-242 7 3.6 ± 0.0 3.4 ± 0.0 3.5 ± 0.0 3.5 ± 0.0 
28 VAFTVGDDYQGRGIGSF (894.933)(+2) 235-251 16 8.0 ± 0.1 8.3 ± 0.0 7.9 ± 0.0 7.7 ± 0.1 
29 VAFTVGDDYQGRGIGSFL (951.473)(+2) 235-252 17 7.6 ± 0.1 7.8 ± 0.1 7.4 ± 0.0 7.5 ± 0.0 
30 FTVGDDYQGRGIGSFL (866.42)(+2) 237-252 15 6.8 ± 0.0 7.0 ± 0.0 6.7 ± 0.0 6.8 ± 0.0 
31 TVGDDYQGRGIGSFL (792.889)(+2) 238-252 14 6.7 ± 0.0 7.0 ± 0.1 6.6 ± 0.1 6.7 ± 0.1 
32 LIVSAN (616.36)(+1) 256-261 5 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 0.2 ± 0.0 
33 IVSANY (666.34)(+1) 257-262 5 0.8 ± 0.1 0.8 ± 0.0 0.8 ± 0.1 0.7 ± 0.1 
34 IVSANYVGVQRFNA (769.409)(+2) 257-270 13 2.6 ± 0.1 2.7 ± 0.1 2.5 ± 0.1 2.4 ± 0.2 
35 RVLTDNM (848.424)(+1) 271-277 6 3.8 ± 0.0 3.9 ± 0.0 3.8 ± 0.0 3.8 ± 0.0 
36 RVLTDNMA (919.459)(+1) 271-278 7 4.4 ± 0.1 4.7 ± 0.0 4.3 ± 0.0 4.3 ± 0.0 
37 AMRKIMDRLGAV (680.882)(+2) 278-289 11 8.1 ± 0.0 7.9 ± 0.1 8.1 ± 0.0 8.3 ± 0.1 
38 AMRKIMDRLGAVW (773.92)(+2) 278-290 12 8.6 ± 0.0 8.7 ± 0.0 8.6 ± 0.1 8.7 ± 0.0 
39 LGAVWVRED,(1044.533)(+1) 286-294 8 3.6 ± 0.0 3.7 ± 0.1 3.6 ± 0.1 3.6 ± 0.0 
40 WVREDLG (437.720)(+2)   290-296 6 3.5 ± 0.0 4.0 ± 0.0 3.6 ± 0.1 3.5 ± 0.0 
41 VREDLGVVM (1017.53)(+1) 291-299 8 5.5 ± 0.01 5.3 ± 0.0 5.5 ± 0.0 5.6 ± 0.0 
42 REDLGVV (787.43)(+1) 292-298 6 3.4 ± 0.0 3.5 ± 0.0 3.0 ± 0.0 3.3 ± 0.1 
43 LGVVMTEVDVP (1158.62)(+1)  295-305 9 2.6 ± 0.0 2.7 ± 0.1 2.6 ± 0.1 2.6 ± 0.0 
44 
TEVDVPPVDTVPFEPEL(941.969) 
(+2) 300-316 12 6.6 ± 0.1 6.6 ± 0.1 6.5 ± 0.0 6.5 ± 0.1 
45 IDQIRDATRKVIRA(827.98)(+2) 317-330 13 5.8 ± 0.0 5.5 ± 0.1 5.7 ± 0.1 5.8 ± 0.1 
Table 3.1: Summary of amide H/D exchange for apo and ligand-bound states of KATms 
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Data are reported as the average number of deuterons exchanged after 10 min 
for at least two independent experiments.  A Butterfly Plot (Houde et al., 2011) was 
used to provide a protein-wide overview of the relative deuterium exchange for apo 
and cAMP-bound states for a short time course (0 -10 min; Fig. 3.3). It should be 
noted that this plot displays all individual deuterium-exchanged pepsin-digest 
fragments equally, and does not factor in the preferential cleavage of pepsin after 
specific amino acids or regions of the protein. Nevertheless, it provides a snapshot 
overview of the exchange across the entire protein and complements information in 
tabular formats.  
Figure 3.3 HDXMS of KATms in the presence and absence of cAMP. A) 
Butterfly plot showing the average relative fractional exchange (deuterons 
exchanged/maximum exchangeable amides) (y-axis) for all the pepsin digest 
fragments of KATms listed from N- to C-terminus (x-axis) for Apo (top) and 
cAMP-bound (bottom).  Each trace represents a time point for deuterium exchange 
1 min (orange), 2 min (brown), 5 min (blue), 10 min (black), and represent the 
results from two independent experiments. B) Difference plot highlighting changes 
in deuterium exchange upon cAMP binding. Color scheme for traces are the same 
as in A. Two blue color boxes with dashed lines highlight the regions of the 
protein showing decreased exchange upon cAMP binding. Domain organization of 
KATms, N-terminal, CNB and C-terminal lysine acetyltransferase domain 




Both the CNB and AT domains showed regions of high and moderate 
deuterium exchange at early time points, but interestingly, decreased exchange upon 
cAMP binding was observable in the CNB domain alone (Fig. 3.3). Mass spectra for 
peptides showing the largest magnitude shifts, along with plots showing deuterium 
exchange versus time, are shown in (Fig. 3.4). No increases in amide exchange upon 
cAMP binding were observed, indicating that the decreased exchange reflected a 
combination of cAMP binding interactions and increased ordering of the CNB domain 
upon cAMP binding. This appeared to be the basis for the allosteric coupling of 
cAMP binding to the acetytransferase domain (Fig. 3.3) and (Table 3.1). 
The region showing the largest magnitude changes in deuterium exchange 
were peptides spanning residues 56-115 in the N-terminal region of the CNB domain. 
These spanned the PBC containing invariant Glu and Arg residues which are critical 
for anchoring the 2’OH of the ribose sugar and the phosphodiester bond in the RIa 
subunit of PKA and other CNB domains. The changes that are observed are similar to 
and consistent with those reported for the CNB domain of PKA (Badireddy et al., 
2011) and are expectedly pronounced within the PBC region of the protein. Peptide 
(77-86) containing conserved Gly 85 and Glu 86, the two residues interacting with 
ribose moiety of cAMP, showed decreased exchange (~1 Deuteron) compared to the 
apo protein (Table 3.1). These two invariant residues, correspond to Gly 199 and Glu 
200 in PKA RIa, that mediate H-bonding with the 2’OH moiety of ribose group of 
cAMP. Peptide (90-115) containing conserved Arg 95 and Ala 88 residues that 
interact with the exocyclic oxygen atoms of the phosphodiester bond, showed 
decreased exchange (~2 Deuterons) in the cAMP-bound state (Table 3.1).  These two 
residues correspond to the invariant Arg (Arg 209 in PKA RIa) and Ala (Ala 202 in 




Figure 3.4: A) ESI-Q-TOF mass spectra for 3 different pepsin digest fragments of 
MSMEG_5458, which showed significant difference upon cAMP/Sp binding. 
Comparison of amide exchange in the apo, ligand bound states. (i) The isotopic envelope 
for the same peptide from apo MSMEG_5458 following 10 min deuteration; (ii) The 
isotopic envelop for the same peptide from Rp bound MSMEG_5458 following 10min 
deuteration; (iii) The isotopic envelope for the same peptide from Sp cAMPS bound 
following 10 min deuteration; (iv) The isotopic envelope for the same peptide from cAMP 
bound MSMEG_5458 following 10min deuteration; (v) Undeuterated apo MSMEG_5458 
apo. The peptides are m/z = 928.164, z=3, MSMEG_5458 (90-115); m/z = 1079.11, z = 2, 
MSMEG-5458 (56-76); m/z = 757.74, z = 3, MSMEG_5458 (153-173). B) Time course 
(0.5-10min) of deuterium exchange for peptides [(90 – 115), (56 – 76) and (153 – 173)] 
from MSMEG_5458. Open circle for apo (o), MSMEG_5458; Closed circle (!), cAMP-
bound MSMEG_5458; closed triangle (!), Sp-bound MSMEG_5458; Closed Square ("), 




Regions outside the PBC within the CNB domain that showed decreased 
amide exchange span peptide (56-76; ~ 3.0 Deuterons decrease in exchange) in the 
cAMP-bound state. An overlapping peptide (68-76) also showed decreased exchange 
in the cAMP bound state. Subtractive analysis enabled localization of cAMP-
dependent shifts in deuterium exchange to residues 57-68 (Table 3.1). Interestingly, 
this segment contains a conserved Val that has been postulated to contribute to a 
‘hydrophobic sandwich’ which positions the adenine ring of cAMP (Berman et al., 
2005).  Peptides (41 – 62), (60 – 88) and (90 – 115) containing conserved 
hydrophobic residues Leu 44, Ile 45, Gly 48, Ile 87 and Ala 97 all showed decreased 
exchange in the cAMP bound state (Fig. 3.3 and Table 3.1). A peptide (18-44) from 
the N-terminus also showed decreased exchange in the cAMP bound state.  
HDXMS results for the cAMP-binding domain of KATms were mapped onto 
the homology modeled cAMP-bound structure of the CNB domains of PKA RI# 
(PDB ID: 1RGS)  using SWISS-MODELLER (Arnold et al., 2006). Comparison of 
the cAMP-dependent shifts in relative deuterium exchange across PKA RI# (7) and 












In PKA RIa, the regions showing the larger relative shifts in deuterium 
exchange were localized to the PBC, compared to the rest of the CNB domain 
(Badireddy et al., 2011). In KATms in contrast, the butterfly plot (Fig. 3.3) 
demonstrates that the rest of the CNB domain, outside the PBC, showed larger 
magnitude shifts in deuterium exchange upon interaction with cAMP. Interestingly, 
no changes were observable in regions previously reported to be associated with 
allosteric relays in PKA or Epac (Bateman et al., 2002; Rehmann et al., 2003). This 
suggests that the CNB domain in KATms functions as a simpler cyclic nucleotide 
binding-induced switch. 
We refer to the region between the N-terminal CNB domain and the C-
terminal AT domain as the linker region. In addition to the changes observed at the 
CNB domain, binding of cAMP induced significant changes in this linker region. For 
example peptide (153 – 172) showed decreased exchange upon cAMP binding (~1 
Deuteron), which is also seen with overlapping peptides (153 – 173), (153 – 164) and 
(154 – 173) (Table I). Subtractive analysis enabled localization of cAMP-dependent 
shifts in deuterium exchange to residues 153-164 (Table 3.1), indicating that effects of 
cAMP binding to the CNB domain were transmitted to distal regions of the protein.  
Finally, no significant changes in exchange were observed in any peptide in the AT 
domain on cAMP binding. We concluded, therefore, that the lower level of AT 
Figure 3.5 Conformational changes in the CNB domain of PKA and KATms.  
Structure of cAMP-bound CNB-A of PKA R-subunit (PDB ID: 1RGS (Su et al., 1995)) 
highlighting in blue the regions showing decreased deuterium exchange in the presence 
of cAMP. Residues Glu 200 and Arg 209 coordinate binding to the ribose 2$-OH, and 
the equatorial and axial oxygen atoms of cAMP are displayed in sticks. Arrow A 
highlights the Arg 209- equatorial oxygen- Asp 170 allosteric relay in PKA RI". Arrow 
B highlights the hydrophobic switch mediated by Leu 203 and Ile 204 with ":B/C 
helices. B) CNB domain of MSMEG_5458 was modeled in the SWISS MODEL 
automated server using structural coordinates of PKA RI" (PDB ID:1RGS) as a 
template. cAMP-bound MSMEG_5458 CNB domain model highlighting in blue the 




activity seen in the absence of cAMP (Nambi et al., 2010) was not due to an inactive 
conformation of the AT domain that precluded substrate binding and/or catalysis. 
Instead, the increase in AT activity seen on cAMP binding to KATms was a 
consequence of the relay of information transmitted from the CNB domain to the AT 
domain via the linker region, which perhaps relieves some inhibition on the AT 
domain in the non-cAMP bound conformation of the protein.  
3.3.4 Differential effects of the cAMP analogs 8Br-Sp-cAMPS and 8Br-Rp-cAMPS 
We have shown earlier that the CNB domain in KATms binds Sp-cAMPS with an 
affinity comparable to that of cAMP (IC50 65 ± 12.3 nM), whereas the corresponding 
Rp isomer showed a much lower affinity of interaction (IC50  23.1± 1.6 mM) (Nambi 
et al., 2010).  Not only  does this underscore the significance of the equatorial oxygen 
atom in the exocyclic oxygens of the cyclic phosphodiester bond of cAMP for binding 
tightly at the PBC of CNBs (Badireddy et al., 2011; Berman et al., 2005), but also 
highlights the importance of equatorial oxygen-guanidinium moiety interactions with 
Arg 95 in anchoring cAMP to the pocket.  
It was of interest to test the effects of these analogs on allostery, as has been 
described earlier for the regulatory subunit of PKA (Anand et al., 2010; Das and 
Melacini, 2007).  We have used 8-bromo substituted cAMP analogs in the current 
study since they are more stable in solution (Schwede et al., 2000).  Sp-bound KATms 
showed nearly identical changes in deuterium exchange to those seen with cAMP, 
with peptide 56 – 76 alone showing slightly higher exchange (~1 Deuteron) in the 
complex with Sp-cAMPS, than in the complex with cAMP (Table 3.1; Figs. 3.4 and 
3.6).  Factoring in the lower affinity of Rp-cAMPS for KATms compared to Sp-
cAMPS (Nambi et al., 2010), we carried out HDXMS studies under conditions where 
a majority of protein would be bound to Rp-cAMPS.  Interestingly, there was no 
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difference in deuterium exchange between the apo-protein and protein bound to Rp-
cAMPS (Fig. 3.6). This was surprising as in comparative studies with PKA, the PBC 
pocket did show decreased exchange in the presence of Rp-cAMPS, even though the 
binding affinity of Rp-cAMPS was lower (Badireddy et al., 2011). Therefore, our 
results seem to indicate a high level of dynamics at the binding site of KATms in the 
presence of Rp-cAMPS, that was faster than the intrinsic rate of deuterium exchange 





Figure 3.6 HDXMS of KATms in the presence of Sp-cAMPS or Rp-cAMPS. (A) 
Butterfly plot showing the average relative fractional exchange (Deuterons 
exchanged/Maximum exchangeable amides) (y-axis) for all the pepsin digest-
fragments of KATms listed from N- to C-terminus (x-axis) for Rp-cAMPS-bound 
(top) and Sp-cAMPS-bound (bottom); each trace represents a time point for deuterium 
exchange 1 min (orange), 2 min (brown), 5 min (blue), 10 min (black). These data 
represent the results from two independent experiments. (B) Difference plot localizing 
changes in deuterium exchange between cAMP analogs Rp-cAMPS and Sp-cAMPS. 
Color scheme for plots same as in A. Two blue color boxes with dashed lines highlight 
the regions of the protein showing decreased exchange in presence of Sp-cAMPS 
binding. Domain organization of KATms, N-terminal, CNB and C-terminal 




3.3.5 Linker region is important for propagating cAMP-induced conformational 
changes in KATms  
HDXMS suggested that the effects of cAMP did not result in a dramatic 
conformational change in the AT domain.  Biochemical evidence for this was 
provided by performing acetytransferase assays with KATms in the presence and 
absence of cAMP.  As shown in (Figure 3.7A), while the Km for acetyl CoA was not 
altered in the presence of cAMP, the Vmax of acetylation of its substrate USP was 
increased.  This indicated enhancement of catalysis in the presence of cAMP in the 
absence of a dramatic change in binding affinities to acetyl CoA.  Acetylation of USP 
was monitored in the presence and absence of cAMP and as shown in (Fig. 3.7B), the 
presence of cAMP increased the efficiency of acetylation of low concentrations of 
USP.  This suggests that the conformational change induced by cAMP facilitates more 
efficient binding of USP to the catalytic site.  
HDXMS indicated significant exchange in the linker region in the presence of 
cAMP. To confirm that the linker region was important in propagating the effects of 
cAMP binding to the acetyltransferase domain, we generated an additional construct 
for BRET analysis that was truncated before the AT domain, encompassing the CNB 
domain and the linker region. As shown in (Figure 3.7C), an increase in the BRET 
ratio was observed in the presence of cAMP, at concentrations that were close to that 
seen for the full length protein (Fig. 3.1C).  Therefore, these results show that the 
linker region does indeed participate in the relay of information from the CNB domain 
to the AT domain in KATms, as suggested by the HDXMS data, emphasizing the 











3.3.6 Mutations in the linker region abolish cAMP-mediated activation of AT 
activity  
A PXXP motif (residues 157-160) is found in the peptide in the linker region which 
showed maximum changes in response to cAMP in HDXMS analysis (residues 153-
164).   In order to validate the importance of this motif in mediating cAMP-induced 
regulation of AT activity, we mutated residues Pro 157 and Pro 160 to Ala.  The 
mutant protein was purified, and it showed a similar to affinity to cAMP as the wild 
type protein (Fig. 3.8A).  We monitored the AT activity of the wild type and mutant 
proteins in the presence of cAMP, Sp-cAMPS or Rp-cAMPS using western blot 
analysis and a coupled acetytransferase enzyme assay (Fig. 3.9).  As shown in (Figs. 
3.8B and 3.8C), Sp-cAMP was able to enhance acetylation of USP by wild type 
KATms to a similar extent to that seen with cAMP.  This is in agreement with the 
Figure 3.7 Allostery in KATms mediated via the linker region. A) KATms was 
incubated with varying concentrations of acetyl CoA, either in the presence or absence 
of cAMP.  Western blot analysis of the samples was performed using acetyl lysine 
antibody and densitometric analysis of immunoreactive bands was analyzed as 
detailed in experimental procedures.  The data shown represents the mean ± SEM of 
assays performed thrice. B) Varying concentrations of USP were used in an 
acetylation reaction using KATms either in the presence or absence of cAMP.  
Samples were subjected to western blot analysis using an acetyl lysine antibody.  The 
blot shown is representative of assays performed thrice and demonstrates that in the 
presence of cAMP, lower concentration of USP can be acetylated more efficiently.  C) 
A construct of the CNB and the linker domain fused at the N-terminus to GFP and the 
C-terminus to luciferase (inset) was transfected into HEK293T cells. Lysates were 
prepared and BRET measured in the presence of varying concentrations of cAMP. 




BRET ratio and HDXMS data that demonstrated similar conformational changes 
induced by Sp-cAMPS and cAMP (Figs. 3.1B and Fig. 3.5). The presence of Rp-
cAMPS did not result in an increase in the rate of acetylation of USP, which can be 
correlated with the lower change in BRET that was induced in the KATms sensor in 
the presence of Rp-cAMPS (Fig. 3.1B). Importantly, no increase in the rate of 
acetylation of USP in the presence of cAMP was observed in the mutant protein, 
indicating the essential requirement of the proline residues in the relay of 
conformational changes from the CNB domain to the AT domain (Fig. 3.8B and 3.8C 
and Fig. 3.9).  Activation of AT activity by Sp-cAMPS was also lost in the mutant 
protein, indicating that similar conformational changes are induced by Sp-cAMPS and 
























Figure 3.9 Acetyltransferase activities of wild type and KATmsP157,160A 
proteins. Activities were measured using the coupled assay (29). Proteins (1 ìg 
each) were assayed in the presence of 30 µM acetyl-CoA and 50 µM USP. The 
initial rate of formation of NADH is shown, after subtracting the change in 
absorbance at 340 nm that is seen in assays performed in the absence of the 
enzymes, which was usually ~ 1% of the change seen in the presence of enzyme. 
Figure 3.8 Identification of critical residues in the linker region that mediate 
cAMP-induced activation of KATms.  A) KATmsP157,160A was purified and 
incubated with 3H-cAMP in the presence of varying concentrations of cAMP as 
indicated.  Radioactivity associated with the protein was monitored following 
filtration through nitrocellulose filters.  Values shown represent the mean ± SEM of 
assays repeated thrice. B) Wild type or mutant KATms was incubated with either 
cAMP, Rp-cAMPS or Sp-cAMPS or buffer alone in the presence of acetyl CoA and 
USP and then subjected to western blot analysis with acetyl lysine antibody (Nambi 
et al., 2010).  Following blotting, the membrane was stained with Coomassie stain to 
visualize equivalent amounts of USP in the lanes. Data shown is representative of a 
blot repeated thrice. C) Continuous acetylation assays were performed with either 
wild type or mutant KATms in the absence or presence of either cAMP, Sp-cAMPS 
or Rp-cAMPS (Nambi et al., 2010).  The kinetic traces are shown in Supplemental 
Figure 3 and the fold increase in rate over that seen in the absence of cAMP is 




3.3.7 Linker-mediated conformational changes in the presence of cAMP are 
conserved in Rv0998  
We have earlier shown that the ortholog of KATms from M. tuberculosis (product of 
the Rv0998 gene; KATmt), was able to acetylate USP in a strictly cAMP-dependent 
manner, and the affinity of KATmt for cAMP was markedly reduced (IC50 ~ 100 mM) 
(Nambi et al., 2010).  A sequence alignment of these two proteins shows striking 
conservation of residues in the linker region which showed the maximum shifts in 
deuterium exchange upon cAMP binding (residues 158-165; Fig. 3.10A).  Therefore, 
Pro 160 and Pro 163 in KATmt (at positions equivalent to Pro 157 and 160 in 
KATms) were mutated to Ala to determine if the conformational relay was similar in 
these two proteins.   
Mutant KATmt showed a similar affinity of cAMP binding as the wild type 
protein (Fig. 3.10B).  While wild type KATmt was able to acetylate USP in a cAMP-
dependent manner (Fig. 3.10C), the mutant protein showed a complete loss of cAMP-
dependent acetytransferase activity. This clearly indicates that the dynamics of 
cAMP-induced conformational change in KATms and KATmt are similar, and 
involve identical residues in the linker region.  Therefore, despite the early divergence 
of mycobacteria into fast growing (e.g. M. smegmatis) and slow growing (M. 
tuberculosis) species, the mechanism by which a CNB domain regulates an associated 
























Figure 3.10 Conserved mechanism of allosteric activation of KATmt by cAMP. 
A) Sequence alignment of Rv0998 (KATmt) and MSMEG_5458 (KATms).  Shown 
in green are residues in the CNB domain.  Residues highlighted in yellow indicate 
regions that showed maximum differences in HDXMS in the presence of cAMP 
which are found in the linker region.  Residues highlighted in pink represent the 
acetyltransferase domain.  Arrow head point to the conserved proline residues that 
were mutated in KATms and KATmt in this study.  B) Pro residues at 160 and 163 
were mutated to Ala in KATmt and the purified protein was interacted with 3H-
cAMP in the presence and absence of varying concentrations of unlabelled cAMP.  
Radioactivity bound to the protein was monitored following filtration through 
nitrocellulose filters, and data obtained was analyzed by GraphPad Prism.  Data 
shown represents the mean ± SEM of triplicate experiments.  C) Either wild type or 
mutant KATmt was incubated with USP and acetyl CoA, in the presence or absence 
of cAMP.  Samples were then subjected to western blotting with the acetyl lysine 





In this current study, the unique combination of BRET assays and HDXMS has 
enabled us to identify and measure the conformational dynamics of cAMP-dependent 
activation of a novel cAMP binding protein.  We have earlier shown that BRET is a 
useful tool to monitor cyclic nucleotide-dependent conformational changes not only in 
an isolated GAF domain (Biswas et al., 2008), but can also report on allostery in the 
full-length cGMP-binding, cGMP-specific phosphodiesterase, PDE5 (Biswas and 
Visweswariah, 2011).  These results formed the basis for our attempting to monitor 
conformational changes using BRET in full length KATms, where biochemical 
evidence indicated that cAMP binding regulated the associated catalytic domain that 
possessed acetytransferase activity (Nambi et al., 2010; Xu et al., 2011).   
There are three possible modes of how cAMP might enhance acetytransferase 
activity in KATms. These include a) relief of inhibition by the CNB domain upon 
binding to cAMP, b) facilitation of substrate/cofactor binding to the enzyme catalytic 
site and c) rearrangements of residues at the acetytransferase catalytic core leading to 
enhancement of catalysis. Comparison of Michaelis-Menten kinetic parameters in the 
cAMP-free and bound states show no difference in the KM for acetyl CoA (Fig. 3.7A) 
indicating that the enhanced acetytransferase activity is the result of an increase in the 
catalytic rate constant (kcat). In contrast, cAMP binding enhances the affinity of the 
enzyme for USP (Fig. 3.7B), suggesting that activation is at least partially through 
mode b.  
HDXMS results show no differences in deuterium exchange between the 
cAMP-bound and free states for any part of the AT domain, thereby precluding a 
model for enhanced catalysis resulting from a large-scale rearrangement of active site 
residues (c).  Together, these results suggest that the basis for activation is via a relief 
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of inhibitory effects of the CNB domain on AT activity by cAMP resulting in 
enhancement of substrate interactions.  
Binding of cAMP to KATms, resulted in decreases in deuterium exchange in 
the CNB domain and linker alone. This points to increased ordering of the CNB 
domain and consequently, reduced dynamics upon cAMP binding. The regions 
showing decreased exchange are consistent with other CNB domain-containing 
proteins, such as the PKA regulatory subunit and Epac (Brock et al., 2007; Rehmann 
et al., 2003). Interestingly however, the relative decreases in exchange across CNB 
domains in KATms differ from that seen in the PKA R-subunit, for the same time 
course of deuterium exchange examined. The reduction in exchange at the PBC in RIa 
was relatively larger than in the other parts of the CNB domain, especially those 
regions mediating interactions with the adenine ring. In contrast, in KATms, the 
magnitude shifts in deuterium exchange were larger in the regions spanning the 
adenine interaction regions relative to the PBC. This is significant as it underscores 
the differential importance of functional moieties of cAMP in the mycobacterial and 
other CNB domains. In PKA and Epac, HDXMS suggests that contacts within the 
PBC are more critical for cAMP binding (Brock et al., 2007; Rehmann et al., 2003), 
while in KATms, our results show that hydrophobic contacts with the adenine are just 
as, if not more, important than contacts at the PBC.  
In this regard, KATms shows interesting parallels with CAP from E. coli.  
CAP is a dimer in solution, with a long C/C’ helix connecting the CNB domain with 
the DNA binding domain. The C/C’ helices of each monomer are solely responsible 
for maintaining the dimeric interface (Popovych et al., 2009). cAMP binding has been 
proposed to activate CAP through coiled-helix transitions in the C/C’ helical region. 
These transitions have been proposed to be mediated by stabilization of CAP by 
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contacts with the adenine ring, interactions with the ribose and phosphodiester bonds 
or through rearrangements of the aromatic cap residue (Popovych et al., 2009). Given 
the larger magnitude shifts in regions of the protein that interact with the adenine ring, 
stabilization of KATms via interactions with the adenine ring might result in 
increased coil to helix transitions in the interdomain linker region, resulting in 
rearrangement of the AT domain and enhanced catalysis. Our BRET results on the 
truncated CNB-linker domain construct are further consistent with such a model).  
 HDXMS has been a valuable method for discerning the mechanistic aspects of 
allostery in cAMP-binding domains (Berman et al., 2005). In the case of Epac2, 
allostery upon cAMP binding is propagated via a conserved hydrophobic aromatic 
switch residue, Phe 435 (hinge region) and hydrophobic Leu 408 in the PBC. In PKA 
RIa, the corresponding residues include Leu 203, Ile 204 (PBC) and Tyr 229 (hinge) 
(Anand et al., 2002). While the importance of these residues in the relay have been 
demonstrated in Epac2, they have not been shown directly to be critical in allosteric 
activation of PKA (Anand et al., 2010). In PKA, allosteric communication relays are 
propagated from the PBC binding site via a conserved Asp 170 which couples the 
PBC and the intersubunit interface with the catalytic subunit (Anand et al., 2010; Das 
et al., 2007; Das and Melacini, 2007; Gibson et al., 1997). Significantly, no changes in 
amide exchange were seen in any regions of KATms outside the PBC that flanks the 
exocyclic equatorial oxygen of cAMP. This was surprising as in both Epac and PKA, 
such changes have provided insights into allosteric relays leading from this signaling 
locus. Importantly, there is no conservation of a residue equivalent to Asp 170 in 
either Epac or KATms, indicating that its role is unique to allosteric activation in PKA.  
Mutation of Arg 95 completely abolished cAMP binding to KATms 
underscoring the importance of this residue for anchoring cAMP interactions with the 
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CNB domain (Nambi et al., 2010), as is seen with all CNB domains. In agreement 
with this, no significant change in BRET was seen in the presence of cAMP with the 
R95K mutant protein (Fig. 3.1C), validating the use of BRET to monitor cAMP-
dependent conformational changes in KATms.  Unlike in Epac or PKA, HDXMS 
with KATms revealed that there is no sophisticated allosteric network radiating from 
the PBC to the AT catalytic core.  It is likely therefore that KATms is an example of a 
primordial CNB domain where conformational changes are a consequence of binding-
induced ordering alone. In the CNB domains of PKA and Epac, elaborate allosteric 
relays have evolved for better specificity. 
Sp-cAMPS and cAMP bind with similar affinities to KATms, and enhance 
acetytransferase activity (Fig. 3.8; (Nambi et al., 2010)).  This is consistent with 
studies on PKA, where Sp-cAMPS also functions as an agonist (Badireddy et al., 
2011; Dostmann and Taylor, 1991).  Rp-cAMPS, on the other hand, is the only 
identified antagonist or reverse agonist of PKA, (Anand et al., 2010; Dostmann and 
Taylor, 1991). In KATms, Rp-cAMPS shows a 1000-fold decreased binding affinity 
in comparison to cAMP or Sp-cAMPS (Nambi et al., 2010), reflecting the importance 
of the exocyclic equatorial oxygen atoms for high-affinity binding to the PBC of 
KATms.  Comparison of HDXMS of KATms with the Rp-cAMPS and Sp-cAMPS 
analogs reveals important differences. Changes seen with Sp-cAMPS were very 
similar to those seen in cAMP-bound KATms. In contrast, no changes in deuterium 
exchange were observable upon binding of Rp-cAMPS.  Since the observed rate of 
exchange, kobs, is dependent on both on-off kinetic rates of complexation, as well as 
the intrinsic deuterium exchange rate (Hughes et al., 2001), our results suggest that 
the kinetic off-rate for Rp-cAMPS is likely much faster, and/or the rate of 
reassociation is much slower, than the observed rate of deuterium exchange. This 
 
117 
would preclude capturing the binding event in Rp-cAMPS and its interactions with 
KATms in HDXMS.  
The only region outside the putative CNB domain that showed any differences 
in deuterium exchange was the linker region (residues 153-168).  That these changes 
in the linker region were important was also inferred from our BRET analyses, as the 
construct containing the CNB domain with the linker region showed the same 
magnitude of BRET responses upon cAMP binding as full-length KATms (Fig. 3.7C). 
This altered dynamics of the linker region upon cAMP binding suggests that the relief 
of inhibition by the N-terminal CNB domain on the acetyltransferase domain is 
achieved via the linker region, and this was supported by mutational analysis in the 
linker region (Figs.3.8 and 3.10). In Epac, the linker region which is entirely a-helical 
and leads away from the core of the CNB domain, is an important ‘lid’ region for 
capping interactions of cAMP at the PBC (Rehmann et al., 2003).  An analogous role 
for the linker in KATms seems less plausible as the putative linker is very long (~ 25 
residues) and furthermore, the decreased exchange is only observed at the C-terminal 
end of the linker region, away from the CNB domain.  However, secondary structure 
predictions do indicate that the residues between the CNB domain and the 
acetyltransferase domain can form a helix (Fig. 3.11 (Petersen et al., 2000)).  
Moreover, it is important to note that the mechanisms of activation via the linker 
regions are conserved in KATms and KATmt (Fig. 3.8 and 3.10), despite dramatic 











In conclusion therefore, HDXMS reveals a mechanism for cAMP-mediated 
activation of KATms explainable either through ‘Induced Fit’ or ‘Conformational 
Selection’ models or a combination of both models (Fig. 3.8 and 3.10), as we have 
reported earlier for PKA (Anand et al., 2002; Badireddy et al., 2011). According to 
the Induced Fit model, reduction in dynamics upon binding of cAMP to the CNB 
domain is propagated to the linker region connecting the CNB and AT domains, 
resulting in activation via rearrangement of domains and relief of inhibition. In the 
Conformational Selection model, cAMP binds and shifts the equilibrium toward the 
active cAMP-bound state. Here the linker region assumes a different conformation in 
the active cAMP-bound state, promoting enhanced catalysis through relief of 
inhibition. In the Induced Fit model, cAMP binding drives the conformational 
changes, while in the Conformational Selection model, cAMP binding shifts the 
equilibrium to favor the active state. Nevertheless, in both models, activation is 
achieved solely through stabilization of the linker region and the PBC and the b-barrel 
subdomain following binding by cAMP, obviating the need for elaborate allosteric 
relays for cAMP action. This is in contrast to what has been seen with other 
eukaryotic CNBs studied so far.  All other CNBs have conserved high affinity binding 
sites coupled to allosteric relays.   
Figure 3.11. Prediction of secondary structure in KATms using NetSurfP. 
Residues mutated in this study (P157 and P160) fall between two regions that are 
predicted to be "-helices. 
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Our HDXMS results are highly consistent with BRET analysis providing 
powerful insights into the mechanism of cAMP action.  This powerful convergence of 
results from two independent techniques reaffirms the complementary power of 
solution biophysical tools in unraveling the mechanistic basis of regulation of proteins, 











































Distinct modes of binding and conformational changes induced 
by cAMP and cGMP in the isolated GAF-B domain of 










GAF domains (cGMP regulated mammalian phosphodiesterases (PDEs), 
cycnobacterial adenylyl cyclases (ACs), and a formate-hydrogen lyase transcriptional 
activator) are small molecule binding regulatory domains. These small molecule 
binding GAF domains are present in >1600 proteins from prokaryotes to eukaryotes 
(Ponting and Aravind, 1997) (Aravind and Ponting, 1997) (Ho et al., 2000) 
(Anantharaman et al., 2001) (Zoraghi et al., 2004) for regulating its associated 
effector domain. Effector domains associated with GAF domains are mostly PAS, 
HTH, PEP_utilizers_C, GGDEF, EAL, HisKA and phosphodiesterase domains 
(Aravind and Ponting, 1997) (Finn et al., 2010) (Ponting and Aravind, 1997). The 
GAF domain (~150 amino acids) receives a signal through wide varieties of ligands in 
all kingdoms of life. In plants and cyanobacteria by bilin chromophores, 
Mycobacterium tuberculosis by haem and in cyanobacteria, unicellular parasitic 
eukaryotes and mammals by cyclic nucleotides cAMP, cGMP (Anantharaman et al., 
2001) (Zoraghi et al., 2004) and modulates activity of effector domain. Out of 11 
mammalian PDE super families, 2, 5, 6, 10 and 11 and adenylyl cyclases (ACs) in the 
cyanobacteria cyaB1 and cyaB2 have two-tandem arrays of N-terminal GAF domains 
(Zoraghi et al., 2004). Binding of cyclic nucleotide to this tandem array of GAF 
domains are assumed to allosterically regulate the C- terminal effector domains in 
mammals (Ho et al., 2000) (Zoraghi et al., 2004) (McAllister-Lucas et al., 1993) 
(McAllister-Lucas et al., 1995) (Soderling and Beavo, 2000). Throughout the 
evolution, the sequence of these domains have diversified substantially (Aravind et al., 
2002) but a motif of five residues (NKFDE) is conserved in most of the characterized 
cNMP-binding GAF domains (Zoraghi et al., 2004) . 
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Crystal and NMR structures of the cyclic nucleotide binding GAF domain for 
YKG9 protein (a yeast protein with unknown function) without cyclic nucleotide (Ho 
et al., 2000), tandem array of GAF domains of PDE2 and cyaB2 (Martinez et al., 
2005), cGMP bound GAFA domain of PDE5A (Heikaus et al., 2008), cGMP bound 
GAFA of PDE6C (Martinez et al., 2008) and cAMP-bound PDE10A GAF-B are 
available. A common structural feature of all these available structures of cyclic 
nucleotide binding GAF domains reveals that the GAF domain consists of a core of a 
six stranded antiparallel %-sheets at center and four # helices with #-helices separated 
by %-sheets in two groups. In all reported GAF domain structures, six-stranded %- 
sheets provide the floor and #-helices (#3 and #4) provide the roof of the binding 
pocket for cAMP binding.  
Unlike cAMP dependent protein kinase A (Arg 209 and Ala 210 residues of 
the protein stabilize phosphate) that is a primary component for cAMP mediated 
signaling, GAF domain bound cAMP`s cyclic phosphate is stabilized by the helical 
dipole at the N terminus of #3. Amino acid residues involved in hydrogen bond 
network with cAMP in the ligand-binding pocket include Arg 291 (H-bond with N1 
of cAMP), Thr 293 (H-bond with N6 and N7 of cAMP), Asp 356 and Asn 359 (water 
mediated H-bond with N3 of cAMP), and Ile 308 (hydrophobic contact to the adenine 
ring of cAMP).The conserved NFKDE motif (Charbonneau et al., 1990) and 
(McAllister-Lucas et al., 1995) found in the cyclic nucleotide binding GAF domain 
from PDE is important for the folding and stability of the GAF domain. Stability is 
attained through Hydrogenbond and salt bridge networks located separate from ligand 
binding pocket, indicating that this motif is not involved in ligand binding and 
nucleotide dependent conformational changes (Martinez et al., 2002). Although GAF 
domains share a common structural fold, PDE 2 and cyaB2 GAF domains display two 
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separate functions in cyclic nucleotide binding and dimerization. In PDE2, GAF 
domain A is involved in dimerization whereas GAF B domain is in complex with 
cGMP. In cyaB2, both tandem GAF domains A and B are involved in dimerization as 
well as are in complex with cAMP. In addition, GAF domains of CyaB2 display some 
structural differences such as presence of an extra loop containing a # helical region 
(Martinez et al., 2005) (Martinez et al., 2002) (Wang et al., 2010). Thus, the 
differences in structures with the conserved global domain fold will allow assimilation 
of regulatory signals to modulate the effector domain through GAF domain to which 
they are associated with.  
The product of the reaction of the adenylyl cyclase, cAMP, stimulates the 
cyaB2 adenylyl cyclase activity. This regulation is achieved by binding of cyclic 
nucleotide at cyaB2 B-domain and signaling to the catalytic domain (Bruder et al., 
2005). Interestingly, a chimera of AC consisting of cyaB1 catalytic domain and 
mammalian PDE2 GAF domain is able to activate cyclase activity in cGMP 
dependent manner. This suggests that the tandem GAF domains in the mammalian 
PDEs and the cyanobacteria ACs which are separated by at least 2 billion years are 
able to share a common mechanism for regulation of enzymatic activities. 
Furthermore, chimeras of the GAF domains from PDE2 (Linder et al., 2007), PDE5 
(Bruder et al., 2006), PDE10 and PDE11 (Gross-Langenhoff et al., 2006) with the 
CyaB2 adenylyl cyclase domain were also able to regulate adenylyl cyclase activity in 
GAF-specific ligand dependent manner, suggesting that all GAF domains may utilize 
a common structural mechanism to regulate the activity of associated effector proteins. 
Availability of crystal and NMR structures addressed several questions related 
to the architecture of these domains but the questions like mechanistic basis for 
nucleotide selectivity of some GAF domains are unanswered. As mentioned earlier 
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substitution of cyaB1 GAF B domain with PDE2 GAF domain enhanced cGMP 
mediated adenylyl cyclase activity. Whereas, the converse experiment with cyaB1 
GAF-B domain to PDE2 GAF was not able to display altered specificity (Linder et al., 
2007). In addition, mutational studies of D164 in the GAF A domain of PDE5 
completely switches its selectivity from cAMP to cGMP (Heikaus et al., 2008) 
whereas, mutation of other residues within ligand binding site (e.g. F195A) reduces or 
abolishes cGMP binding (Sopory et al., 2003). Structures of GAF domains bound to 
cyclic nucleotides revealed an invariant pattern of helix dipole-cyclic phosphate 
interaction and hydrophobic interactions. However, there is no absolute consensus 
regarding Hydrogen-bond networks between protein and ligand. In addition, available 
structures also revealed that ligand can bind in various ways with protein with high 
affinity. In our study, we have monitored structural changes associated with cyclic 
nucleotide binding on GAF domain using HDX. Our results show that cAMP and 
cGMP induce distinct structural changes upon binding conserved structure fold of 
GAF domain.  
4.2 Materials and Methods 
4.2.1. Reagents 
TALON metal affinity resin was from Clontech laboratories (Mountain View, CA). 8-
Bromoadenosine- 3`, 5`- cyclic monophosphorothioate, Rp-isomer, cAMP and 8- 
Bromoadenosine- 3`, 5`- cyclic monophosphorothioate, Sp-isomer were from Biolog 
Life Science Institute (Bremen,Germany). Poroszyme-immobilized pepsin cartridge 
was from Applied Biosystems (Foster city, CA). Deuterium oxide (D2O) and protein 
sequence analysis grade trifluoroacetic acid were from Fluka BioChemika (Buchs, 
Switzerland). All other reagents were reagent grade. 
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4.2.2. Expression and Purification of N-terminal hexahistidine tagged GAF-B 
domain: 
GAF B-domain with an N-terminal hexahistidine tag was expressed in cyclase& cells 
and purified using the Talon resin as per manufacturer’s specifications. Large-scale 
expression was achieved by inducing cells with 500 mM IPTG. Cells were harvested 
at 6000 ' g (Beckman Coulter JA-10 rotor) for 20 min and the cell pellet was 
resuspended in lysis buffer [20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 5 mM %-
mercaptoethanol, 5 mM imidazole and EDTA free protease inhibitor tablet (Roche)]. 
Bacterial cells expressing GAF-B domain with an N-terminal hexahistidine tag were 
lysed by a sonicator (Misonix) and centrifuged at 17,000 ' g (Sigma, Sartorius, 
19776-H rotor,) at 4 °C for 40 min and the supernatant was incubated with talon resin 
at 4 °C for 1 h. The resin was then transferred into columns (Bio Rad). Washes were 
performed with both lysis buffer and wash buffer (Lysis buffer with 10mM imidazole) 
followed by elution buffer containing lysis buffer with 150 mM imidazole. Further 
purification was achieved by size-exclusion chromatography [S200 column, AKTA 
system (GE Healthcare)]. 
4.2.3. Amide hydrogen/deuterium exchange mass spectrometry of GAF-B: 
The cAMP-free GAF-B domain purified by size exclusion chromatography was 
concentrated to 50 µM using vivaspin concentrators (Sartorius Stedim Biotech GmbH, 
Goettingen, Germany). Samples were prepared by adding 1 mM cAMP, cGMP, Rp 
and Sp each to 50 mM apo GAF-B domain protein. 2 µl each of apo, cAMP-, Rp- and 
Sp- bound GAF-B domain in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl and 5 mM 
buffer were diluted and incubated with 18 µL of D2O (99.90%) resulting in a final 
deuterium concentration of 90%. HDX was carried out at 20 °C for various time 
points (0.5, 1, 2, 5 and 10min). The exchange reaction was quenched by adding 40 µl 
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of prechilled quench buffer (0.1% TFA) to get a final pH read of 2.5. A 50 µl aliquot 
of the quenched sample was then injected on to a chilled nanoUPLC sample manager 
(beta test version, Waters, Milford, MA) as previously described (Wales et al., 2008). 
The sample was washed through a 2.1 ' 30 mm immobilized pepsin column 
(Porozyme, ABI, Foster City, CA) using 100 µl/min 0.05% formic acid in water. 
Digested peptides were trapped on a 2.1 ' 5 mm C18 trap (ACQUITY BEH C18 
VanGuard precolumn, 1.7 µm resin, Waters, Milford, MA). The peptides were eluted 
using an 8%– 40% gradient of acetonitrile in 0.1% formic acid at 40 µl/min, which 
was supplied by a nanoACQUITY Binary Solvent Manager onto a reverse phase 
column (Acquity UPLC BEH C18 column, 1.0 ' 100 mm, 1.7 µm, Waters, Milford, 
MA). Peptides were detected and mass was measured on a Synapt HDMS mass 
spectrometer (Waters, Manchester, UK) acquiring in the MSE mode, a nonbiased, 
nonselective CID method (Bateman et al., 2002) (Silva et al., 2005) (Shen et al., 
2009) (Li et al., 2009). 
 Sequence identifications were made from MSE data from undeuterated samples 
using ProteinLynx Global Server 2.4 (beta test version) (Waters, Milford, MA) (Li et 
al., 2009) (Geromanos et al., 2009) and searched against sequence of GAF-B domain 
with no enzyme specified and no modifications of amino acids. Identifications were 
only considered if they appeared at least twice out of three replicate runs. The 
precursor ion mass tolerance was set at <10 ppm and fragment ion tolerance was set at 
<20 ppm. Only those peptides that satisfied the above criteria through Database search 
pass 1 were selected and are listed in Table 4.1 (Li et al., 2009). The default criterion 
for false positive identification (Value = 4) was applied. These results showed that 
MSE data searched with PLGS 2.4 maximized identification of peptides and were used 
for deuterium exchange analysis. These identifications were mapped to subsequent 
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deuteration experiments using prototype custom software (HDX browser, Waters, 
Milford). Data on each individual peptide at all time points were extracted using this 
software, and exported to HX-Express (Weis et al., 2006) for analysis. A total number 













Continuous instrument calibration was carried out with Glu-fibrinogen peptide at 100 
fmol/µl. We also visually analyzed the data to ensure only well resolved peptide 
isotopic envelopes were subjected to quantitative analysis. A control experiment was 
carried out to calculate the deuterium back exchange loss during the experiment by 
incubating ligand-free protein kinase A regulatory subunit for 24 h at room 
temperature. All reported deuterium exchange values were corrected for a 32.7% back 












Figure 4.1: Sequence coverage map of GAF-B domain. Primary amino acid 
sequence of GAF-B (273 – 431) from N-terminal to C-terminal. Solid line denotes 





Although crystal structures of the tandem GAF domains from cycnobacterial adenylyl 
cyclase are available, questions like ligand specificity and activation mechanism of 
these domains remains unclear. To probe the ligand specificity and conformational 
dynamics of the GAF-B domain in ligand mediated activation, we carried out HDX 
experiments of apo, cAMP and cGMP bound GAF-B. Furthermore, to determine the 
role of equatorial and axial oxygen of cyclic nucleotides, we extended our study using 
Rp and Sp bound GAF-B. His6 - GAF-B yielded primary sequence coverage of ~96% 
(Figure 4.1). Subtractive analysis of overlapping peptides of His6 - GAF-B allowed us 
to monitor the importance of crucial residues with improved resolution. 
Our HDX results reveal GAF-B protein to be highly dynamic and 
conformationally flexible in the absence of ligand. To understand the structural 
features of apo GAF-B, we have campared the relative deuteration after 10 min across 
the entire GAF-B apo protein. Peptides at C-terminal half (#5 helix (423-430), (423-
431) and (424-431)) showed highest number of amides exchanged, with peptide (423-
431) showing almost ~90% of amide hydrogen atoms exchanged. In addition, 
peptides (273-285), (273-289), (273-296) and (277-289) at #2 helix, #2 – %1 loop, and 
%1 sheet displayed ( 50% of amide hydrogens. Ligand binding site of GAF-B domain 
spanning, #4 helix, a number of peptides (344-360), (344-363) and (344-366) 
displayed exchange 31 to 40% consistent with ligand free apo. In addition, peptides at 
#3 helix (305-331), (318-331) and (318-343) also showed 41 to 48% exchange. Least 
exchange was observed at peptide (331-343) (Table 4.1).  
4.3.1. cAMP mediated changes in GAF-B domain structure: 
Binding of cAMP induced a global decrease in the HDX of the GAF-B domain. None 
of the peptides of GAF-B domain showed increase in exchange upon cAMP binding. 
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A number of residues involved in interaction with ligand showed a decrease in HDX 
compared to apo protein. For example, peptides (305-331), (318-331) and (318-343) 
spanning the #3 helix displayed a decrease in exchange in the presence of cAMP 
(Figure 4.2 and Figure 4.3). Importantly, peptide (305-317) spanning the part of %1 
and %2 sheets and %1-%2 loop showed lower exchange in the presence of cAMP. The 
peptide (305-317) contains two residues that are important for interaction with cAMP. 
They are Ile 308 and Thr 309. Thr 309 interacts with N6 of cAMP forming H-bond 
through carbonyl back bone. In addition, a large decrease in exchange of the peptide 
(305-331) and (318-331) while significant but comparatively less exchange in peptide 
(305-317) and (318-326) suggests that major changes are contributed from 
interactions mediated by the residues 327 to 331. These residues form part of the #3 
helix, which stabilizes the negatively charged cyclic phosphate moiety of cAMP 
through its positively charged dipole. This common interaction is seen in GAF 
domains unlike PKA in which cyclic phosphate is stabilized by electrostatic and H-
bond formation between cAMP and conserved residues of the protein. In addition, 
equatorial and axial oxygen of cAMP form H-bonds with consecutive residues namely, 
Phe 326 and Ala 327. Thus, the highly exchangeable #3 helix in apo protein showed a 
drastic decrease in their exchange profile upon binding of cAMP (Figure 4.2 and 
Figure 4.3). 
From the crystal structures of tandem GAF domain it has been clear that #4 
helix acts as a ‘lid’ for ligand binding pocket (Martinez, Bruder et al. 2005). In 
consistent with the crystal structure, peptides (344-360), (344-363) and (344-366) 
spanning #4 helix displayed a decrease in exchange in presence of cAMP (Figure 4.2 
and figure 4.3). These peptides harbor two important residues namely, Thr 351 and 
Ala 252. Thr 351 and Ala 252 through their backbone amides position a water 
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molecule which in turn is H-bonded to phosphate oxygen of cAMP. Thus, shielding of 
these two amides resulted in decrease of ~1.5 (obtained by subtractive analysis 
between (344-366) and (355-366)) deuterons in presence of cAMP. A reduction (~2) 
of exchange observed in peptides (344-360) indicates that residues Gln 358, Asn 359 
and Gly 360 are shielded from the solvent on cAMP binding. This is consistent with 





















































































































Figure 4.2: A) ESI-QTOF mass spectra for 2 different pepsin digest fragments of 
GAF-B domain, which showed significant difference upon cAMP/cGMP binding. 
Comparison of HDX in the apo, ligand bound states. (i) The isotopic envelope for the 
same peptide from cGMP bound GAF-B domain following 10 min deuteration; (ii) 
The isotopic envelop for the same peptide from cAMP bound GAF-B domain 
following 10min deuteration; (iii) The isotopic envelope for the same peptide from Sp 
bound following 10 min deuteration; (iv) The isotopic envelope for the same peptide 
from Rp bound GAF-B domain following 10min deuteration; (v) The isotopic 
envelope for the same peptide from apo GAF-B domain (vi) Undeuterated apo GAF-
B. The peptides are m/z = 699.44, z=3, GAF-B domain (318-331); m/z = 871.06, z = 
3, GAF-B domain (344-366). B) Time course (0.5-10min) of deuterium exchange for 
peptides [(318-331) and (344-366)]. The isotopic envelope for the same peptide from 
cGMP bound GAF-B domain. Closed circle (!), apo GAF-B; Closed Square ("), 
cAMP-bound GAF-B and Closed triangle ()) for cGMP-bound GAF-B. 
 
132 
Decreased exchange was observed at N-terminal region of the GAF-B domain in 
presence of cAMP. Peptides (273-285), (273-289) and (273-296) spanning #2, #2-%1 
loop and %1 sheet at N-terminal domain, displayed a large decrease in exchange 
(Figure 4.3 and Table 4.1). Subtractive analysis between (273-296) and (286-296) 
have shown that the reduction in exchange can be localized to residues from Glu 273 
to Glu 285 and spanning #2 helix.  
Peptides (286-294), (286-296) and (288-296) spanning %1 sheet of the GAF-B 
domain consists of three residues involved in interaction with cAMP in crystal 
structure. For example, Arg 291 H-bonds with N1 of cAMP, Thr 293 with N6 of 
cAMP and Trp 295 provides hydrophobic interaction to C5` of cAMP, provide 3 out 
of 17 residues that interact with cAMP. There is no change in exchange at these three 















Figure 4.3: Structure of cAMP bound GAF-B domain highlighting the regions showing 
reduction in deuterium exchange (blue) in the presence of cAMP. Grey depicts no 




Highly exchanging peptides (385-407) and (385-408) in the apo protein spanning the  
unique %6-#5 loop displayed a less but significant (~0.5) decrease in exchange (Table 
4.1). This is consistent with the prediction from the crystal structure that the highly 
flexible loop becomes more ordered in presence of ligand. However, short 
overlapping peptides (385-400), (385-401) and (385-404) do not show any change in 
exchange indicating that the decrease in exchange raised from the residues Pro 405 
and Phe 408. Significantly, there is no change in the hydrogen exchange of the highly 
exchanging (~90%) #5 helix observed implying that this region is not altered by 
binding of cAMP (Figure 4.3 and Table 4.1) . 
4.3.2. Cyclic GMP mediated changes in GAF-B domain structure: 
After delineating the exchange studies on the structural features of GAF-B domain in 
the presence of its ‘preferred ligand’, we set out experiments to determine the cGMP 
mediated changes. Detailed analysis of the exchange profile in presence of cAMP or 
cGMP made us understand the similarities and differences between these ligand 
bound structures. 
Decrease in the exchange observed in peptides (305-317), (305-331), (318-
326) and (318-331) spanning #3 helix of the protein suggest cAMP stabilized by #3 
dipole interaction. This trend is similar to cAMP bound GAF-B domain. Peptide (305-
317) spanning %1 and %1-%2 loop from cGMP bound state showed a decrease in 
exchange similar to cAMP bound state (Figure 4.2, 4.4 and Table 4.1). Further, the 
HDX profile of peptides spanning #4 helix also displayed a trend similar to cAMP 
bound state. Peptides (273-285), (273-289) and (273-296) spanning #2, #2-%1 loop 
and %1 sheet showed a large decrease in exchange profile upon binding of cGMP in a 
similar manner with cAMP (Figure 4.3 and Table 1). Thus, it is evident that there are 
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no global differences in conformational changes mediated by cAMP or cGMP binding 
to GAF-B domain. 
 
However, close examination of the exchange profile of some peptides 
displayed a number of differences. Most of the peptides have shown a greater 
reduction in exchange pattern in cGMP bound state compared to cAMP bound state. 
These peptides include ligand binding pocket of the protein (305-331), (318-331), 
(318-343), (329-366), (344-360), (344-363) and (344-366) (Table 4.1). Interestingly, 
highly exchangeable amide in apo (~90%) showed no change in cAMP bound state; 
whereas cGMP bound state displayed a decrease in exchange. For example, three 
overlapping peptides (423-431), (423-431) and (424-431) spanning the highly 













Figure 4.4: Structure of cAMP bound GAF-B domain highlighting the regions 
showing reduction in deuterium exchange (blue) in the presence of cGMP. Grey 





bound state (Figure 4.4 and Table 4.1). Subtractive analysis at this region showed 
decreased exchange, spanning residues Val 429 to Leu 431, present at C-terminal end 
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273-285 EDTLKRVMDEAKE,782.38 (+2) 12 6.2 ± 0.1 4.3 ± 0.1 3.8 ± 0.2 6.8 ± 0.1 6.5 ± 0.1 
273-289 EDTLKRVMDEAKELMNA,664.99 (+3)  16 9.1 ± 0.1 0.0 5.1 ± 0.2 8.8 ± 0.1 8.5 ± 0.1 
273-296 EDTLKRVMDEAKELMNADRSTLWL,716.86 (+4)  23 12.5 ± 0.2 9.1 ± 0.3 8.8 ± 0.3 11.6 ± 0.1 11.2 ± 0.0 
277-289 KRVMDEAKELMNA,767.89 (+2)  12 6.3 ± 0.2 3.4 ± 0.1 3.1 ± 0.2 5.5 ± 0.1 5.4 ± 0.1 
283-288 AKELMN,705.37 (+1)  5 1.2 ± 0.0 1.0 ± 0.0 0.8 ± 0.1 1.1 ± 0.1 0.6 ± 0.0 
286-294 LMNADRSTL,1020.51 (+1)  8 1.8 ± 0.1 1.5 ± 0.1 1.4 ± 0.1 1.8 ± 0.1 1.6 ± 0.1 
286-296 LMNADRSTLWL,660.35 (+2)  10 1.8 ± 0.0 1.7 ± 0.0 1.6 ± 0.0 1.9 ± 0.1 1.7 ± 0.1 
288-296 NADRSTLWL,1075.56 (+1) 8 1.4 ± 0.0 1.4 ± 0.2 1.2 ± 0.1 1.4 ± 0.1 1.3 ± 0.2 
289-305 ADRSTLWLIDRDRHELW,728.04 (+3)  16 2.9 ± 0.2 2.9 ± 0.1 2.9 ± 0.1 3.3 ± 0.1 2.5 ± 0.0 
295-304 WLIDRDRHEL,676.85 (+2)  9 0.6 ± 0.0 0.0 0.0 0.4 ± 0.0 0.2 ± 0.0 
297-304 IDRDRHEL,1053.54 (+1)  7 1.1 ± 0.0 0.5 ± 0.0 0.4 ± 0.0 0.7 ± 0.0 0.3 ± 0.0 
305-317 WTKITQDNGSTKE,754.37 (+2) 12 1.6 ± 0.0 1.0 ± 0.1 0.8 ± 0.0 1.7 ± 0.2 1.2 ± 0.1 
305-331 WTKITQDNGSTKELRVPIGKGFAGIVA,722.40 (+4)  26 12.3 ± 0.0 10.5 ± 0.5 8.8 ± 0.1 11.0 ± 0.6 10.9 ± 0.1 
318-326 LRVPIGKGF,986.61 (+1)  7 1.3 ± 0.1 0.7 ± 0.1 0.4 ± 0.1 0.0 0.0 
318-331 LRVPIGKGFAGIVA,699.44 (+2)  12 4.9 ± 0.1 3.7 ± 0.1 2.9 ± 0.1 3.9 ± 0.1 4.0 ± 0.1 
318-343 LRVPIGKGFAGIVAASGQKLNIPFDL,894.52 (+3)  23 9.5 ± 0.1 7.5 ± 0.0 6.6 ± 0.1 8.0 ± 0.2 8.0 ± 0.1 
329-343 IVAASGQKLNIPFDL,793.45 (+2) 13 1.9 ± 0.0 1.0 ± 0.1 1.0 ± 0.1 1.8 ± 0.1 1.6 ± 0.1 
331-343 AASGQKLNIPFDL,687.38 (+2)  11 0.5 ± 0.1 0.3 ± 0.0 0.2 ± 0.0 0.5 ± 0.1 0.3 ± 0.0 
341-347 FDLYDHP,906.40 (+1)  5 2.0 ± 0.1 0.0  1.6 ± 0.1 2.0 ± 0.0 1.6 ± 0.0 
344-360 YDHPDSATAKQIDQQNG,944.43 (+2)  15 5.2 ± 0.0 3.4 ± 0.0 2.5 ± 0.1 4.5 ± 0.1 5.1 ± 0.1 
344-363 YDHPDSATAKQIDQQNGYRT,770.02 (+3) 18 6.5 ± 0.1 4.4 ± 0.1 3.3 ± 0.1 5.3 ± 0.4 5.7 ± 0.1 
344-366 YDHPDSATAKQIDQQNGYRTCSL,871.06 (+3) 21 8.0 ± 0.1 5.7 ± 0.1 4.7 ± 0.1 6.3 ± 0.1 7.2 ± 0.1 
355-366 IDQQNGYRTCSL,699.33 (+2)  11 2.2 ± 0.0 1.3 ± 0.1 1.1 ± 0.0 1.7 ± 0.2 1.9 ± 0.0 
367-378 LCMPVFNGDQEL,683.31 (+2)  10 2.3 ± 0.1 2.0 ± 0.0 2.0 ± 0.1 0.0 0.0 
4.1 Summary of amide H/D exchange for apo and ligand bound states of GAF-B domain. 
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370-378 PVFNGDQEL,1018.48 (+1)  8 3.1 ± 0.0 3.0 ± 0.1 2.8 ± 0.1 3.8 ± 0.1 3.4 ± 0.0 
370-380 PVFNGDQELIG,594.80 (+2)  10 1.7 ± 0.1 1.6 ± 0.0 1.4 ± 0.0 1.7 ± 0.1 1.5 ± 0.1 
379-408 IGVTQLVNKKKTGEFPPYNPETWPIAPECF,1135.26 (+3) 24 10.3 ± 0.1 10.0 ± 0.0 9.8 ± 0.1 10.4 ± 0.2 9.8 ± 0.1 
385-400 VNKKKTGEFPPYNPET,924.97 (+2)  12 2.0 ± 0.1 1.8 ± 0.1 1.9 ± 0.0 2.2 ± 0.1 1.6 ± 0.0 
385-401 VNKKKTGEFPPYNPETW,679.01 (+3)  13 2.7 ± 0.1 2.7 ± 0.1 2.7 ± 0.0 3.1 ± 0.1 2.4 ± 0.1 
385-404 VNKKKTGEFPPYNPETWPIA,772.74 (+3)  15 3.5 ± 0.1 3.4 ± 0.1 3.3 ± 0.1 3.8 ± 0.1 3.1 ± 0.1 
385-407 VNKKKTGEFPPYNPETWPIAPEC,882.44 (+3)  17 5.5 ± 0.1 4.8 ± 0.1 4.7 ± 0.1 6.0 ± 0.3 5.1 ± 0.1 
385-408 VNKKKTGEFPPYNPETWPIAPECF,931.47 (+3) 18 8.3 ± 0.0 7.7 ± 0.1 7.3 ± 0.0 8.7 ± 0.2 8.0 ± 0.1 
413-419 DRNDEEF,924.36 (+1)  6 0.6 ± 0.0 0.8 ± 0.0 0.5 ± 0.2 1.0 ± 0.0 0.8 ± 0.0 
413-420 DRNDEEFM,1055.41 (+1)  7 0.6 ± 0.0 0.7 ± 0.2 0.3 ± 0.2 1.1 ± 0.1 0.6 ± 0.1 
423-428 FNIQAG,649.33 (+1)  5 3.0 ± 0.1 3.1 ± 0.1 2.9 ± 0.1 3.3 ± 0.1 3.0 ± 0.0 
423-430 FNIQAGVA,819.43 (+1)  7 5.6 ± 0.1 5.6 ± 0.1 5.1 ± 0.0 6.0 ± 0.1 5.7 ± 0.1 
423-431 FNIQAGVAL,932.52 (+1)  8 6.9 ± 0.1 6.8 ± 0.1 6.0 ± 0.2 7.1 ± 0.1 6.9 ± 0.0 
424-431 NIQAGVAL,785.45 (+1) 7 5.5 ± 0.0 5.5 ± 0.0 5.0 ± 0.1 5.6 ± 0.1 5.4 ± 0.0 
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4.3.3 Sp and Rp mediated changes in GAF-B domain structure:   
We have also performed experiments with stereospecific analogs (Rp and Sp) of 
cAMP to delineate the importance of equatorial and axial oxygens of cAMP. Crystal 
structure of tandem GAF domains has revealed that negative charge of the cyclic 
phosphate is stabilized by positive charge of the helix dipole !3. Our HDX results of  
Sp, Rp bound GAF-B domain showed that Phe 326 and Ala 327 residues containing 
peptides such as (305-331), (318-331) and (318-343) displayed lower HDX upon 
binding to GAF-B domain. This is consistent with cAMP and cGMP (Table 4.1), 
suggesting that dipole interaction between analogs and !3 helix of the protein is 
retained. In addition, the exchange profile of peptides covering !4 helix also 
displayed a decrease in exchange in presence of Sp or Rp. This trend is similar to that 
seen in both cAMP and cGMP. Peptides (273-296) and (277-289) also followed the 
similar trend like cAMP and cGMP in analog bound states, but overlapping peptides 
displayed no or less change. Thus, it appears that conformational changes associated 
with binding of ligands are broadly similar in all ligand bound states (Table 4.1).  
Strikingly, a careful analysis of the exchange profile of Sp and Rp bound 
states revealed a number of differences from natural ligands. Though, there is a 
reduction in exchange upon ligand binding, stereospecific analogs display an 
intermediate exchange pattern between apo and natural ligand bound states (Table 
4.1). For instance, peptides (305-331), (318-331), (318-343), (344-360), (344-363) 
and (344-366) that are part of ligand binding pocket (Table 4.1). Similar pattern was 
observed on peptides (273-296) and (277-289) at !2 helix and "1 sheet region of the 
protein. In addition, the magnitude of decrease of exchange profile is less and also 
high exchange profile of stereospecific ligands throughout the protein suggests a 
weaker interaction between GAF-B and stereospecific ligands. 
 
139 
 In addition to the similarities and differences of stereospecific ligand bound 
states with natural ligand bound states, Sp and Rp bound states also reveal similarities 
and differences between themselves. Compared to Sp bound state, Rp bound GAF-B 
domain displayed a lower exchange through out the protein except at !4 helix 
containing peptides (344-360), (344-363) and (344-366) (Table 4.1). Notably, Sp 
bound GAF-B domain showed slight increase (~0.5) in exchange compared to apo 
and all ligand bound states at "6 – !5 loop of the protein, however, no change in 
exchange is observed at this region upon binding of Rp (Table 4.1). 
4.4 Discussion 
All GAF domains bound to cyclic nucleotides adopt a conserved structural fold but 
displays slight differences within the binding pocket architecture which allows a large 
range of nucleotide affinities and specificities. In our study, we used natural ligands 
and stereospecific analogs to delineate nucleotide specificity and mode of binding. 
Our HDX results indicate that GAF-B apo protein is highly dynamic and 
conformationally flexible. Calculation of percentage of deuterons exchanged for apo 
protein displayed that the highest percentage of exchange (~90%) occurred at highly 
flexible C-terminal half of the of the !5 helix of the protein. In GAF-B apo state there 
are three regions showing high exchange in the absence of ligands. These include !2 
helix, !2-"1 loop and "1 sheet displaying maximum exchange (52 -57%); !3 helix of 
GAF-B apo which is the next high exchange region (41-47%); and !4 helix of the 
protein which falls in the low exchange region (35-40%). In addition, "6-!5 loop also 
displays a significant exchange (32-46%). Higher dynamics observed at helices of 
GAF-B domain suggests that the absence of ligand affects the helical region of the 
GAF-B domain fold. This is consistent with the idea that GAF-B domain exists as 
‘open’ conformation in the absence of ligand. This analysis reveals the flexibility of 
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apo protein in the absence of ligand, which is consistent with the available NMR 
structure of PDE5-B apo state (Heikaus et al., 2008). 
4.4.1 Ligand mediated conformational changes: 
Comparative analysis of HDX analysis between apo and ligand bound state revealed 
an interesting feature of ligand mediated conformational changes on GAF-B domain. 
Reduction in dynamics/conformational flexibility of GAF-B apo state upon binding of 
cAMP/cGMP resulted in higher ordering of the protein (Figure 4.3 and 4.4). This 
implies that interaction between cAMP/cGMP and protein leads to changes in 
conformation of the protein for closely wrapped ‘closed’ conformation (~97% of 
ligand buried) in the ligand at ligand binding pocket in contrast to the ‘open’ 
conformation in the absence of ligand (Figure 4.3 and 4.4). Previous H-D data 
suggests that the backbone amides of !3 is  protected compared to !4 helix which is 
more exchangeable, suggesting that !4 is more dynamic in closed cAMP/cGMP 
bound state whereas !3 is in buried position (Heikaus et al., 2008). Our HDX data is 
consistent with NMR data indicating that not only in tandem array GAF but also in 
isolated GAF-B domain, !3 is buried. Significantly, highest difference in exchange 
between apo and ligand bound states was observed at !2, !2-"1 loop and "1 sheet, 
displaying a large decrease upon binding of ligand. Thus, binding of cAMP/cGMP 
induce conformational changes on !4, !3 helices and "2, "3 sheets which results in a 
compact or tighter packing of helix !2 against "1. Indeed, this packing could be 
stabilized by interactions between residues present in !2 and "1 such as Ser 292 
present in "1 and the backbone carbonyl of Met 280 present in !2 helix, elucidated 
from crystal structure of cAMP bound GAF-B domain. These conformational changes 
binding of cAMP/cGMP leads to large rearrangements of secondary structural 
elements, which allows nucleotides to enter and exit the binding pocket.   
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Both cAMP and cGMP displayed a similar global conformation changes upon 
binding. However, close inspection of HDX data pointed out significant differences 
between these two natural ligands. From previous studies, it has been known that Cya 
B2 GAF domains are cAMP-specific and the ‘preferred’ ligand is cAMP. In contrast, 
our HDX results display higher reduction in exchange upon binding of cGMP instead 
of its preferred ligand cAMP. This observation may be due to isolated single domain 
of GAF-B. The absence of GAF-A domain provides additional elements for GAF-B 
to interact with cGMP, presumably no need to stabilize dimerization interface and 
overall fold of the protein. In addition, the absence of GAF-A might lead to loss of 
regulatory elements which determine the entry of cGMP and moreover, the 
substitution of cAMP with cGMP provides additional moieties for interacting with the 
protein. High difference in reduction between cAMP bound state and cGMP bound 
state is observed at !3, !4 helices compared to !2 helix (Figure 4.3 and 4.4). The 
striking difference between cAMP bound state and cGMP bound state is shown at C-
terminal !5 helix with cGMP bound state displaying additional protection whereas no 
significant change is observed in amide hydrogen exchange in cAMP bound state. 
Such conformational changes are associated with cGMP alone and are cGMP specific 
(Figure 4.4).  
The NKFDE motif is highly invariant in cyclic nucleotide binding GAF 
domains and thought to be involved in direct ligand binding (Charbonneau et al., 
1990) (Turko et al., 1996). (Berman et al., 2005). Crystal structure of the cyclic 
nucleotide binding GAF domain structures revealed that none of the residues of the 
motif directly interact with the ligand. This suggests that NKFDE motif is required for 
the transmission of allosteric signal of ligand binding to the GAF domain to the 
associated catalytic domain. Our HDX result shows that there is no significant change 
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in the exchange of all the peptides containing these residues. Absence of change 
indicates that binding of cAMP molecule does not alter the HDX and hence it appears 
that NKFDE motif is important for stabilization of the GAF domain fold. 
4.4.2 Importance of equatorial and axial oxygens:    
Our HDX experiments with Sp and Rp analogs have shown that stereo specific 
analogs also induce similar conformational signature like natural ligand bound states. 
Though Sp/Rp bound states displayed similar conformational changes, detailed 
analysis have shown that the magnitude of exchange upon binding of Sp/Rp is very 
less in comparison with cAMP/cGMP bound states. This suggests that the dipole 
interaction between N- terminal !3 helix and cyclic phosphate is effected in presence 
of either equatorial or axial oxygen substituted with sulfur atom. The S-P bond in 
phosphorothioate is more electronegative than the O-P bond of the cAMP, making 
stronger acid relative to cAMP (Frey and Sammons, 1985) (Liang and Allen, 1987) 
(Basch et al., 1991). This reduces the dipole interaction between !3 helix and the 
Sp/Rp leading to disruption of allosteric relay for ligand mediated conformational 
changes. In addition, high HDX throughout the protein in Sp/Rp bound states 
compared to cAMP/cGMP indicates that Sp/Rp bound state is not ordered by ligand 
binding. Furthermore, Sp/Rp bound states displayed increase in exchange pattern at 
"6-!5 loop of the protein suggesting that this region is highly dynamic (Table 4.1).   
 Sp/Rp bound states displayed a similar pattern on global structure of GAF-B 
domain with bound cAMP/cGMP but close inspection revealed quite significant 
differences between themselves. The !4 helix of the GAF-B domain displayed a 
difference in exchange pattern for both Sp and Rp bound states (Table 4.1). Sp bound 
state has showed reduction in exchange upon binding following a trend similar to 
cAMP/cGMP. Whereas, Rp bound state showed low or no exchange indicating that 
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this is a result of sulfur substitution at equatorial position not being able to stabilize 
the protein. 
In summary, our HDX analysis reveals small but crucial differences between 
cGMP and cAMP modes of binding. This will contribute to the absence of ligand 

























We report here the cAMP mediated activation of three proteins from 
eukaryotes to prokaryotes namely, eukaryotic PKA-R, prokaryotic mycobacterial 
MSMEG_5458 and cyanobacterial GAF domains. All these proteins regulate effector 
domain in a cAMP dependent manner to which they are associated with. PKA-R is 
different from MSMEG_5458 and GAF domain in which binding of cAMP leads to 
the dissociation of the effector protein, whereas in MSMEG_5458 and GAF domains, 
the consequence of cAMP removal and binding result in induced conformational 
changes without dissociation of the target domains and proteins (Berman et al., 2005). 
Studies on these cyclic nucleotide binding domains have revealed many characteristic 
features of nucleotide mediated conformational changes of these proteins. 
Though PKA-R and MSMEG_5458 structural folds and amino acid sequence 
of CNBs are similar to each other, but different from the GAF domains, both of these 
display some common features in cAMP mediated conformational change upon 
binding of cAMP. For instance, CNB domains of PKA-R and MSMEG_5458 display 
a high conformational flexibility and dynamics in the absence of ligand. In addition, 
binding of ligand induces structural rearrangements in the secondary structural 
elements of the CNB domain for cAMP entry and exit. Furthermore, cAMP is deeply 
buried in the tightly packed compact CNB domains and is protected from 
phosphodiesterases. Similar trend is also observed in GAF-B domain with and 
without cAMP molecule. Interaction between cAMP and GAF-B domain leads to 
changes in conformation of the protein for closely packed ‘closed’ conformation at 
ligand binding pocket in contrast to the ‘open’ conformation in the absence of ligand. 
Thus, binding of cAMP will leave similar signature of global conformation in PKA, 
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MSMEG_5458 and GAF-B domain but close examination of these individual proteins 
pointed out various differences among themselves. 
Our studies on PKA R-subunit isolated CNB-A domain have revealed 1000-
fold difference in affinity between apo and cAMP bound R subunit for the C-subunit. 
R-subunit exists as ensemble of conformations and binding of cAMP or C-subunit 
would then occur through ‘conformational selection’ where cAMP, which is a natural 
ligand, specifically binds to and selects the B-conformation whereas the C-subunit 
binds preferentially to the H-conformation. Thus, the higher affinity of apo R-subunit 
for the C-subunit is entirely due to 'conformational selection'. This was obtained 
based on the studies with natural ligand and its analog Rp. Studies using Rp analog 
indicates that the sulfur substitution at the equatorial oxygen is uniquely important for 
determining the preferred conformation that a ligand can bind. In summary, apo R-
subunit is uniquely poised to interact with all ligands and the C-subunit via 
conformational selection while interconversion of stable end-point conformations as 
seen in the cAMP-dependent activation of PKA holoenzyme is through induced fit.  
We have extended our study from isolated CNB-A to PKA containing tandem 
array of CNBs. Binding of cAMP to CNB-B increases HDX at one of the four sites of 
R–C inter subunit interactions suggesting that conformational changes associated with 
cAMP binding at the CNB-B domain partially disrupt intersubunit interactions 
without leading to dissociation of the C-subunit. In addition, our result also showed 
an increase in exchange upon cAMP binding at two key regions, the !C/C#: A helix 
and the !A:B helix. Both these regions are critical in relaying the effects of cAMP 
binding from CNB-B to CNB-A. The increased exchange in these two regions, 
exclusively in the cAMP-bound to the RI!(92–379)R209K:C holoenzyme but not 
cAMP-bound to RI!(92–379)R209K specifically highlights the role of CNB-B 
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domain in facilitating the cooperative cAMP dependent activation of PKA by 
potentially enhancing affinity of binding of a second molecule of cAMP to CNB-A 
domain. Our results provide unique insights into the role of CNB-B domain and its 
communication with CNB-A domain to allow a coordinated and cooperative 
regulation of PKA where the two domains function as closely coupled rather than 
individual isolated domains.  
With the expertise on eukaryotic PKA, we have set up experiments to study 
the cAMP mediated activation of KATms. As mentioned earlier, all the global 
conformational changes observed on KATms CNB domain followed similar pattern 
as occurred in PKA CNB-A upon binding of cAMP. The only region outside the 
putative CNB domain that showed any differences in deuterium exchange was the 
linker region (residues 153_168). That these changes in the linker region were 
important was also inferred from our BRET analyses. Inaddition, cAMP binding 
enhances the affinity of the enzyme for USP (Fig. 6B), suggesting that activation is at 
least partially through facilitation of substrate/cofactor binding to the enzyme 
catalytic site. Our results suggest Powerful convergence of results from HDXMS and 
BRET reaffirms the complementary power of solution biophysical tools in unraveling 
the mechanistic basis of regulation of proteins, in the absence of high resolution 
structural information.  
We extended our study to a cyclic nucleotide binding domain which is 
different in both structural fold as well as amino acid sequence. Our results imply that 
binding of a ligand leads to high rearrangements in secondary structural elements of 
the protein to conformationally change from ‘open’ to ‘close’ conformation. Our 
experiments with cAMP and cGMP ligand bound states and comparison of these 
states with apo protein elucidated that the extent of closed or compact conformation 
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attained by binding of ligands is huge in cGMP bound state rather than CyaB2 GAF 
domain ‘preferred’ cAMP bound state. In addition, bound cGMP conferred an 
additional conformational change on C-terminal !5 helix region of the protein. This 
change in specificity might be due to the isolated domain. Studies with stereospecific 
analogs revealed that presence of sulfur at either equatorial or axial position was not 
able to order the protein structure and the interaction between these analogs and 
protein was weaker. This was observed clearly from high HDX throughout the protein 






















Structural information obtained by studying the deletion mutants of PKA RI!(91-244), 
RI!($91) and GAF-B domain revealed many insights in cAMP mediated 
conformational changes in isolated domains. However, native construct of these 
proteins will allow us to determine physiologically relevant cAMP mediated 
activation in vivo.  
1. cAMP mediated conformational dynamics of full length RI! dimer and 
holoenzyme formed by RI! dimer and two C- subunit monomers. 
Studies on RI!(91-244) and RI!($91) have unraveled that RI!(91-244) exists as an 
ensemble of conformations and binding of cAMP will lead to ‘B’ conformation and 
binding of C-subunit will sample out ‘H’ conformation. Extension of our study with 
RI!($91) allowed us to understand the cooperativity between two CNB domains and 
role of CNB-B domain in the process of activation. Further studies on full length RI! 
dimer and physiologically relevant holoenzyme will elucidate the mode of 
dimerization. However, we can not get this information by using traditional methods 
like X-ray and NMR because of flexible dimerization domain and large size of the 
protein. HDX experiments with this physiological R-subunit and holoenzyme will 
help us in determining the structure of physiologically relevant holoenzyme. In 
addition, studies using CNB-B specific ligands on these full length proteins will allow 
us to determine step wise activation process and also role of dimerization in the 
process activation. 
2. Elucidation of MSMEG_5458 activation in presence of acetyl-CoA to USP. 
Because of the lack of structural information of the MSMEG_5458, we have modeled 
CNB domain and transferase domain separately using MODELLER and mapped our 
HDX results on it. Lack of continuous full length crystal structure for MSMEG_5458 
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created a barrier to predict cAMP mediated action confidently. Crystallization of full 
length MSMEG_5458 with and with out cAMP and acetyl-CoA will help us 
completely in understanding the cAMP mediated activation of this unique protein. In 
addition, extending our experiments to MSMEG_5458 ortholog Rv0998 obtained 
from pathogenic strain of mycobacteria will help us identify the novel targets for drug 
development. 
3. Structural characterization of physiologically relevant GAF domain of 
cyanobacteria.   
Our results have shown that isolated GAF-B domain of CyaB2 lost its specificity and 
displayed a more compact structure in cGMP bound state compared to cAMP bound 
state. We believe, HDX experiments with tandem array of GAF domains with and 
without cAMP and its comparison with isolated domains will elucidate the ligand 
specificity. Further, HDX experiments with tandem array GAF domains containing 
N-terminal region and comparison with tandem array of GAF domain without N-
terminal region will allow us to understand the role of N-terminal region in activation 
process. Generation of domain specific mutants such as GAF-A and GAF-B domain 
mutants in different constructs which will fail to bind to ligand in one domain where 
as second domain occupied with ligand will reveal allosteric coupling between these 
two domains in the process of activation. In addition, having HDX experimental data 
of the above mentioned constructs will also help us understand role of dimerization 
between these tandem array GAF domains. Extension of these studies to GAF domain 
containing PDEs will help us understand the different mode of dimerization between 
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